{"questions": [{"id": "58ec6eb5eda5a5767200000c", "body": "Is Enlimomab effective for stroke treatment?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/11673584"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "BACKGROUND: There has been recent interest in the possible role of reperfusion-induced inflammation with neuronal injury after stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 135, "offsetInEndSection": 283, "text": "Enlimomab, a murine intercellular adhesion molecule-1 (ICAM-1) antibody, reduces leukocyte adhesion and infarct size in experimental stroke studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 284, "offsetInEndSection": 385, "text": "The purpose of the current clinical trial was to evaluate the use of enlimomab after ischemic stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 385, "offsetInEndSection": 545, "text": "METHODS: A total of 625 patients with ischemic stroke were randomized to receive either enlimomab (n = 317) or placebo (n = 308) within 6 hours of stroke onset.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 546, "offsetInEndSection": 578, "text": "Treatment was given over 5 days.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 906, "offsetInEndSection": 1033, "text": "RESULTS: At day 90, the Modified Rankin Scale score was worse in patients treated with enlimomab than with placebo (p = 0.004).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 1034, "offsetInEndSection": 1148, "text": "Fewer patients had symptom-free recovery on enlimomab than placebo (p = 0.004), and more died (22.2 versus 16.2%).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 1149, "offsetInEndSection": 1242, "text": "The negative effect of enlimomab was apparent on days 5, 30, and 90 of treatment (p = 0.005).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}, {"offsetInBeginSection": 1243, "offsetInEndSection": 1358, "text": "There were significantly more adverse events with enlimomab treatment than placebo, primarily infections and fever.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584"}]}, {"id": "5a885add61bb38fb24000017", "body": "What is the H4S47C cleavage mapping method used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24737863", "http://www.ncbi.nlm.nih.gov/pubmed/25491770", "http://www.ncbi.nlm.nih.gov/pubmed/26275423"], "snippets": [{"offsetInBeginSection": 708, "offsetInEndSection": 939, "text": "Chromatin immunoprecipitation mapping of selected nucleosome remodelers indicated that asymmetric nucleosomes are bound by the RSC chromatin remodeling complex, which is required for maintaining nucleosomes at asymmetric positions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770"}, {"offsetInBeginSection": 439, "offsetInEndSection": 707, "text": "Micrococcal nuclease (MNase) sequence-based profiles of asymmetric nucleosome positions revealed a corresponding asymmetry in MNase protection near the dyad axis, suggesting that the loss of DNA contacts around H4S47 is accompanied by protection of the DNA from MNase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770"}, {"offsetInBeginSection": 164, "offsetInEndSection": 327, "text": "To map fission yeast centromeres, we applied H4S47C-anchored cleavage mapping and native and cross-linked chromatin immunoprecipitation with paired-end sequencing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275423"}]}, {"id": "5ac725250340b9f058000006", "body": "Which miRNA is associated with the circular RNA ciRS-7?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24014594", "http://www.ncbi.nlm.nih.gov/pubmed/23446346", "http://www.ncbi.nlm.nih.gov/pubmed/25873049", "http://www.ncbi.nlm.nih.gov/pubmed/27929395"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 33, "text": "Circular RNA and miR-7 in cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "MicroRNAs (miRNA) play important roles in fine-tuning gene expression and are often deregulated in cancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 107, "offsetInEndSection": 299, "text": "The identification of competing endogenous RNA and circular RNA (circRNA) as important regulators of miRNA activity underscores the increasing complexity of ncRNA-mediated regulatory networks.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 300, "offsetInEndSection": 484, "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 485, "offsetInEndSection": 652, "text": "As miR-7 modulates the expression of several oncogenes, disclosing the regulation of miR-7 activity will likely advance the understanding of various cancer etiologies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 653, "offsetInEndSection": 852, "text": "Here, we review the current knowledge about the ciRS-7/miR-7 axis in cancer-related pathways and discuss possible models explaining the relevance of coexpressing miR-7 along with a circRNA inhibitor.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594"}, {"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Natural RNA circles function as efficient microRNA sponges.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346"}, {"offsetInBeginSection": 179, "offsetInEndSection": 357, "text": "Recently, miRNA activity has been shown to be affected by the presence of miRNA sponge transcripts, the so-called competing endogenous RNA in humans and target mimicry in plants.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346"}, {"offsetInBeginSection": 358, "offsetInEndSection": 450, "text": "We previously identified a highly expressed circular RNA (circRNA) in human and mouse brain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346"}, {"offsetInBeginSection": 451, "offsetInEndSection": 578, "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346"}]}, {"id": "5aae6a86fcf456587200000e", "body": "What are the 3 types of ultraviolet (UV) solar radiation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25040832", "http://www.ncbi.nlm.nih.gov/pubmed/20519675", "http://www.ncbi.nlm.nih.gov/pubmed/17204418", "http://www.ncbi.nlm.nih.gov/pubmed/12821280", "http://www.ncbi.nlm.nih.gov/pubmed/9577442", "http://www.ncbi.nlm.nih.gov/pubmed/22268421", "http://www.ncbi.nlm.nih.gov/pubmed/21192130", "http://www.ncbi.nlm.nih.gov/pubmed/11920550", "http://www.ncbi.nlm.nih.gov/pubmed/22163847", "http://www.ncbi.nlm.nih.gov/pubmed/16897517"], "snippets": [{"offsetInBeginSection": 95, "offsetInEndSection": 205, "text": "One large group of phenolics, flavonoids, is considered particularly responsive to ultraviolet (UV) radiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832"}, {"offsetInBeginSection": 372, "offsetInEndSection": 490, "text": "Meteor) outdoors, in Finland during the summer, under five types of filters differing in their spectral transmittance.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832"}, {"offsetInBeginSection": 491, "offsetInEndSection": 565, "text": "These filters were used to (1) attenuate UV-B; (2) attenuate UV-B and UV-A", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832"}, {"offsetInBeginSection": 0, "offsetInEndSection": 111, "text": "Effects of solar UV-A and UV-B radiation on gene expression and phenolic accumulation in Betula pendula leaves.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519675"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "Ultraviolet (UV) radiation is an important environmental factor for plant communities; however, plant responses to solar UV are not fully understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519675"}, {"offsetInBeginSection": 150, "offsetInEndSection": 364, "text": "Here, we report differential effects of solar UV-A and UV-B radiation on the expression of flavonoid pathway genes and phenolic accumulation in leaves of Betula pendula Roth (silver birch) seedlings grown outdoors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519675"}, {"offsetInBeginSection": 1101, "offsetInEndSection": 1255, "text": "Our findings in silver birch contribute to a more detailed understanding of plant responses to solar UV radiation at both molecular and metabolite levels.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519675"}, {"offsetInBeginSection": 0, "offsetInEndSection": 259, "text": "Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418"}, {"offsetInBeginSection": 126, "offsetInEndSection": 415, "text": "We have shown that patients that have to protect themselves against solar UV radiation for medical reasons, including patients with xeroderma pigmentosum (XP), basal cell nevus syndrome (BCNS), lupus erythematodes (LE) or transplant recipients, are at risk to develop vitamin D deficiency.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418"}, {"offsetInBeginSection": 416, "offsetInEndSection": 610, "text": "We conclude that 25-hydroxyvitamin D serum levels as a measure of vitamin D status have to be analyzed in patients that have to protect themselves against solar UV radiation for medical reasons.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418"}]}, {"id": "5ac08fe7d0c506ce46000003", "body": "Of what origin is the MCF-7 cell line?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21116879", "http://www.ncbi.nlm.nih.gov/pubmed/176383", "http://www.ncbi.nlm.nih.gov/pubmed/15183541", "http://www.ncbi.nlm.nih.gov/pubmed/16158200", "http://www.ncbi.nlm.nih.gov/pubmed/25725141", "http://www.ncbi.nlm.nih.gov/pubmed/7604203", "http://www.ncbi.nlm.nih.gov/pubmed/25733816"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 146, "text": "MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 0, "offsetInEndSection": 107, "text": "MCF-7/ADR cells have been widely used as a multidrug-resistant breast cancer cell model in cancer research.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 108, "offsetInEndSection": 221, "text": "The origin of MCF-7/ADR has been a matter of debate since MCF-7/ADR cells were re-designated NCI/ADR-RES in 1998.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 222, "offsetInEndSection": 327, "text": "Many recent studies still describe MCF-7/ADR cells as originating from the breast cancer cell line MCF-7.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 328, "offsetInEndSection": 390, "text": "Thus, the real origin of MCF-7/ADR cells remains more unclear.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 391, "offsetInEndSection": 555, "text": "In this study, a new adriamycin (ADR)-resistant cell line MCF-7/ADR' was reproduced using the same procedure employed during the initial establishment of MCF-7/ADR.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 556, "offsetInEndSection": 838, "text": "Since the MCF-7/ADR' cell line was definitely derived from parental MCF-7 cells, we were able to directly compare these cell lines together with MCF-7/ADR using immunocytochemical, morphological, and consecutive DNA fingerprinting analyses to determine the true origin of MCF-7/ADR.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 1058, "offsetInEndSection": 1188, "text": "With increasing concentrations of ADR, the DNA fingerprints of MCF-7/ADR' cells were always identical to the parental MCF-7 cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 1189, "offsetInEndSection": 1276, "text": "However, the DNA fingerprints of MCF-7/ADR cells did not relate to MCF-7 or MCF-7/ADR'.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}, {"offsetInBeginSection": 1277, "offsetInEndSection": 1352, "text": "MCF-7/ADR and the breast cancer cell line MCF-7 are not of the same origin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879"}]}, {"id": "589a247078275d0c4a000035", "body": "Dinutuximab is used for treatment of which disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26917818", "http://www.ncbi.nlm.nih.gov/pubmed/28389455", "http://www.ncbi.nlm.nih.gov/pubmed/25940913", "http://www.ncbi.nlm.nih.gov/pubmed/26934530", "http://www.ncbi.nlm.nih.gov/pubmed/26891967", "http://www.ncbi.nlm.nih.gov/pubmed/25851859", "http://www.ncbi.nlm.nih.gov/pubmed/28549783", "http://www.ncbi.nlm.nih.gov/pubmed/27456981"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 73, "text": "Dinutuximab: An Anti-GD2 Monoclonal Antibody for High-Risk Neuroblastoma.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 0, "offsetInEndSection": 151, "text": "OBJECTIVE: To review the pharmacology, pharmacokinetics, efficacy, safety, dosage and administration, and formulary considerations for dinutuximab.DATA", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 551, "offsetInEndSection": 659, "text": "SYNTHESIS: High-risk neuroblastoma is primarily a childhood cancer with 5-year survival rates of 40% to 50%.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 660, "offsetInEndSection": 841, "text": "Treatment for high-risk neuroblastoma includes induction chemotherapy, surgery, myeloablative chemotherapy with autologous hematopoietic stem cell transplant, and radiation therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 934, "offsetInEndSection": 1338, "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 1339, "offsetInEndSection": 1466, "text": "In phase III trials, dinutuximab increased 2-year event-free survival and overall survival when compared to standard treatment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 1588, "offsetInEndSection": 1870, "text": "CONCLUSIONS: Dinutuximab is the first anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818"}, {"offsetInBeginSection": 0, "offsetInEndSection": 63, "text": "Dinutuximab for maintenance therapy in pediatric neuroblastoma.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455"}, {"offsetInBeginSection": 625, "offsetInEndSection": 774, "text": "Dinutuximab causes antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity by binding to GD2, a tumor-associated antigen.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455"}, {"offsetInBeginSection": 825, "offsetInEndSection": 988, "text": "CONCLUSION: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455"}]}, {"id": "5ac24c9495d0062724000002", "body": "What is the ChIP-exo method used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28060339", "http://www.ncbi.nlm.nih.gov/pubmed/23026909", "http://www.ncbi.nlm.nih.gov/pubmed/24373287", "http://www.ncbi.nlm.nih.gov/pubmed/25249628", "http://www.ncbi.nlm.nih.gov/pubmed/27246337"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 88, "text": "The ChIP-exo Method: Identifying Protein-DNA Interactions with Near Base Pair Precision.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 0, "offsetInEndSection": 159, "text": "Chromatin immunoprecipitation (ChIP) is an indispensable tool in the fields of epigenetics and gene regulation that isolates specific protein-DNA interactions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 160, "offsetInEndSection": 306, "text": "ChIP coupled to high throughput sequencing (ChIP-seq) is commonly used to determine the genomic location of proteins that interact with chromatin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 307, "offsetInEndSection": 431, "text": "However, ChIP-seq is hampered by relatively low mapping resolution of several hundred base pairs and high background signal.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 432, "offsetInEndSection": 544, "text": "The ChIP-exo method is a refined version of ChIP-seq that substantially improves upon both resolution and noise.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 545, "offsetInEndSection": 775, "text": "The key distinction of the ChIP-exo methodology is the incorporation of lambda exonuclease digestion in the library preparation workflow to effectively footprint the left and right 5' DNA borders of the protein-DNA crosslink site.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 776, "offsetInEndSection": 848, "text": "The ChIP-exo libraries are then subjected to high throughput sequencing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 986, "offsetInEndSection": 1138, "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "ChIP-exo method for identifying genomic location of DNA-binding proteins with near-single-nucleotide accuracy.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909"}, {"offsetInBeginSection": 0, "offsetInEndSection": 171, "text": "This unit describes the ChIP-exo methodology, which combines chromatin immunoprecipitation (ChIP) with lambda exonuclease digestion followed by high-throughput sequencing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909"}]}, {"id": "5a74acd80384be9551000006", "body": "Are AAV vectors considered for the treatment of retinal dystrophies?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21818300", "http://www.ncbi.nlm.nih.gov/pubmed/28596937", "http://www.ncbi.nlm.nih.gov/pubmed/21880665", "http://www.ncbi.nlm.nih.gov/pubmed/19373675", "http://www.ncbi.nlm.nih.gov/pubmed/24327302", "http://www.ncbi.nlm.nih.gov/pubmed/27416076", "http://www.ncbi.nlm.nih.gov/pubmed/27653967", "http://www.ncbi.nlm.nih.gov/pubmed/26609316", "http://www.ncbi.nlm.nih.gov/pubmed/15960597", "http://www.ncbi.nlm.nih.gov/pubmed/26015954"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 55, "text": "MicroRNA-restricted transgene expression in the retina.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300"}, {"offsetInBeginSection": 0, "offsetInEndSection": 164, "text": "BACKGROUND: Gene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300"}, {"offsetInBeginSection": 271, "offsetInEndSection": 502, "text": "Here we evaluated the ability of retinal-expressed microRNAs to restrict AAV-mediated transgene expression to specific retinal cell types that represent the main targets of common inherited blinding conditions.METHODOLOGY/PRINCIPAL", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300"}, {"offsetInBeginSection": 790, "offsetInEndSection": 999, "text": "Our results demonstrate that miR-124 and miR-204 target sequences can efficiently restrict AAV2/5-mediated transgene expression to retinal pigment epithelium and photoreceptors, respectively, in mice and pigs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300"}, {"offsetInBeginSection": 144, "offsetInEndSection": 293, "text": "To develop better treatments for patients, we need to understand how inherited retinal disease mutations result in the dysfunction of photoreceptors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28596937"}, {"offsetInBeginSection": 924, "offsetInEndSection": 1081, "text": "FINDINGS: Ground-breaking advances in differentiation of iPSCs into retinal organoids and methods to derive mature light sensitive photoreceptors from iPSCs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28596937"}, {"offsetInBeginSection": 1082, "offsetInEndSection": 1224, "text": "Furthermore, single AAV systems for in vivo gene editing have been developed which makes retinal in vivo gene editing therapy a real prospect.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28596937"}, {"offsetInBeginSection": 0, "offsetInEndSection": 241, "text": "Defects in the photoreceptor-specific gene aryl hydrocarbon receptor interacting protein-like 1 (Aipl1) are associated with Leber congenital amaurosis (LCA), a childhood blinding disease with early-onset retinal degeneration and vision loss.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665"}, {"offsetInBeginSection": 468, "offsetInEndSection": 654, "text": "Using this model, we evaluated if gene replacement therapy using recent advancements in adeno-associated viral vectors (AAV) provides advantages in preventing rapid retinal degeneration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665"}, {"offsetInBeginSection": 655, "offsetInEndSection": 887, "text": "Specifically, we demonstrated that the novel self-complementary Y733F capsid mutant AAV2/8 (sc-Y733F-AAV) provided greater preservation of photoreceptors and functional vision in Aipl1 null mice compared with single-stranded AAV2/8.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665"}]}, {"id": "5ab2cc66fcf4565872000015", "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18799805", "http://www.ncbi.nlm.nih.gov/pubmed/15726657", "http://www.ncbi.nlm.nih.gov/pubmed/10620362", "http://www.ncbi.nlm.nih.gov/pubmed/23071008", "http://www.ncbi.nlm.nih.gov/pubmed/23974699", "http://www.ncbi.nlm.nih.gov/pubmed/11090943", "http://www.ncbi.nlm.nih.gov/pubmed/9413920", "http://www.ncbi.nlm.nih.gov/pubmed/10628745", "http://www.ncbi.nlm.nih.gov/pubmed/16432264", "http://www.ncbi.nlm.nih.gov/pubmed/26910068"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 157, "text": "Cytochrome P450 3A4 (CYP3A4), the most abundant human cytochrome P450 in liver, participates in the metabolism of approximately 50% of clinically used drugs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805"}, {"offsetInBeginSection": 996, "offsetInEndSection": 1232, "text": "Most antihuman immunodeficiency virus protease inhibitors are CYP3A substrates and their interactions with rifamycins are a source of major concern in patients coinfected with human immunodeficiency virus and Mycobacterium tuberculosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805"}, {"offsetInBeginSection": 131, "offsetInEndSection": 311, "text": "CYP3A is of key importance in human drug metabolism, being involved in presystemic extraction of more than 50% of all drugs currently available and of various endogenous compounds.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657"}, {"offsetInBeginSection": 312, "offsetInEndSection": 489, "text": "Therefore, we compared the induction potential of UDCA with that of the prototypical inducer rifampicin in a human model study with the CYP3A substrates budesonide and cortisol.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657"}, {"offsetInBeginSection": 490, "offsetInEndSection": 685, "text": "Twelve patients with early-stage primary biliary cirrhosis and eight healthy volunteers were treated with UDCA (15 mg/kg daily) for 3 weeks and subsequently with rifampicin (600 mg/d) for 1 week.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657"}, {"offsetInBeginSection": 1355, "offsetInEndSection": 1532, "text": "In contrast, administration of rifampicin markedly induced CYP3A metabolism, resulting in abolished budesonide plasma levels and high urinary excretion of 6beta-hydroxycortisol.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657"}, {"offsetInBeginSection": 1533, "offsetInEndSection": 1739, "text": "Metabolite formation was enhanced by rifampicin, but not by UDCA (e.g., AUC(16alpha-hydroxyprednisolone)/AUC(budesonide) in patients: baseline, 8.6 +/- 3.9; UDCA, 10.7 +/- 7.1; rifampicin, 527.0 +/- 248.7).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657"}, {"offsetInBeginSection": 439, "offsetInEndSection": 604, "text": "Based on its homology with mammalian CYP3As, this fragment was used to clone a full-length cDNA consisting of 1638 bp encoding a putative protein of 509 amino acids.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10620362"}, {"offsetInBeginSection": 1252, "offsetInEndSection": 1319, "text": "Used as control, the human CYP3A4 gave similar hydroxylation rates.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10620362"}, {"offsetInBeginSection": 1320, "offsetInEndSection": 1572, "text": "Finally, in both chicken embryo liver and chicken hepatoma cells (LMH), CYP3A37 mRNA was increased after treatment with typical CYP3A inducers, such as metyrapone, phenobarbital, dexamethasone, and pregnenolone 16alpha-carbonitrile, but not rifampicin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10620362"}]}, {"id": "5ac0fccf19833b0d7b000007", "body": "What is the dardarin protein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/16750377"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 75, "text": "Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Mutations in the LRRK2 gene, coding for dardarin, cause dominantly inherited Parkinson's disease (PD).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 103, "offsetInEndSection": 204, "text": "Dardarin is a large protein, and mutations are found throughout the gene including the kinase domain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 205, "offsetInEndSection": 311, "text": "However, it is not clear if kinase activity is important for the damaging effects of pathogenic mutations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 393, "offsetInEndSection": 480, "text": "First, pathogenic mutations increase the tendency of dardarin to form inclusion bodies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 578, "offsetInEndSection": 723, "text": "Manipulating activity by replacing the kinase domain with a 'kinase-dead' version blocks inclusion body formation and strongly delays cell death.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 724, "offsetInEndSection": 857, "text": "This predicts that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}, {"offsetInBeginSection": 858, "offsetInEndSection": 1000, "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377"}]}, {"id": "58ec709aeda5a5767200000e", "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18637642", "http://www.ncbi.nlm.nih.gov/pubmed/22691567", "http://www.ncbi.nlm.nih.gov/pubmed/23600725", "http://www.ncbi.nlm.nih.gov/pubmed/27234918", "http://www.ncbi.nlm.nih.gov/pubmed/11706098", "http://www.ncbi.nlm.nih.gov/pubmed/19351232", "http://www.ncbi.nlm.nih.gov/pubmed/27072975", "http://www.ncbi.nlm.nih.gov/pubmed/10582983", "http://www.ncbi.nlm.nih.gov/pubmed/9305321", "http://www.ncbi.nlm.nih.gov/pubmed/12468781"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 121, "text": "Evaluation of a sequential global test of improved recovery following stroke as applied to the ICTUS trial of citicoline.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642"}, {"offsetInBeginSection": 0, "offsetInEndSection": 213, "text": "The International Citicoline Trial in acUte Stroke is a sequential phase III study of the use of the drug citicoline in the treatment of acute ischaemic stroke, which was initiated in 2006 in 56 treatment centres.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642"}, {"offsetInBeginSection": 214, "offsetInEndSection": 390, "text": "The primary objective of the trial is to demonstrate improved recovery of patients randomized to citicoline relative to those randomized to placebo after 12 weeks of follow-up.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642"}, {"offsetInBeginSection": 629, "offsetInEndSection": 1177, "text": "This approach was previously used in the analysis of the influential National Institute of Neurological Disorders and Stroke trial of recombinant tissue plasminogen activator in stroke.The purpose of this paper is to describe how this trial was designed, and in particular how the simultaneous objectives of taking into account three assessment scales, performing a series of interim analyses and conducting treatment allocation and adjusting the analyses to account for prognostic factors, including more than 50 treatment centres, were addressed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}, {"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "BACKGROUND: Citicoline is approved in some countries for the treatment of acute ischaemic stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}, {"offsetInBeginSection": 165, "offsetInEndSection": 231, "text": "We sought to confirm the efficacy of citicoline in a larger trial.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}, {"offsetInBeginSection": 231, "offsetInEndSection": 428, "text": "METHODS: We undertook a randomised, placebo-controlled, sequential trial in patients with moderate-to-severe acute ischaemic stroke admitted at university hospitals in Germany, Portugal, and Spain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}, {"offsetInBeginSection": 1350, "offsetInEndSection": 1479, "text": "Of the 2298 patients who gave informed consent and underwent randomisation, 1148 were assigned to citicoline and 1150 to placebo.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}, {"offsetInBeginSection": 1595, "offsetInEndSection": 1713, "text": "The final randomised analysis was based on data for 2298 patients: 1148 in citicoline group and 1150 in placebo group.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567"}]}, {"id": "5ace238e0340b9f05800000d", "body": "Which human chromosome is the product of fusion?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27423248", "http://www.ncbi.nlm.nih.gov/pubmed/3325883", "http://www.ncbi.nlm.nih.gov/pubmed/7284984", "http://www.ncbi.nlm.nih.gov/pubmed/28333343", "http://www.ncbi.nlm.nih.gov/pubmed/9310467", "http://www.ncbi.nlm.nih.gov/pubmed/15815621", "http://www.ncbi.nlm.nih.gov/pubmed/8364539", "http://www.ncbi.nlm.nih.gov/pubmed/3289649", "http://www.ncbi.nlm.nih.gov/pubmed/7786792", "http://www.ncbi.nlm.nih.gov/pubmed/10470089"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 123, "text": "Chromosome-Specific Centromere Sequences Provide an Estimate of the Ancestral Chromosome 2 Fusion Event in Hominin Genomes.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 144, "offsetInEndSection": 338, "text": "Genomic signatures of this event are limited to inverted telomeric repeats at the precise site of chromosomal fusion and to the small amount of relic centromeric sequences that remain on 2q21.2.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 339, "offsetInEndSection": 705, "text": "Unlike the site of fusion, which is enriched for sequences that are shared elsewhere in the human genome, the region of the nonfunctioning and degenerate ancestral centromere appears to share limited similarity with other sites in the human genome, thereby providing an opportunity to study this genomic arrangement in short, fragmented ancient DNA genomic datasets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 842, "offsetInEndSection": 1239, "text": "By doing so, one is able to provide evidence for the presence of both active and degenerate centromeric satellite profiles on chromosome 2 in these archaic genomes, supporting the hypothesis that the chromosomal fusion event took place prior to our last common ancestor with Denisovan and Neandertal hominins and presenting a genomic reference for predicting karyotype in ancient genomic datasets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248"}, {"offsetInBeginSection": 0, "offsetInEndSection": 177, "text": "The primary structure of the protein tyrosine kinase domain of the human met gene has been determined from cDNA clones prepared from transcripts of the activated human met gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883"}, {"offsetInBeginSection": 178, "offsetInEndSection": 371, "text": "These analyses reveal that the met kinase domain (located on human chromosome 7) possesses unique features that distinguish met from other members of the src family of protein tyrosine kinases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883"}, {"offsetInBeginSection": 372, "offsetInEndSection": 592, "text": "The results also demonstrate that the product of the activated met gene is a fusion protein and that the amino terminal end of this fusion protein, which is encoded by human chromosome 1, exhibits homology to laminin B1.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883"}, {"offsetInBeginSection": 0, "offsetInEndSection": 62, "text": "Premature chromosome condensation in human large bowel cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7284984"}, {"offsetInBeginSection": 0, "offsetInEndSection": 150, "text": "Two patients with large bowel cancer are described in whose tumors the presence of cells with premature chromosome condensation (PCC) was encountered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7284984"}]}, {"id": "5a7d5580faa1ab7d2e00001a", "body": "What in vivo tau tracers are being used?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24833492", "http://www.ncbi.nlm.nih.gov/pubmed/28219440", "http://www.ncbi.nlm.nih.gov/pubmed/28587897", "http://www.ncbi.nlm.nih.gov/pubmed/24924676", "http://www.ncbi.nlm.nih.gov/pubmed/28750496", "http://www.ncbi.nlm.nih.gov/pubmed/27683159", "http://www.ncbi.nlm.nih.gov/pubmed/27334944", "http://www.ncbi.nlm.nih.gov/pubmed/26697966", "http://www.ncbi.nlm.nih.gov/pubmed/26802556", "http://www.ncbi.nlm.nih.gov/pubmed/25239654"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 81, "text": "Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492"}, {"offsetInBeginSection": 140, "offsetInEndSection": 342, "text": "In vivo detection of these key proteins, namely amyloid-\u03b2, tau, \u03b1-synuclein, and trans-active response DNA-binding protein 43 kDa, is possible by means of molecular neuroimaging techniques, such as PET.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492"}, {"offsetInBeginSection": 526, "offsetInEndSection": 658, "text": "Selective PET radiotracers for amyloid-\u03b2 are already available, and potential tau tracers are emerging as new-generation biomarkers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492"}, {"offsetInBeginSection": 659, "offsetInEndSection": 798, "text": "An overview of the tau-PET radiotracer development scenario, focusing on tracers that are presently being examined in humans, is presented.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492"}, {"offsetInBeginSection": 0, "offsetInEndSection": 47, "text": "Tau PET imaging: present and future directions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440"}, {"offsetInBeginSection": 325, "offsetInEndSection": 536, "text": "The advances of molecular imaging in the recent years have now led to the recent development of promising tau-specific tracers for positron emission tomography (PET), such as THK5317, THK5351, AV-1451, and PBB3.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440"}, {"offsetInBeginSection": 537, "offsetInEndSection": 693, "text": "These tracers are now available for clinical assessment in patients with various tauopathies, including Alzheimer's disease, as well as in healthy subjects.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440"}, {"offsetInBeginSection": 694, "offsetInEndSection": 902, "text": "Exploring the patterns of tau deposition in vivo for different pathologies will allow discrimination between neurodegenerative diseases, including different tauopathies, and monitoring of disease progression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440"}, {"offsetInBeginSection": 903, "offsetInEndSection": 1078, "text": "The variety and complexity of the different types of tau deposits in the different diseases, however, has resulted in quite a challenge for the development of tau PET tracers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440"}, {"offsetInBeginSection": 1079, "offsetInEndSection": 1261, "text": "Extensive work remains in order to fully characterize the binding properties of the tau PET tracers, and to assess their usefulness as an early biomarker of the underlying pathology.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440"}]}, {"id": "5ab90a79fcf456587200001b", "body": "What drug treatment can cause a spinal epidural hematoma?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22175167", "http://www.ncbi.nlm.nih.gov/pubmed/15043358", "http://www.ncbi.nlm.nih.gov/pubmed/11707724", "http://www.ncbi.nlm.nih.gov/pubmed/21082060", "http://www.ncbi.nlm.nih.gov/pubmed/28614233", "http://www.ncbi.nlm.nih.gov/pubmed/27495842", "http://www.ncbi.nlm.nih.gov/pubmed/23351908", "http://www.ncbi.nlm.nih.gov/pubmed/18685937", "http://www.ncbi.nlm.nih.gov/pubmed/8447556", "http://www.ncbi.nlm.nih.gov/pubmed/21799620"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 39, "text": "[Risk management in spinal anesthesia].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167"}, {"offsetInBeginSection": 89, "offsetInEndSection": 169, "text": "Spinal anesthesia now spreads all over the world because it has many advantages.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167"}, {"offsetInBeginSection": 170, "offsetInEndSection": 331, "text": "Spinal anesthesia requires both a simple technique and a small volume of drug, produces profound analgesia, and is devoid of systemic pharmacologic side effects.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167"}, {"offsetInBeginSection": 493, "offsetInEndSection": 618, "text": "Those include cardiac arrest, meningitis, intracranial subdural hematoma, spinal epidural hematoma and cauda equina syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167"}, {"offsetInBeginSection": 782, "offsetInEndSection": 947, "text": "The prediction, early detection and prompt start of the treatment of the complications after spinal anesthesia are important to minimize the risk of adverse outcome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167"}, {"offsetInBeginSection": 0, "offsetInEndSection": 88, "text": "More than one hundred years have passed since Bier first succeeded in spinal anesthesia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22175167"}, {"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Spinal epidural hematoma associated with oral anticoagulation therapy.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "Spontaneous spinal epidural hematoma is an uncommon cause of spinal cord compression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358"}, {"offsetInBeginSection": 86, "offsetInEndSection": 195, "text": "It may be associated with various causative factors, but in many patients, anticoagulation can be implicated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358"}, {"offsetInBeginSection": 291, "offsetInEndSection": 511, "text": "Spontaneous spinal epidural hematoma should be suspected in any patient receiving anticoagulant agents who complains of local or referred spinal pain associated with limb weakness, sensory deficits, or urinary retention.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358"}]}, {"id": "5ac28c0c95d006272400000a", "body": "What is the basis of the Sp3 procedure used in proteomics?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25358341", "http://www.ncbi.nlm.nih.gov/pubmed/28948796", "http://www.ncbi.nlm.nih.gov/pubmed/27668303"], "snippets": [{"offsetInBeginSection": 125, "offsetInEndSection": 304, "text": "Despite great progress in proteomics technologies, thorough interrogation of the proteome from quantity-limited biological samples is hampered by inefficiencies during processing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341"}, {"offsetInBeginSection": 460, "offsetInEndSection": 698, "text": "SP3 provides a rapid and unbiased means of proteomic sample preparation in a single tube that facilitates ultrasensitive analysis by outperforming existing protocols in terms of efficiency, scalability, speed, throughput, and flexibility.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341"}, {"offsetInBeginSection": 699, "offsetInEndSection": 927, "text": "To illustrate these benefits, characterization of 1,000 HeLa cells and single Drosophila embryos is used to establish that SP3 provides an enhanced platform for profiling proteomes derived from sub-microgram amounts of material.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341"}, {"offsetInBeginSection": 588, "offsetInEndSection": 769, "text": "When handling sample sizes below 10 \u03bcg, the number of identified proteins and peptides as well as the quantitative reproducibility and precision drastically dropped in case of FASP.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796"}, {"offsetInBeginSection": 853, "offsetInEndSection": 1007, "text": "Even when digesting 1 \u03bcg of starting material, both methods still enabled the identification of over 3000 proteins and between 25\u202f000 and 30\u202f000 peptides.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796"}, {"offsetInBeginSection": 197, "offsetInEndSection": 511, "text": "In this study, we examined the effect of TFF2 on gastric cancer cell lines in\u00a0vitro and characterized the interaction between TFF2 and Sp3, including the mechanisms that mediate this interaction, using genomics and proteomics approaches, as well as genetics techniques, such as RNA interference and gene knockdown.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27668303"}]}, {"id": "5a896c26fcd1d6a10c000007", "body": "In which syndrome is the RPS19 gene most frequently mutated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24675553", "http://www.ncbi.nlm.nih.gov/pubmed/23990987", "http://www.ncbi.nlm.nih.gov/pubmed/21223253", "http://www.ncbi.nlm.nih.gov/pubmed/12351378", "http://www.ncbi.nlm.nih.gov/pubmed/18515656", "http://www.ncbi.nlm.nih.gov/pubmed/17053056", "http://www.ncbi.nlm.nih.gov/pubmed/21989989", "http://www.ncbi.nlm.nih.gov/pubmed/21435505", "http://www.ncbi.nlm.nih.gov/pubmed/15075082"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "Ribosomal protein mutations in Korean patients with Diamond-Blackfan anemia.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}, {"offsetInBeginSection": 352, "offsetInEndSection": 540, "text": "In this study, nine Korean DBA patients were screened for mutations in eight known DBA genes (RPS19, RPS24, RPS17, RPS10, RPS26, RPL35A, RPL5 and RPL11) using the direct sequencing method.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}, {"offsetInBeginSection": 895, "offsetInEndSection": 1216, "text": "The relative mRNA expression of RPS19 estimated using real-time quantitative PCR analysis revealed two- to fourfold reductions in RPS19 mRNA expression in three patients with RPS19 mutations, and p53 protein expression analysis by immunohistochemistry showed variable but significant nuclear staining in the DBA patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}, {"offsetInBeginSection": 1357, "offsetInEndSection": 1422, "text": "Among these patients, RPS19 was the most frequently mutated gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}, {"offsetInBeginSection": 1423, "offsetInEndSection": 1674, "text": "In addition, decreased RPS19 mRNA expression and p53 overexpression were observed in the Korean DBA patients, which supports the hypothesis that haploinsufficiency and p53 hyperactivation represent a central pathway underlying the pathogenesis of DBA.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553"}, {"offsetInBeginSection": 163, "offsetInEndSection": 309, "text": "It has been proven that defects of ribosomal proteins can lead to this disease and that RPS19 is the most frequently mutated gene in DBA patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987"}, {"offsetInBeginSection": 310, "offsetInEndSection": 421, "text": "Previous studies suggest that p53-dependent genes and pathways play important roles in RPS19-deficient embryos.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987"}, {"offsetInBeginSection": 1031, "offsetInEndSection": 1184, "text": "However, the hematopoietic genes, which were down-regulated significantly in RPS19 MO embryos, were not completely recovered by the co-inhibition of p53.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987"}, {"offsetInBeginSection": 1409, "offsetInEndSection": 1574, "text": "The detection of potential pathogenic genes and pathways provides us a new paradigm for future research on DBA, which is a systematic and complex hereditary disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987"}, {"offsetInBeginSection": 142, "offsetInEndSection": 231, "text": "The ribosomal protein S19 gene (RPS19) is the most frequently mutated gene in DBA (~25%).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21223253"}]}, {"id": "5ab908d4fcf456587200001a", "body": "What is the alternative lengthening of telomeres?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26428317", "http://www.ncbi.nlm.nih.gov/pubmed/26022452", "http://www.ncbi.nlm.nih.gov/pubmed/20403221", "http://www.ncbi.nlm.nih.gov/pubmed/19154407", "http://www.ncbi.nlm.nih.gov/pubmed/27726944", "http://www.ncbi.nlm.nih.gov/pubmed/26769142", "http://www.ncbi.nlm.nih.gov/pubmed/24531712", "http://www.ncbi.nlm.nih.gov/pubmed/22575867", "http://www.ncbi.nlm.nih.gov/pubmed/18215414", "http://www.ncbi.nlm.nih.gov/pubmed/21574432"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 105, "offsetInEndSection": 197, "text": "Alternative lengthening of telomeres is a telomere-maintenance mechanism common in sarcomas.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 371, "offsetInEndSection": 567, "text": "We previously reported that alternative lengthening of telomeres and loss of ATRX expression were common in leiomyosarcoma, angiosarcoma, pleomorphic liposarcoma, and dedifferentiated liposarcoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 568, "offsetInEndSection": 766, "text": "In the present study, we screened an additional 245 sarcomas of other types to determine the prevalence of alternative lengthening of telomeres, loss of ATRX/DAXX expression, and their relationship.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 767, "offsetInEndSection": 981, "text": "Undifferentiated pleomorphic sarcomas were frequently alternative lengthening of telomeres positive (65%) and loss of ATRX was seen in approximately half of the alternative lengthening of telomeres-positive tumors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 982, "offsetInEndSection": 1099, "text": "Nineteen of 25 myxofibrosarcomas were alternative lengthening of telomeres-positive, but only one was ATRX deficient.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 1100, "offsetInEndSection": 1230, "text": "Three of 15 radiation-associated sarcomas were alternative lengthening of telomeres positive, but none of them was ATRX deficient.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 1231, "offsetInEndSection": 1412, "text": "Alternative lengthening of telomeres and/or loss of ATRX were uncommon in malignant peripheral nerve sheath tumors, gastrointestinal stromal tumors, and embryonal rhabdomyosarcomas.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 1413, "offsetInEndSection": 1541, "text": "By contrast, none of the 71 gene fusion-associated sarcomas was ATRX deficient or alternative lengthening of telomeres positive.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}, {"offsetInBeginSection": 1739, "offsetInEndSection": 1904, "text": "By telomere-specific fluorescence in situ hybridization, 45% (138/308) were alternative lengthening of telomeres positive, 55% (76/138) of which were ATRX deficient.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317"}]}, {"id": "5abcf010fcf4565872000023", "body": "What nerve is involved in carpal tunnel syndrome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27894853", "http://www.ncbi.nlm.nih.gov/pubmed/7235907", "http://www.ncbi.nlm.nih.gov/pubmed/19336461", "http://www.ncbi.nlm.nih.gov/pubmed/25206437", "http://www.ncbi.nlm.nih.gov/pubmed/25630774", "http://www.ncbi.nlm.nih.gov/pubmed/26014322", "http://www.ncbi.nlm.nih.gov/pubmed/7594983", "http://www.ncbi.nlm.nih.gov/pubmed/6231697", "http://www.ncbi.nlm.nih.gov/pubmed/23590784", "http://www.ncbi.nlm.nih.gov/pubmed/28718333"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "Concurrent carpal tunnel syndrome and pronator syndrome: A retrospective study of 21 cases.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "PURPOSE: Concurrent carpal tunnel syndrome and pronator syndrome are rarely considered and the proximal compression sites are easily overlooked.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 349, "offsetInEndSection": 535, "text": "If paresthesia involved the thenar eminence and proximal forearm pain was noted in cases of carpal tunnel syndrome, carpal tunnel syndrome combined with pronator syndrome was considered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 614, "offsetInEndSection": 716, "text": "Therefore, if nocturnal symptoms occurred in pronator syndrome, carpal tunnel syndrome was considered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 717, "offsetInEndSection": 785, "text": "We included concurrent carpal tunnel syndrome and pronator syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 947, "offsetInEndSection": 1093, "text": "However, recurrent carpal tunnel cases were treated with the open carpal tunnel release and open pronator decompression procedure in our hospital.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 1274, "offsetInEndSection": 1422, "text": "RESULTS: We retrospectively reviewed 344 cases of sustained carpal tunnel syndrome or pronator syndrome from the medical records of our institution.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 1423, "offsetInEndSection": 1591, "text": "Of the 344 cases, 322 involved carpal tunnel syndrome alone, 1 involved pronator syndrome alone, and 21 involved carpal tunnel syndrome combined with pronator syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 1592, "offsetInEndSection": 1690, "text": "The 21 cases of carpal tunnel syndrome combined with pronator syndrome were included in our study.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}, {"offsetInBeginSection": 1691, "offsetInEndSection": 1774, "text": "Among the total cases of carpal tunnel syndrome, 6% (21/343) had pronator syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853"}]}, {"id": "5ad240f70340b9f058000015", "body": "Is human lysyl oxidase-like 2 a glycoprotein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20306300", "http://www.ncbi.nlm.nih.gov/pubmed/28112368", "http://www.ncbi.nlm.nih.gov/pubmed/25146937", "http://www.ncbi.nlm.nih.gov/pubmed/28350101", "http://www.ncbi.nlm.nih.gov/pubmed/21954900", "http://www.ncbi.nlm.nih.gov/pubmed/17018530", "http://www.ncbi.nlm.nih.gov/pubmed/27063404", "http://www.ncbi.nlm.nih.gov/pubmed/7706256", "http://www.ncbi.nlm.nih.gov/pubmed/23319596", "http://www.ncbi.nlm.nih.gov/pubmed/11334717"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300"}, {"offsetInBeginSection": 0, "offsetInEndSection": 194, "text": "The lysyl oxidase-like 2 (LOXL2) protein is a human paralogue of lysyl oxidase (LOX) that functions as an amine oxidase for formation of lysine-derived cross-links found in collagen and elastin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300"}, {"offsetInBeginSection": 362, "offsetInEndSection": 550, "text": "In order to assess the amine oxidase activity of LOXL2, we expressed a series of recombinant LOXL2 proteins with deletions in the SRCR domains, using an Escherichia coli expression system.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300"}, {"offsetInBeginSection": 551, "offsetInEndSection": 878, "text": "All of the purified recombinant LOXL2 proteins, with or without the SRCR domains in the N-terminus, showed significant amine oxidase activity toward several different types of collagen and elastin in in\u00a0vitro amine oxidase assays, indicating deletion of the SRCR domains does not interfere with amine oxidase activity of LOXL2.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300"}, {"offsetInBeginSection": 879, "offsetInEndSection": 1085, "text": "Further, amine oxidase activity of LOXL2 was not susceptible to inhibition by \u03b2-aminopropionitrile, an irreversible inhibitor of LOX, suggesting a different enzymatic mechanism between these two paralogues.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "LOXL3-sv2, a novel variant of human lysyl oxidase-like 3 (LOXL3), functions as an amine oxidase.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "Human lysyl oxidase-like 3\u00a0(LOXL3) functions as a copper-dependent amine oxidase toward collagen and elastin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368"}, {"offsetInBeginSection": 110, "offsetInEndSection": 413, "text": "The LOXL3\u00a0protein contains four scavenger receptor cysteine-rich\u00a0(SRCR) domains in the N-terminus in addition to the C-terminal characteristic domains of the lysyl oxidase\u00a0(LOX) family, such as a copper-binding domain, a cytokine receptor\u2011like domain and residues for the lysyl-tyrosyl quinone cofactor.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368"}, {"offsetInBeginSection": 826, "offsetInEndSection": 948, "text": "The recombinant LOXL3-sv2\u00a0protein showed a \u03b2-aminopropionitrile-inhibitable amine oxidase activity toward collagen type\u00a0I.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368"}, {"offsetInBeginSection": 1095, "offsetInEndSection": 1250, "text": "These findings indicate that the human LOXL3\u00a0gene encodes at least three variants, LOXL3, LOXL3-sv1 and\u00a0LOXL3-sv2, all of which function as amine oxidases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368"}]}, {"id": "5a86e6fafaa1ab7d2e000036", "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25602132", "http://www.ncbi.nlm.nih.gov/pubmed/26359231", "http://www.ncbi.nlm.nih.gov/pubmed/25559185", "http://www.ncbi.nlm.nih.gov/pubmed/24717229", "http://www.ncbi.nlm.nih.gov/pubmed/23934658", "http://www.ncbi.nlm.nih.gov/pubmed/25784758"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 143, "text": "Distinct features of lamin A-interacting chromatin domains mapped by ChIP-sequencing from sonicated or micrococcal nuclease-digested chromatin.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "The nuclear lamina has been shown to interact with the genome through lamina-associated domains (LADs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 104, "offsetInEndSection": 265, "text": "LADs have been identified by DamID, a proximity labeling assay, and more recently by chromatin immunoprecipitation-sequencing (ChIP-seq) of A- and B-type lamins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 266, "offsetInEndSection": 370, "text": "LADs form megabase-size domains at the nuclear periphery, they are gene-poor and mostly heterochromatic.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 602, "offsetInEndSection": 775, "text": "Using ChIP-seq, we show the existence of lamin A/C (LMNA) LiDs with distinct gene contents, histone composition enrichment and relationships to lamin B1-interacting domains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 776, "offsetInEndSection": 999, "text": "The extent of genome coverage of lamin A/C (LMNA) LiDs in sonicated or MNase-digested chromatin is similar (\u223c730 megabases); however over half of these domains are uniquely detected in sonicated or MNase-digested chromatin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 1000, "offsetInEndSection": 1223, "text": "Sonication-specific LMNA LiDs are gene-poor and devoid of a broad panel of histone modifications, while MNase-specific LMNA LiDs are of higher gene density and are enriched in H3K9me3, H3K27me3 and in histone variant H2A.Z.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 1298, "offsetInEndSection": 1540, "text": "Comparison of published LMNB1 DamID LADs with LMNB1 and LMNA LiDs identified here by ChIP-seq further shows that LMNA can associate with 'open' chromatin domains displaying euchromatin characteristics, and which are not associated with LMNB1.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 1541, "offsetInEndSection": 1800, "text": "The differential genomic and epigenetic properties of lamin-interacting domains reflect the existence of distinct LiD populations identifiable in different chromatin contexts, including nuclease-accessible regions presumably localized in the nuclear interior.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231"}]}, {"id": "5ac716810340b9f058000003", "body": "Name an lncRNA associated with dilated cardiomyopathy.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26951817"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 144, "text": "Myocardial Infarction-Associated Transcript, a Long Noncoding RNA, Is Overexpressed During Dilated Cardiomyopathy Due to Chronic Chagas Disease.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Long noncoding RNAs (lncRNAs) modulate gene expression at the epigenetic, transcriptional, and posttranscriptional levels.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 123, "offsetInEndSection": 258, "text": "Dysregulation of the lncRNA known as myocardial infarction-associated transcript (MIAT) has been associated with myocardial infarction.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}, {"offsetInBeginSection": 259, "offsetInEndSection": 340, "text": "Chagas disease causes a severe inflammatory dilated chronic cardiomyopathy (CCC).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817"}]}, {"id": "5abcf108fcf4565872000025", "body": "What is myelin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28377211", "http://www.ncbi.nlm.nih.gov/pubmed/7650750", "http://www.ncbi.nlm.nih.gov/pubmed/24684721", "http://www.ncbi.nlm.nih.gov/pubmed/20186338", "http://www.ncbi.nlm.nih.gov/pubmed/25682762", "http://www.ncbi.nlm.nih.gov/pubmed/21401967", "http://www.ncbi.nlm.nih.gov/pubmed/2752082", "http://www.ncbi.nlm.nih.gov/pubmed/22102008", "http://www.ncbi.nlm.nih.gov/pubmed/2470784", "http://www.ncbi.nlm.nih.gov/pubmed/6191815"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "Myelin content is an important marker for neuropathology and MRI generated myelin water fraction (MWF) has been shown to correlate well with myelin content.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 345, "offsetInEndSection": 453, "text": "This is of special concern when there is a mix of intact myelin and myelin debris, as in the case of injury.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 650, "offsetInEndSection": 830, "text": "A rat spinal cord injury model was used with time points at normal (normal myelin), 3 weeks post-injury (myelin debris), and 8 weeks post-injury (myelin debris, partially cleared).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 831, "offsetInEndSection": 1047, "text": "The myelin period between normal and 3 or 8 weeks post-injury cords did not differ significantly, suggesting that as long as the bilayer structure is intact, myelin debris has the same water content as intact myelin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 1048, "offsetInEndSection": 1227, "text": "The MWF also correlated strongly with the TEM-derived myelin fraction, suggesting that MWF measures the amount of compact appearing myelin in both intact myelin and myelin debris.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 1228, "offsetInEndSection": 1391, "text": "From the TEM images, it appears that as myelin degenerates, it tends to form large watery spaces within the myelin sheaths that are not classified as myelin water.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 1392, "offsetInEndSection": 1531, "text": "The results presented in this study improve our understanding and allows for better interpretation of MWF in the presence of myelin debris.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211"}, {"offsetInBeginSection": 0, "offsetInEndSection": 54, "text": "Myelin vesicles: what we know and what we do not know.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7650750"}, {"offsetInBeginSection": 131, "offsetInEndSection": 279, "text": "The emphasis is on CNS myelin of adult mammals although both central nervous system (CNS) and peripheral nervous system (PNS) myelin are considered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7650750"}, {"offsetInBeginSection": 440, "offsetInEndSection": 569, "text": "Special attention is paid to myelin swelling phenomena because these indicate ways in which the myelin multilayer can break down.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7650750"}]}, {"id": "5ad3013d0340b9f058000019", "body": "Can GDF15 be a biomarker for metformin treatment?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27974345"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 62, "text": "OBJECTIVE: Metformin is a commonly used glucose-lowering drug.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 63, "offsetInEndSection": 179, "text": "However, apart from glycemic measures, no biomarker for its presence or dose has been identified.RESEARCH DESIGN AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 443, "offsetInEndSection": 695, "text": "RESULTS: Growth differentiation factor 15 (GDF15) was strongly linked to metformin, such that the odds of metformin use per SD increase in level varied from 3.73 (95% CI 3.40, 4.09) to 3.94 (95% CI 3.59, 4.33) depending on the other included variables.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 771, "offsetInEndSection": 846, "text": "A 1.64 ng/mL higher GDF15 level predicted a 188-mg higher metformin dose (P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}, {"offsetInBeginSection": 847, "offsetInEndSection": 995, "text": "CONCLUSIONS: GDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345"}]}, {"id": "5a8d8f39fcd1d6a10c000024", "body": "What is the TALE-iD method used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27940490", "http://www.ncbi.nlm.nih.gov/pubmed/23840477", "http://www.ncbi.nlm.nih.gov/pubmed/26854857", "http://www.ncbi.nlm.nih.gov/pubmed/24976123", "http://www.ncbi.nlm.nih.gov/pubmed/27811079", "http://www.ncbi.nlm.nih.gov/pubmed/26876161", "http://www.ncbi.nlm.nih.gov/pubmed/28074901", "http://www.ncbi.nlm.nih.gov/pubmed/23316790", "http://www.ncbi.nlm.nih.gov/pubmed/23869221", "http://www.ncbi.nlm.nih.gov/pubmed/23821439"], "snippets": [{"offsetInBeginSection": 778, "offsetInEndSection": 1139, "text": "Using different cell types and loci, computational modeling, and a methylation-based orthogonal validation method, \"TALE-iD\", we show that native interactions resemble cross-linked ones, but display improved signal-to-noise ratios and are more focal on regulatory elements and CTCF sites, while strictly abiding to topologically associating domain restrictions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490"}, {"offsetInBeginSection": 0, "offsetInEndSection": 83, "text": "A simple and efficient method for assembling TALE protein based on plasmid library.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 0, "offsetInEndSection": 93, "text": "DNA binding domain of the transcription activator-like effectors (TALEs) from Xanthomonas sp.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 439, "offsetInEndSection": 636, "text": "Although several new methodologies for efficiently assembling TALE repeats have been recently reported, all of them require either sophisticated facilities or skilled technicians to carry them out.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 637, "offsetInEndSection": 816, "text": "Here, we described a simple and efficient method for generating customized TALE nucleases (TALENs) and TALE transcription factors (TALE-TFs) based on TALE repeat tetramer library.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 1061, "offsetInEndSection": 1307, "text": "12 TALE constructs including 4 TALEN pairs targeted to mouse Gt(ROSA)26Sor gene and mouse Mstn gene sequences as well as 4 TALE-TF constructs targeted to mouse Oct4, c-Myc, Klf4 and Sox2 gene promoter sequences were generated by using our method.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 1468, "offsetInEndSection": 1563, "text": "Sequencing results suggested that all TALE constructs were performed with high successful rate.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 1564, "offsetInEndSection": 1676, "text": "This is a rapid and cost-efficient method using the most common enzymes and facilities with a high success rate.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477"}, {"offsetInBeginSection": 0, "offsetInEndSection": 259, "text": "Transcription activator-like effectors (TALEs) are extremely effective, single-molecule DNA-targeting molecular cursors used for locus-specific genome science applications, including high-precision molecular medicine and other genome engineering applications.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26854857"}, {"offsetInBeginSection": 771, "offsetInEndSection": 1062, "text": "Here we describe FusX, a streamlined Golden Gate TALE assembly system that (1) is backward compatible with popular TALE backbones, (2) is functionalized as a single-tube 3-day TALE assembly process, (3) requires only commonly used basic molecular biology reagents, and (4) is cost-effective.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26854857"}]}, {"id": "5aa395fcd6d6b54f79000007", "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22007328", "http://www.ncbi.nlm.nih.gov/pubmed/28243993", "http://www.ncbi.nlm.nih.gov/pubmed/28984295", "http://www.ncbi.nlm.nih.gov/pubmed/28164324", "http://www.ncbi.nlm.nih.gov/pubmed/21247220", "http://www.ncbi.nlm.nih.gov/pubmed/10589082", "http://www.ncbi.nlm.nih.gov/pubmed/28782884", "http://www.ncbi.nlm.nih.gov/pubmed/28235209", "http://www.ncbi.nlm.nih.gov/pubmed/28877546", "http://www.ncbi.nlm.nih.gov/pubmed/28856423"], "snippets": [{"offsetInBeginSection": 129, "offsetInEndSection": 319, "text": "Survey questions addressed demographics; familiarity with MCS; etiology; overlapping conditions; accommodations made for patients and practices regarding evaluation, treatment, and referral.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328"}, {"offsetInBeginSection": 561, "offsetInEndSection": 772, "text": "Participants cited a range of etiologies and overlapping conditions including asthma, Reactive Airway Dysfunction Syndrome (RADS), Sick Building Syndrome (SBS), Chronic Fatigues Syndrome (CFS), and Fibromyalgia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328"}, {"offsetInBeginSection": 186, "offsetInEndSection": 288, "text": "Upon CLL diagnosis, physicians should determine whether treatment or careful observation is indicated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 772, "offsetInEndSection": 1061, "text": "Healthy, young patients with low-risk disease (mutated IgVH, del (13q)) should be offered fludarabine, chlorambucil, and rituximab (FCR), while similar patients with high-risk disease (unmutated IgVH, del (17p), del (11q), and complex karyotype) should be considered for ibrutinib therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 1062, "offsetInEndSection": 1215, "text": "For those young, fit patients with high-risk disease and a contraindication to ibrutinib, FCR, or high-dose methylprednisolone and rituximab are options.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 1370, "offsetInEndSection": 1484, "text": "Those who have poor performance and multiple medical comorbidities should be considered for palliative care alone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 1485, "offsetInEndSection": 1558, "text": "However, those who are fit enough for treatment can be offered ibrutinib.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 1668, "offsetInEndSection": 1773, "text": "For the low-risk patients, bendamustine and rituximab or obinutuzumab and chlorambucil can be considered.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 1774, "offsetInEndSection": 1857, "text": "For the high-risk patients, treatment with rituximab and lenalidomide is an option.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}, {"offsetInBeginSection": 1858, "offsetInEndSection": 1981, "text": "Herein, we provide an evidence-based front-line treatment algorithm for CLL patients based upon fitness and molecular risk.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993"}]}, {"id": "5aa67b4fd6d6b54f7900000f", "body": "What disease is tinea ?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21169831", "http://www.ncbi.nlm.nih.gov/pubmed/15050029", "http://www.ncbi.nlm.nih.gov/pubmed/12040364", "http://www.ncbi.nlm.nih.gov/pubmed/24739076", "http://www.ncbi.nlm.nih.gov/pubmed/8021081", "http://www.ncbi.nlm.nih.gov/pubmed/7742235", "http://www.ncbi.nlm.nih.gov/pubmed/19231646", "http://www.ncbi.nlm.nih.gov/pubmed/8821157", "http://www.ncbi.nlm.nih.gov/pubmed/134458", "http://www.ncbi.nlm.nih.gov/pubmed/19942789"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 32, "text": "Tinea imbricata in the Americas.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831"}, {"offsetInBeginSection": 11, "offsetInEndSection": 354, "text": "REVIEW: The aim is to provide an overview on tinea imbricata, or Tokelau, a superficial mycosis caused by Trichophyton concentricum, a strictly anthropophilic dermatophyte with a well-defined geographic distribution and predisposing factors that include genetic, racial and immunologic susceptibility patterns and a specific environment.RECENT", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831"}, {"offsetInBeginSection": 355, "offsetInEndSection": 689, "text": "FINDINGS: This review covers the most interesting aspects of the infrequent disease tinea imbricata, including the historical background, the epidemiologic aspects, highlighting the genetic and racial patterns of susceptibility to the acquisition of the disease, and the immunologic aspects that help to explain its clinical behavior.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831"}, {"offsetInBeginSection": 690, "offsetInEndSection": 892, "text": "We also present a clinical description of the disease, the differential diagnosis and how currently some other emerging diseases such as syphilis in immunocompromised patients can mimic tinea imbricata.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831"}, {"offsetInBeginSection": 893, "offsetInEndSection": 1126, "text": "The therapeutic options are still griseofulvin and nowadays terbinafine, but the access to the treatments in the endemic zones and the changes in habits of the affected population make control and prevention of the disease difficult.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169831"}, {"offsetInBeginSection": 0, "offsetInEndSection": 76, "text": "Dermatology for the practicing allergist: Tinea pedis and its complications.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Tinea pedis is a chronic fungal infection of the feet, very often observed in patients who are immuno-suppressed or have diabetes mellitus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029"}, {"offsetInBeginSection": 311, "offsetInEndSection": 424, "text": "In other patients, tinea pedis may complicate allergy and asthma and may contribute to refractory atopic disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029"}, {"offsetInBeginSection": 882, "offsetInEndSection": 1039, "text": "Three groups of fungal pathogens, referred to as dermatophytes, have been shown to cause tinea pedis: Trychophyton sp, Epidermophyton sp, and Microsporum sp.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029"}, {"offsetInBeginSection": 1245, "offsetInEndSection": 1390, "text": "Tinea pedis may be associated with recurrent cellulitis, as the fungal pathogens provide a portal for bacterial invasion of subcutaneous tissues.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029"}]}, {"id": "5ad4dd93133db5eb78000008", "body": "What is the clathrin triskelia structure?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19925798", "http://www.ncbi.nlm.nih.gov/pubmed/22563470", "http://www.ncbi.nlm.nih.gov/pubmed/18502808", "http://www.ncbi.nlm.nih.gov/pubmed/7738035", "http://www.ncbi.nlm.nih.gov/pubmed/1587861", "http://www.ncbi.nlm.nih.gov/pubmed/7674375", "http://www.ncbi.nlm.nih.gov/pubmed/2571614", "http://www.ncbi.nlm.nih.gov/pubmed/23270814", "http://www.ncbi.nlm.nih.gov/pubmed/11943181", "http://www.ncbi.nlm.nih.gov/pubmed/10926122"], "snippets": [{"offsetInBeginSection": 387, "offsetInEndSection": 605, "text": "Increased numbers of triskelion dimers and assembly intermediates, as well as structures having dimensions similar to those of clathrin cages, are observed when the triskelia were immersed in a low salt, low pH buffer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19925798"}, {"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "New clathrin-based nanoplatforms for magnetic resonance imaging.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 272, "offsetInEndSection": 426, "text": "We herein introduce new bio-nanotechnology approaches for designing CNS contrast media based on the ubiquitous clathrin cell protein.METHODOLOGY/PRINCIPAL", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 427, "offsetInEndSection": 538, "text": "FINDINGS: The first approach utilizes three-legged clathrin triskelia modified to carry 81 gadolinium chelates.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 656, "offsetInEndSection": 783, "text": "Clathrin triskelia and cages were characterized by size, structure, protein concentration, and chelate and gadolinium contents.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 784, "offsetInEndSection": 1049, "text": "Relaxivity was evaluated at 0.47 T. A series of studies were conducted to ascertain whether fluorescent-tagged clathrin nanoplatforms could cross the blood brain barriers (BBB) unaided following intranasal, intravenous, and intraperitoneal routes of administration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 1050, "offsetInEndSection": 1165, "text": "Clathrin nanoparticles can be constituted as triskelia (18.5 nm in size), and as cages assembled from them (55 nm).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 1276, "offsetInEndSection": 1475, "text": "Triskelia had ionic relaxivity of 16 mM(-1) s(-1), and molecular relaxivity of 1,166 mM(-1) s(-1), while cages had ionic relaxivity of 81 mM(-1) s(-1) and molecular relaxivity of 31,512 mM(-1) s(-1).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 1607, "offsetInEndSection": 1808, "text": "Clathrin nanoplatforms modified with fluorescent tags were able to cross or bypass the BBB without enhancements following intravenous, intraperitoneal and intranasal administration in rats.CONCLUSIONS/", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}, {"offsetInBeginSection": 1808, "offsetInEndSection": 1918, "text": "SIGNIFICANCE: Use of clathrin triskelia and cages as carriers of CNS contrast media represents a new approach.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470"}]}, {"id": "5ace37d50340b9f058000011", "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/16034947", "http://www.ncbi.nlm.nih.gov/pubmed/19009138", "http://www.ncbi.nlm.nih.gov/pubmed/19127040", "http://www.ncbi.nlm.nih.gov/pubmed/21982529", "http://www.ncbi.nlm.nih.gov/pubmed/17290547", "http://www.ncbi.nlm.nih.gov/pubmed/16011530", "http://www.ncbi.nlm.nih.gov/pubmed/14716388", "http://www.ncbi.nlm.nih.gov/pubmed/14617302", "http://www.ncbi.nlm.nih.gov/pubmed/19245939", "http://www.ncbi.nlm.nih.gov/pubmed/28483415"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 131, "offsetInEndSection": 250, "text": "Primary prophylaxis with antifungal interventions may decrease cryptococcal disease incidence and associated mortality.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 250, "offsetInEndSection": 389, "text": "OBJECTIVES: To assess the efficacy of antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV.SEARCH", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 1382, "offsetInEndSection": 1643, "text": "Key words used include: meningitis, cryptococcal, cryptococcus, cryptococcosis, acquired immunodeficiency syndrome, human immunodeficiency virus, prophylaxis, chemoprevention, antifungal agents, and the Cochrane screen for randomized controlled trials.SELECTION", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 2163, "offsetInEndSection": 2210, "text": "All study patients had CD4 cell counts AUTHORS'", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 2046, "offsetInEndSection": 2114, "text": "Data were pooled, where appropriate, to yield summary estimates.MAIN", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "BACKGROUND: Cryptococcal disease is an opportunistic infection that causes significant morbidity and mortality in adults with HIV.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947"}, {"offsetInBeginSection": 0, "offsetInEndSection": 67, "text": "Cryptococcal meningitis in Rio de Janeiro State, Brazil, 1994-2004.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138"}, {"offsetInBeginSection": 142, "offsetInEndSection": 271, "text": "Six hundred and ninety-six cases of cryptococcal meningitis were reported, with a mean incidence of 0.45 per 100,000 inhabitants.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138"}, {"offsetInBeginSection": 496, "offsetInEndSection": 633, "text": "AIDS is the main predisposing condition for cryptococcal meningitis, and thus the profile of most patients mirrors that of HIV infection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138"}]}, {"id": "5ab8fb5bfcf4565872000017", "body": "How is the nuclear localization of lncRNA mediated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24732794", "http://www.ncbi.nlm.nih.gov/pubmed/27198227", "http://www.ncbi.nlm.nih.gov/pubmed/26578588"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 83, "text": "A novel RNA motif mediates the strict nuclear localization of a long noncoding RNA.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 150, "offsetInEndSection": 427, "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 428, "offsetInEndSection": 600, "text": "Subcellular localization of BORG was not dependent on the context or level of its expression or decay but rather depended on the sequence of the mature, spliced transcript.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 601, "offsetInEndSection": 863, "text": "Mutational analyses indicated that nuclear localization of BORG was mediated through a novel RNA motif consisting of the pentamer sequence AGCCC with sequence restrictions at positions -8 (T or A) and -3 (G or C) relative to the first nucleotide of the pentamer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 864, "offsetInEndSection": 1092, "text": "Mutation of the motif to a scrambled sequence resulted in complete loss of nuclear localization, while addition of even a single copy of the motif to a cytoplasmically localized RNA was sufficient to impart nuclear localization.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 1093, "offsetInEndSection": 1300, "text": "Further, the presence of this motif in other cellular RNAs showed a direct correlation with nuclear localization, suggesting that the motif may act as a general nuclear localization signal for cellular RNAs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}, {"offsetInBeginSection": 0, "offsetInEndSection": 166, "text": "Some mitochondrial long noncoding RNAs (lncRNAs) are encoded by nuclear DNA, but the mechanisms that mediate their transport to mitochondria are poorly characterized.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}, {"offsetInBeginSection": 167, "offsetInEndSection": 440, "text": "Using affinity RNA pull-down followed by mass spectrometry analysis, we found two RNA-binding proteins (RBPs), HuR (human antigen R) and GRSF1 (G-rich RNA sequence-binding factor 1), that associated with the nuclear DNA-encoded lncRNA RMRP and mobilized it to mitochondria.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}, {"offsetInBeginSection": 441, "offsetInEndSection": 584, "text": "In cultured human cells, HuR bound RMRP in the nucleus and mediated its CRM1 (chromosome region maintenance 1)-dependent export to the cytosol.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227"}]}, {"id": "5aa67b6ad6d6b54f79000010", "body": "What is Paget's Disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/7695525", "http://www.ncbi.nlm.nih.gov/pubmed/24160789", "http://www.ncbi.nlm.nih.gov/pubmed/17447970", "http://www.ncbi.nlm.nih.gov/pubmed/15389972", "http://www.ncbi.nlm.nih.gov/pubmed/6290548", "http://www.ncbi.nlm.nih.gov/pubmed/25025000", "http://www.ncbi.nlm.nih.gov/pubmed/3026195", "http://www.ncbi.nlm.nih.gov/pubmed/16429324", "http://www.ncbi.nlm.nih.gov/pubmed/8009241", "http://www.ncbi.nlm.nih.gov/pubmed/19032921"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 71, "text": "Paget's disease of the breast: what the radiologist may expect to find.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7695525"}, {"offsetInBeginSection": 0, "offsetInEndSection": 121, "text": "Paget's disease of the nipple is characterized by the presence of Paget's cells in the epidermis of the nipple or areola.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7695525"}, {"offsetInBeginSection": 122, "offsetInEndSection": 226, "text": "Two case reports of Paget's disease are described and used to highlight unusual features of the disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7695525"}, {"offsetInBeginSection": 0, "offsetInEndSection": 134, "text": "Paget's disease of the nipple with parenchymal ductal carcinoma in situ is associated with worse prognosis than Paget's disease alone.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "Paget's disease of the nipple is often found in conjunction with underlying ductal carcinoma in situ (DCIS).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789"}, {"offsetInBeginSection": 109, "offsetInEndSection": 209, "text": "In isolation, Paget's disease of the nipple, like DCIS, confers an excellent prognosis for survival.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789"}, {"offsetInBeginSection": 210, "offsetInEndSection": 358, "text": "Our objective was to determine if Paget's disease identified with synchronous parenchymal DCIS has as favorable an outcome as Paget's disease alone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789"}, {"offsetInBeginSection": 359, "offsetInEndSection": 543, "text": "We analyzed a prospectively maintained pathology database and medical records to identify all patients diagnosed with Paget's disease of the nipple between June 1996 and December 2011.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789"}, {"offsetInBeginSection": 643, "offsetInEndSection": 847, "text": "Seventy-four patients were identified with Paget's disease: five (6%) with isolated Paget's of the nipple, 22 (30%) associated with parenchymal DCIS, and 47 (64%) associated with invasive cancer (\u00b1 DCIS).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789"}, {"offsetInBeginSection": 848, "offsetInEndSection": 961, "text": "Unexpectedly, patients with Paget's disease and DCIS had a worse prognosis than those with Paget's disease alone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789"}]}, {"id": "5a8980d2fcd1d6a10c00000d", "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24809334", "http://www.ncbi.nlm.nih.gov/pubmed/27339605", "http://www.ncbi.nlm.nih.gov/pubmed/19906816", "http://www.ncbi.nlm.nih.gov/pubmed/1763812", "http://www.ncbi.nlm.nih.gov/pubmed/22535970", "http://www.ncbi.nlm.nih.gov/pubmed/18407130", "http://www.ncbi.nlm.nih.gov/pubmed/21373720", "http://www.ncbi.nlm.nih.gov/pubmed/16464973", "http://www.ncbi.nlm.nih.gov/pubmed/27498420", "http://www.ncbi.nlm.nih.gov/pubmed/27641099"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 73, "text": "Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "Brown adipose tissue (BAT) is specialized for energy expenditure, a process called adaptive thermogenesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 107, "offsetInEndSection": 239, "text": "PET-CT scans recently demonstrated the existence of metabolically active BAT in adult humans, which revitalized our interest in BAT.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 368, "offsetInEndSection": 436, "text": "PGC1\u03b1 is the master regulator of UCP1-mediated thermogenesis in BAT.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 437, "offsetInEndSection": 609, "text": "A number of proteins have been identified to influence thermogenesis either positively or negatively through regulating the expression or transcriptional activity of PGC1\u03b1.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 610, "offsetInEndSection": 776, "text": "Therefore, BAT activation can be achieved by either inducing the expression of positive regulators of PGC1\u03b1 or by inhibiting the repressors of the PGC1\u03b1/UCP1 pathway.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 777, "offsetInEndSection": 916, "text": "Here, we review the most important negative regulators of PGC1\u03b1/UCP1 signaling and their mechanism of action in BAT-mediated thermogenesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334"}, {"offsetInBeginSection": 0, "offsetInEndSection": 67, "text": "Thermogenic activation represses autophagy in brown adipose tissue.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339605"}, {"offsetInBeginSection": 0, "offsetInEndSection": 149, "text": "BACKGROUND: Brown adipose tissue (BAT) thermogenesis is an adaptive process, essential for energy expenditure and involved in the control of obesity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339605"}, {"offsetInBeginSection": 233, "offsetInEndSection": 397, "text": "Autophagy has been proposed as relevant for brown-vs-white adipocyte differentiation; however, its role in the response of BAT to thermogenic activation is unknown.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339605"}]}, {"id": "5a99566e1d1251d03b00000f", "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12566936", "http://www.ncbi.nlm.nih.gov/pubmed/16436187", "http://www.ncbi.nlm.nih.gov/pubmed/16110245", "http://www.ncbi.nlm.nih.gov/pubmed/29075213", "http://www.ncbi.nlm.nih.gov/pubmed/16360899", "http://www.ncbi.nlm.nih.gov/pubmed/19657584", "http://www.ncbi.nlm.nih.gov/pubmed/18845200", "http://www.ncbi.nlm.nih.gov/pubmed/19194374", "http://www.ncbi.nlm.nih.gov/pubmed/25794322", "http://www.ncbi.nlm.nih.gov/pubmed/12554604"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 78, "text": "A regulatory monoamine oxidase a promoter polymorphism and personality traits.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}, {"offsetInBeginSection": 0, "offsetInEndSection": 132, "text": "Monoamine oxidase type A (MAOA) has been implicated to be part of mechanisms underlying human temperament and psychiatric disorders.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}, {"offsetInBeginSection": 133, "offsetInEndSection": 274, "text": "We hypothesised that a functional polymorphism in the 5' untranslated region of the MAOA gene is associated with specific personality traits.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}, {"offsetInBeginSection": 275, "offsetInEndSection": 567, "text": "In 371 healthy Caucasians, we estimated personality traits by the use of the Karolinska Scales of Personality (KSP), Scandinavian Universities Scales of Personality, Health-Relevant 5-Factor Personality inventory, Temperament and Character Inventory and the revised NEO Personality Inventory.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}, {"offsetInBeginSection": 568, "offsetInEndSection": 753, "text": "In the same subjects, we analysed the genotype of a polymorphic region consisting of a variable number of a 30-bp repeat sequence located approximately 1.2 kb upstream of the MAOA gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}, {"offsetInBeginSection": 754, "offsetInEndSection": 926, "text": "After correction for multiple testing, no statistically significant differences between MAOA genotype and personality were observed in men (n = 206) nor in women (n = 165).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}, {"offsetInBeginSection": 927, "offsetInEndSection": 1099, "text": "We conclude that the structure of this MAOA promoter region does not have a large impact on the expression of personality characteristics in the present Swedish population.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936"}, {"offsetInBeginSection": 0, "offsetInEndSection": 103, "text": "Structural variation of the monoamine oxidase A gene promoter repeat polymorphism in nonhuman primates.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187"}, {"offsetInBeginSection": 0, "offsetInEndSection": 377, "text": "By conferring allele-specific transcriptional activity on the monoamine oxidase A (MAOA) gene in humans, length variation of a repetitive sequence [(variable number of tandem repeat (VNTR)] in the MAOA promoter influences a constellation of personality traits related to aggressive and antisocial behavior and increases the risk of neurodevelopmental and psychiatric disorders.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187"}, {"offsetInBeginSection": 378, "offsetInEndSection": 499, "text": "Here, we have analyzed the presence and variability of this MAOA promoter repeat in several species of nonhuman primates.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187"}]}, {"id": "5ab9032afcf4565872000018", "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20177397", "http://www.ncbi.nlm.nih.gov/pubmed/27725641", "http://www.ncbi.nlm.nih.gov/pubmed/25959793", "http://www.ncbi.nlm.nih.gov/pubmed/21311564", "http://www.ncbi.nlm.nih.gov/pubmed/26292731", "http://www.ncbi.nlm.nih.gov/pubmed/23204322", "http://www.ncbi.nlm.nih.gov/pubmed/21641882", "http://www.ncbi.nlm.nih.gov/pubmed/24845676", "http://www.ncbi.nlm.nih.gov/pubmed/27160911", "http://www.ncbi.nlm.nih.gov/pubmed/20098673"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 52, "text": "Genomic instability--an evolving hallmark of cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397"}, {"offsetInBeginSection": 0, "offsetInEndSection": 56, "text": "Genomic instability is a characteristic of most cancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397"}, {"offsetInBeginSection": 57, "offsetInEndSection": 213, "text": "In hereditary cancers, genomic instability results from mutations in DNA repair genes and drives cancer development, as predicted by the mutator hypothesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397"}, {"offsetInBeginSection": 214, "offsetInEndSection": 488, "text": "In sporadic (non-hereditary) cancers the molecular basis of genomic instability remains unclear, but recent high-throughput sequencing studies suggest that mutations in DNA repair genes are infrequent before therapy, arguing against the mutator hypothesis for these cancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397"}, {"offsetInBeginSection": 489, "offsetInEndSection": 846, "text": "Instead, the mutation patterns of the tumour suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "Increased global transcription activity as a mechanism of replication stress in cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641"}, {"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "Cancer is a disease associated with genomic instability that often results from oncogene activation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641"}, {"offsetInBeginSection": 101, "offsetInEndSection": 165, "text": "This in turn leads to hyperproliferation and replication stress.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641"}, {"offsetInBeginSection": 166, "offsetInEndSection": 278, "text": "However, the molecular mechanisms that underlie oncogene-induced replication stress are still poorly understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641"}, {"offsetInBeginSection": 0, "offsetInEndSection": 139, "text": "Recurrent genomic instability in cancer is attributed to positive selection and/or the sensitivity of specific genomic regions to breakage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793"}]}, {"id": "5aa6800ad6d6b54f79000011", "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25566611", "http://www.ncbi.nlm.nih.gov/pubmed/17296251", "http://www.ncbi.nlm.nih.gov/pubmed/23942901", "http://www.ncbi.nlm.nih.gov/pubmed/16739129", "http://www.ncbi.nlm.nih.gov/pubmed/23837364", "http://www.ncbi.nlm.nih.gov/pubmed/4295848", "http://www.ncbi.nlm.nih.gov/pubmed/10941733", "http://www.ncbi.nlm.nih.gov/pubmed/25480485", "http://www.ncbi.nlm.nih.gov/pubmed/20117540", "http://www.ncbi.nlm.nih.gov/pubmed/4882024"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Mouse cytokine profile skewed towards Th2 in pregnancy during infection with Brucella abortus S19 strain.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611"}, {"offsetInBeginSection": 154, "offsetInEndSection": 290, "text": "Brucellosis is an intracellular bacterium that elicits the Th1 response and is known to cause spontaneous abortion in mammalian species.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611"}, {"offsetInBeginSection": 291, "offsetInEndSection": 449, "text": "This study sought to determine if Brucella infection causes spontaneous abortion by causing the circulating cytokine profile be Th1 dominant during pregnancy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611"}, {"offsetInBeginSection": 450, "offsetInEndSection": 584, "text": "Forty-eight Swiss white mice were used in this murine model and the S19 strain of Brucella abortus was used in as the infective agent.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296251"}, {"offsetInBeginSection": 0, "offsetInEndSection": 177, "text": "Brucella abortus, a facultative intracellular pathogen, is of tremendous zoonotic importance because of its ability to induce spontaneous abortion in cattle and other livestock.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296251"}, {"offsetInBeginSection": 178, "offsetInEndSection": 295, "text": "It is also known to cause persistent undulant fever, endocarditis, arthritis, osteomyelitis and meningitis in humans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296251"}, {"offsetInBeginSection": 755, "offsetInEndSection": 970, "text": "The liposomisation of rL7/L12 protein causes tremendous increase in cell-mediated immune response in terms of delayed type hypersensitivity, T-cell proliferation and up-regulation in type I cytokine expression, etc.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296251"}, {"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "Abortion and premature birth in cattle following vaccination with Brucella abortus strain RB51.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23942901"}, {"offsetInBeginSection": 0, "offsetInEndSection": 126, "text": "Brucella abortus RB51 is the vaccine strain currently licensed for immunizing cattle against brucellosis in the United States.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23942901"}]}, {"id": "5abd3707fcf456587200002d", "body": "Is the petrous bone used in ancient DNA sampling?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28129388", "http://www.ncbi.nlm.nih.gov/pubmed/28625158", "http://www.ncbi.nlm.nih.gov/pubmed/26086078"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388"}, {"offsetInBeginSection": 0, "offsetInEndSection": 118, "text": "Large-scale genomic analyses of ancient human populations have become feasible partly due to refined sampling methods.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388"}, {"offsetInBeginSection": 618, "offsetInEndSection": 723, "text": "Despite sample-to-sample variation, petrous bone overall performs better than tooth cementum (p = 0.001).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388"}, {"offsetInBeginSection": 435, "offsetInEndSection": 617, "text": "Both substrates display significantly higher endogenous DNA content (average of 16.4% and 40.0% for teeth and petrous bones, respectively) than parietal skull bone (average of 2.2%).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 0, "offsetInEndSection": 208, "text": "Ancient DNA (aDNA) research involves invasive and destructive sampling procedures that are often incompatible with anthropological, anatomical, and bioarcheological analyses requiring intact skeletal remains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 209, "offsetInEndSection": 495, "text": "The osseous labyrinth inside the petrous bone has been shown to yield higher amounts of endogenous DNA than any other skeletal element; however, accessing this labyrinth in cases of a complete or reconstructed skull involves causing major structural damage to the cranial vault or base.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 731, "offsetInEndSection": 943, "text": "We assessed this method by comparing the aDNA results from one petrous bone processed using our novel method to its pair, which was processed using established protocols for sampling disarticulated petrous bones.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 944, "offsetInEndSection": 1160, "text": "We show a decrease in endogenous DNA and molecular copy numbers when the drilling method is used; however, we also show that this method produces more endogenous DNA and higher copy numbers than any postcranial bone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158"}, {"offsetInBeginSection": 0, "offsetInEndSection": 77, "text": "Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078"}]}, {"id": "5abc9157fcf456587200001e", "body": "What is \"enhancer hijacking\"?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27869826", "http://www.ncbi.nlm.nih.gov/pubmed/25043047", "http://www.ncbi.nlm.nih.gov/pubmed/29059320", "http://www.ncbi.nlm.nih.gov/pubmed/26229090"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826"}, {"offsetInBeginSection": 751, "offsetInEndSection": 880, "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826"}, {"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047"}, {"offsetInBeginSection": 737, "offsetInEndSection": 902, "text": "Somatic structural variants juxtapose GFI1 or GFI1B coding sequences proximal to active enhancer elements, including super-enhancers, instigating oncogenic activity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047"}, {"offsetInBeginSection": 903, "offsetInEndSection": 1131, "text": "Our results, supported by evidence from mouse models, identify GFI1 and GFI1B as prominent medulloblastoma oncogenes and implicate 'enhancer hijacking' as an efficient mechanism driving oncogene activation in a childhood cancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047"}, {"offsetInBeginSection": 154, "offsetInEndSection": 346, "text": "Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29059320"}, {"offsetInBeginSection": 1060, "offsetInEndSection": 1264, "text": "DiseaseEnhancer provides a promising avenue for researchers to facilitate the understanding of enhancer deregulation in disease pathogenesis, and identify new biomarkers for disease diagnosis and therapy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29059320"}, {"offsetInBeginSection": 1172, "offsetInEndSection": 1311, "text": "SIGNIFICANCE: We demonstrate a novel approach for simultaneous detection of genomic rearrangements and enhancer activity in tumor biopsies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090"}, {"offsetInBeginSection": 1312, "offsetInEndSection": 1503, "text": "We identify novel mechanisms of enhancer-driven regulation of the oncogenes MYC and BCL6, and show that the BCL6 locus can serve as an enhancer donor in an \"enhancer hijacking\" translocation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090"}]}, {"id": "5ab9050bfcf4565872000019", "body": "What is break induced replication?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28427283", "http://www.ncbi.nlm.nih.gov/pubmed/25329304", "http://www.ncbi.nlm.nih.gov/pubmed/11030337", "http://www.ncbi.nlm.nih.gov/pubmed/12660252", "http://www.ncbi.nlm.nih.gov/pubmed/17671506", "http://www.ncbi.nlm.nih.gov/pubmed/21183718", "http://www.ncbi.nlm.nih.gov/pubmed/26055704", "http://www.ncbi.nlm.nih.gov/pubmed/28732309", "http://www.ncbi.nlm.nih.gov/pubmed/20479284", "http://www.ncbi.nlm.nih.gov/pubmed/6275090"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 81, "text": "Break induced replication in eukaryotes: mechanisms, functions, and consequences.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283"}, {"offsetInBeginSection": 0, "offsetInEndSection": 124, "text": "Break-induced replication (BIR) is an important pathway specializing in repair of one-ended double-strand DNA breaks (DSBs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283"}, {"offsetInBeginSection": 0, "offsetInEndSection": 112, "text": "Break-induced replication requires DNA damage-induced phosphorylation of Pif1 and leads to telomere lengthening.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Broken replication forks result in DNA breaks that are normally repaired via homologous recombination or break induced replication (BIR).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304"}, {"offsetInBeginSection": 412, "offsetInEndSection": 602, "text": "This telomere lengthening required functional telomerase, the core DNA damage signaling cascade Mec1-Rad9-Rad53, and the components of the BIR repair pathway - Rad51, Rad52, Pol32, and Pif1.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304"}, {"offsetInBeginSection": 603, "offsetInEndSection": 819, "text": "The Mec1-Rad53 induced phosphorylation of Pif1, previously found necessary for inhibition of telomerase at double strand breaks, was also important for the role of Pif1 in BIR and telomere elongation in cdc9-1 cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304"}, {"offsetInBeginSection": 820, "offsetInEndSection": 990, "text": "Two other mutants with impaired DNA replication, cdc44-5 and rrm3\u0394, were similar to cdc9-1: their long telomere phenotype was dependent on the Pif1 phosphorylation locus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Tn7 transposes proximal to DNA double-strand breaks and into regions where chromosomal DNA replication terminates.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337"}, {"offsetInBeginSection": 298, "offsetInEndSection": 467, "text": "When DNA double-strand breaks are induced at specific sites in the chromosome, Tn7 transposition is stimulated and insertions are directed proximal to the induced break.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337"}, {"offsetInBeginSection": 0, "offsetInEndSection": 195, "text": "Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12660252"}]}, {"id": "5aac543bfcf4565872000004", "body": "What biologic process in the body is associated with Mast cells?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22706316", "http://www.ncbi.nlm.nih.gov/pubmed/17386403", "http://www.ncbi.nlm.nih.gov/pubmed/22906983", "http://www.ncbi.nlm.nih.gov/pubmed/9354811", "http://www.ncbi.nlm.nih.gov/pubmed/6184614", "http://www.ncbi.nlm.nih.gov/pubmed/10359893", "http://www.ncbi.nlm.nih.gov/pubmed/16141514", "http://www.ncbi.nlm.nih.gov/pubmed/17468237", "http://www.ncbi.nlm.nih.gov/pubmed/17062134", "http://www.ncbi.nlm.nih.gov/pubmed/6178551"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 173, "text": "Insulin-containing lipogenic stimuli suppress mast cell degranulation potential and up-regulate lipid body biogenesis and eicosanoid secretion in a PPAR\u03b3-independent manner.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 110, "offsetInEndSection": 248, "text": "Here, we test the hypothesis that insulin may regulate lipid body content in mast cells and hence, modify their proinflammatory potential.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 249, "offsetInEndSection": 327, "text": "Our data show that insulin causes lipid body accumulation in RBL2H3 and BMMCs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 328, "offsetInEndSection": 454, "text": "Lipid body accumulation in mast cells is associated with enhanced levels of leukotriene-synthesizing enzymes (LTC4S and 5-LO).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 455, "offsetInEndSection": 552, "text": "Increased basal and antigen-stimulated release of LTC4 is observed in insulin-treated mast cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 553, "offsetInEndSection": 806, "text": "Concomitantly, the insulin-containing lipogenic stimulus induces a phenotypic change in mast cells, where this enhancement in leukotriene levels is accompanied by a marked down-regulation in secretory granule content and release in response to stimulus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 807, "offsetInEndSection": 1075, "text": "Mast cells exposed to insulin exhibit altered scatter and fluorescence properties, accumulating in a SSC(lo)FSC(hi) population that exhibits decreased BS staining and degranulation responses and is enriched in NR-positive lipid bodies and eicosanoid synthesis enzymes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 1076, "offsetInEndSection": 1299, "text": "Lipid body accumulation in mast cells is mechanistically distinct from the process in adipocytes; for example, it is independent of PPAR\u03b3 up-regulation and does not involve significant accumulation of conjugated glycerides.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 1300, "offsetInEndSection": 1433, "text": "Thus, chronic exposure to metabolic stimuli, such as insulin, may be a determinant of the proinflammatory potential of the mast cell.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316"}, {"offsetInBeginSection": 0, "offsetInEndSection": 50, "text": "Different approaches to study mast cell functions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403"}]}, {"id": "5abd44b1fcf4565872000030", "body": "List proteins with HEAT repeats", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19777061", "http://www.ncbi.nlm.nih.gov/pubmed/11042144", "http://www.ncbi.nlm.nih.gov/pubmed/11491282", "http://www.ncbi.nlm.nih.gov/pubmed/23895768", "http://www.ncbi.nlm.nih.gov/pubmed/25435324", "http://www.ncbi.nlm.nih.gov/pubmed/14970380", "http://www.ncbi.nlm.nih.gov/pubmed/24053231", "http://www.ncbi.nlm.nih.gov/pubmed/27802131", "http://www.ncbi.nlm.nih.gov/pubmed/15099583", "http://www.ncbi.nlm.nih.gov/pubmed/20060908"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "Highly sensitive detection of individual HEAT and ARM repeats with HHpred and COACH.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061"}, {"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "BACKGROUND: HEAT and ARM repeats occur in a large number of eukaryotic proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061"}, {"offsetInBeginSection": 81, "offsetInEndSection": 182, "text": "As these repeats are often highly diverged, the prediction of HEAT or ARM domains can be challenging.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061"}, {"offsetInBeginSection": 951, "offsetInEndSection": 1172, "text": "When we applied a new protocol using both HHpred and COACH to these structures, it detected 82% of HEAT repeats and 90% of ARM repeats, with the minimum for a given protein of 57% for HEAT repeats and 60% for ARM repeats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061"}, {"offsetInBeginSection": 1173, "offsetInEndSection": 1323, "text": "Application to bona fide HEAT and ARM proteins or domains indicated that similar numbers can be expected for the full complement of HEAT/ARM proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061"}, {"offsetInBeginSection": 1457, "offsetInEndSection": 1563, "text": "Double false positive hits for a given protein were rare for HEAT and not at all observed for ARM repeats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061"}, {"offsetInBeginSection": 1904, "offsetInEndSection": 2037, "text": "SIGNIFICANCE: A protocol is presented for the identification of individual HEAT or ARM repeats which is straightforward to implement.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061"}, {"offsetInBeginSection": 0, "offsetInEndSection": 112, "text": "HEAT repeats associated with condensins, cohesins, and other complexes involved in chromosome-related functions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144"}, {"offsetInBeginSection": 0, "offsetInEndSection": 154, "text": "HEAT repeats correspond to tandemly arranged curlicue-like structures that appear to serve as flexible scaffolding on which other components can assemble.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144"}, {"offsetInBeginSection": 155, "offsetInEndSection": 438, "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144"}]}, {"id": "5abc974bfcf456587200001f", "body": "Is recursive splicing more common in short introns?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27965595", "http://www.ncbi.nlm.nih.gov/pubmed/15802507", "http://www.ncbi.nlm.nih.gov/pubmed/25970244", "http://www.ncbi.nlm.nih.gov/pubmed/25970246"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 69, "text": "Cutting a Long Intron Short: Recursive Splicing and Its Implications.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595"}, {"offsetInBeginSection": 481, "offsetInEndSection": 648, "text": "Introns are differentially removed in a cell type-specific manner to produce a range of alternatively-spliced transcripts, and many span tens to hundreds of kilobases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595"}, {"offsetInBeginSection": 649, "offsetInEndSection": 843, "text": "Recent work in human and fruitfly tissues revealed that long introns are extensively processed cotranscriptionally and in a stepwise manner, before their two flanking exons are spliced together.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595"}, {"offsetInBeginSection": 844, "offsetInEndSection": 1029, "text": "This process, called \"recursive splicing,\" often involves non-canonical splicing elements positioned deep within introns, and different mechanisms for its deployment have been proposed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595"}, {"offsetInBeginSection": 1030, "offsetInEndSection": 1218, "text": "Still, the very existence and widespread nature of recursive splicing offers a new regulatory layer in the transcript maturation pathway, which may also have implications in human disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595"}, {"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "Over time eukaryotic genomes have evolved to host genes carrying multiple exons separated by increasingly larger intronic, mostly non-protein-coding, sequences.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "Subdivision of large introns in Drosophila by recursive splicing at nonexonic elements.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507"}, {"offsetInBeginSection": 0, "offsetInEndSection": 166, "text": "Many genes with important roles in development and disease contain exceptionally long introns, but special mechanisms for their expression have not been investigated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507"}, {"offsetInBeginSection": 167, "offsetInEndSection": 364, "text": "We present bioinformatic, phylogenetic, and experimental evidence in Drosophila for a mechanism that subdivides many large introns by recursive splicing at nonexonic elements and alternative exons.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507"}, {"offsetInBeginSection": 365, "offsetInEndSection": 638, "text": "Recursive splice sites predicted with highly stringent criteria are found at much higher frequency than expected in the sense strands of introns >20 kb, but they are found only at the expected frequency on the antisense strands, and they are underrepresented within introns", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507"}]}, {"id": "5ac0a82d19833b0d7b000003", "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28373570", "http://www.ncbi.nlm.nih.gov/pubmed/24942628", "http://www.ncbi.nlm.nih.gov/pubmed/20924363", "http://www.ncbi.nlm.nih.gov/pubmed/19796077", "http://www.ncbi.nlm.nih.gov/pubmed/8213828", "http://www.ncbi.nlm.nih.gov/pubmed/19277018", "http://www.ncbi.nlm.nih.gov/pubmed/21851223"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 151, "text": "Duchenne muscular dystrophy (DMD) is a lethal genetic disorder caused by an absence of the dystrophin protein in bodywide muscles, including the heart.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570"}, {"offsetInBeginSection": 203, "offsetInEndSection": 395, "text": "Exon skipping via synthetic phosphorodiamidate morpholino oligomers (PMOs) represents one of the most promising therapeutic options, yet PMOs have shown very little efficacy in cardiac muscle.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 0, "offsetInEndSection": 298, "text": "Antisense therapy with both chemistries of phosphorodiamidate morpholino oligomers (PMOs) and 2'-O-methyl phosphorothioate has demonstrated the capability to induce dystrophin expression in Duchenne muscular dystrophy (DMD) patients in phase II-III clinical trials with benefit in muscle functions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 407, "offsetInEndSection": 701, "text": "In this study, we examined the effect of peptide-conjugated PMO (PPMO)-mediated exon skipping on disease progression of utrophin-dystrophin-deficient mice (dko) of four age groups (21-29, 30-39, 40-49 and 50+ days), representing diseases from early stage to advanced stage with severe kyphosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 730, "offsetInEndSection": 848, "text": "administration of the PPMO restored the dystrophin expression in nearly 100% skeletal muscle fibers in all age groups.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 849, "offsetInEndSection": 1000, "text": "This was associated with the restoration of dystrophin-associated proteins including functional glycosylated dystroglycan and neuronal nitric synthase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 1110, "offsetInEndSection": 1271, "text": "The PPMO treatment alleviated the disease pathology and significantly prolonged the life span of the mice receiving treatment at younger age with mild phenotype.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 1272, "offsetInEndSection": 1446, "text": "However, restoration of high levels of dystrophin expression failed to prevent disease progression to the mice receiving treatment when disease was already at advanced stage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}, {"offsetInBeginSection": 1447, "offsetInEndSection": 1537, "text": "The results could be critical for design of clinical trials with antisense therapy to DMD.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628"}]}, {"id": "5aac5469fcf4565872000005", "body": "What are 7 symptoms of yellow fever?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12410495", "http://www.ncbi.nlm.nih.gov/pubmed/8599063", "http://www.ncbi.nlm.nih.gov/pubmed/19869938", "http://www.ncbi.nlm.nih.gov/pubmed/19868337", "http://www.ncbi.nlm.nih.gov/pubmed/16498293", "http://www.ncbi.nlm.nih.gov/pubmed/559399", "http://www.ncbi.nlm.nih.gov/pubmed/9402373", "http://www.ncbi.nlm.nih.gov/pubmed/20300380", "http://www.ncbi.nlm.nih.gov/pubmed/28358796", "http://www.ncbi.nlm.nih.gov/pubmed/11000957"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "A Belgian traveler who acquired yellow fever in the Gambia.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "A 47-year-old Belgian woman acquired yellow fever during a 1-week vacation in The Gambia; she had never been vaccinated against yellow fever.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495"}, {"offsetInBeginSection": 142, "offsetInEndSection": 233, "text": "She died of massive gastrointestinal bleeding 7 days after the onset of the first symptoms.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495"}, {"offsetInBeginSection": 234, "offsetInEndSection": 482, "text": "This dramatic case demonstrates that it is important for persons to be vaccinated against yellow fever before they travel to countries where yellow fever is endemic, even if the country, like The Gambia, does not require travelers to be vaccinated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495"}, {"offsetInBeginSection": 0, "offsetInEndSection": 91, "text": "Jungle yellow fever: clinical and laboratorial studies emphasizing viremia on a human case.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "The authors report the clinical, laboratorial and epidemiological aspects of a human case of jungle yellow fever.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063"}, {"offsetInBeginSection": 114, "offsetInEndSection": 257, "text": "The patient suffered from fever, chills, sweating, headaches, backaches, myalgia, epigastric pains, nausea, vomiting, diarrhea and prostration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063"}, {"offsetInBeginSection": 258, "offsetInEndSection": 362, "text": "He was unvaccinated and had been working in areas where cases of jungle yellow fever had been confirmed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063"}, {"offsetInBeginSection": 363, "offsetInEndSection": 427, "text": "Investigations concerning the yellow fever virus were performed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063"}, {"offsetInBeginSection": 869, "offsetInEndSection": 984, "text": "The yellow fever virus, recovered from the two first samples and the virus titration, showed high level of viremia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063"}]}, {"id": "5ac07b67dd95b2cd42000001", "body": "Is Lysyl oxidase crosslinking collagen?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12918034", "http://www.ncbi.nlm.nih.gov/pubmed/8116", "http://www.ncbi.nlm.nih.gov/pubmed/2870873", "http://www.ncbi.nlm.nih.gov/pubmed/906929", "http://www.ncbi.nlm.nih.gov/pubmed/8096378", "http://www.ncbi.nlm.nih.gov/pubmed/4531019", "http://www.ncbi.nlm.nih.gov/pubmed/2890532", "http://www.ncbi.nlm.nih.gov/pubmed/26918", "http://www.ncbi.nlm.nih.gov/pubmed/22633114", "http://www.ncbi.nlm.nih.gov/pubmed/9524359"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12918034"}, {"offsetInBeginSection": 105, "offsetInEndSection": 361, "text": "In this study, we utilized lysyl oxidase (LO) to enzymatically crosslink extracellular matrix (ECM) proteins, particularly collagen and elastin, to enhance the mechanical integrity of the ECM and thereby impart mechanical strength to the engineered tissue.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12918034"}, {"offsetInBeginSection": 857, "offsetInEndSection": 1098, "text": "When smooth muscle cells transfected with lysyl oxidase were seeded in collagen gels, the tensile strength and elastic modulus in these constructs increased by approximately two-fold compared to constructs seeded with mock-transfected VSMCs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12918034"}, {"offsetInBeginSection": 0, "offsetInEndSection": 52, "text": "Lysyl oxidase: a pituitary hormone-dependent enzyme.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8116"}, {"offsetInBeginSection": 312, "offsetInEndSection": 480, "text": "The enzyme lysyl oxidase which catalyses the aldehyde formation in certain lysyl residues of collagen and elastin was extracted from the skin of hypophysectomized rats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8116"}, {"offsetInBeginSection": 650, "offsetInEndSection": 817, "text": "The result showed that the aldehyde deficient collagen did not crosslink while in the hypophysectomized animal indicating the lack of active lysyl oxidase in the rats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8116"}, {"offsetInBeginSection": 0, "offsetInEndSection": 109, "text": "Skin lysyl oxidase activity is not rate limiting for collagen crosslinking in the glucocorticoid-treated rat.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873"}, {"offsetInBeginSection": 0, "offsetInEndSection": 181, "text": "Lysyl oxidase activity in the skin of rats receiving triamcinolone diacetate (12 mg/kg) for three consecutive days was decreased by sixty-four percent as compared to control values.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873"}, {"offsetInBeginSection": 182, "offsetInEndSection": 288, "text": "A decrease of lysyl oxidase activity was observed twelve hours after the initial glucocorticoid injection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873"}, {"offsetInBeginSection": 289, "offsetInEndSection": 411, "text": "The decreased lysyl oxidase activity was accompanied by a forty-nine percent decrease of acetic acid extractable collagen.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873"}]}, {"id": "5abc9c1efcf4565872000020", "body": "How are deletion breakpoints defined?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/1684331", "http://www.ncbi.nlm.nih.gov/pubmed/1741389", "http://www.ncbi.nlm.nih.gov/pubmed/16293123", "http://www.ncbi.nlm.nih.gov/pubmed/11001932", "http://www.ncbi.nlm.nih.gov/pubmed/11336982", "http://www.ncbi.nlm.nih.gov/pubmed/9326327", "http://www.ncbi.nlm.nih.gov/pubmed/10631140", "http://www.ncbi.nlm.nih.gov/pubmed/19484265", "http://www.ncbi.nlm.nih.gov/pubmed/17351135", "http://www.ncbi.nlm.nih.gov/pubmed/12297986"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 175, "text": "The albino-deletion complex of the mouse: molecular mapping of deletion breakpoints that define regions necessary for development of the embryonic and extraembryonic ectoderm.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331"}, {"offsetInBeginSection": 694, "offsetInEndSection": 879, "text": "Here we report the use of a probe derived from a deletion breakpoint fusion fragment cloned from c24R75M/c24R75M DNA to clone a breakpoint fusion fragment caused by the c14CoS deletion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389"}, {"offsetInBeginSection": 1225, "offsetInEndSection": 1465, "text": "Therefore, the Fah gene maps within or proximal to the hsdr-1 locus, as defined by deletion breakpoints, and disruption of this gene may be partially or completely responsible for the phenotypes associated with the hsdr-1 deletion syndrome.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389"}, {"offsetInBeginSection": 0, "offsetInEndSection": 179, "text": "Murine fumarylacetoacetate hydrolase (Fah) gene is disrupted by a neonatally lethal albino deletion that defines the hepatocyte-specific developmental regulation 1 (hsdr-1) locus.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389"}, {"offsetInBeginSection": 282, "offsetInEndSection": 499, "text": "Subsequently, the deletion of exon 2 of the copper metabolism domain containing 1 (COMMD1) gene (formerly MURR1) was shown to be the major cause of copper toxicosis, although the deletion breakpoints were not defined.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123"}, {"offsetInBeginSection": 500, "offsetInEndSection": 684, "text": "In this investigation, polymerase chain reaction (PCR)-based techniques and sequencing were used to isolate the deletion breakpoints, utilizing the newly available dog genome sequence.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123"}, {"offsetInBeginSection": 837, "offsetInEndSection": 965, "text": "The two breakpoints share sequence homology suggesting that homologous recombination may have been responsible for the deletion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123"}, {"offsetInBeginSection": 1131, "offsetInEndSection": 1242, "text": "Results from the 40 samples showed allele 2 of C04107 to be in linkage disequilibrium with the COMMD1 deletion.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123"}, {"offsetInBeginSection": 0, "offsetInEndSection": 119, "text": "Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11001932"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "Deletion of any of three regions of the human Y chromosome results in spermatogenic failure and infertility.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11001932"}]}, {"id": "5ac7185f0340b9f058000004", "body": "Which cellular functions are affected by lncRNA H19 in the heart?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27317124", "http://www.ncbi.nlm.nih.gov/pubmed/29036538", "http://www.ncbi.nlm.nih.gov/pubmed/27895893", "http://www.ncbi.nlm.nih.gov/pubmed/26853553", "http://www.ncbi.nlm.nih.gov/pubmed/28790415", "http://www.ncbi.nlm.nih.gov/pubmed/27796346", "http://www.ncbi.nlm.nih.gov/pubmed/27307343", "http://www.ncbi.nlm.nih.gov/pubmed/27040767", "http://www.ncbi.nlm.nih.gov/pubmed/28063931", "http://www.ncbi.nlm.nih.gov/pubmed/28881833"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Long noncoding RNA dysregulation in ischemic heart failure.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 0, "offsetInEndSection": 142, "text": "BACKGROUND: Long noncoding RNAs (lncRNAs) are non-protein coding transcripts regulating a variety of physiological and pathological functions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 143, "offsetInEndSection": 212, "text": "However, their implication in heart failure is still largely unknown.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 213, "offsetInEndSection": 334, "text": "The aim of this study is to identify and characterize lncRNAs deregulated in patients affected by ischemic heart failure.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 334, "offsetInEndSection": 503, "text": "METHODS: LncRNAs were profiled and validated in left ventricle biopsies of 18 patients affected by non end-stage dilated ischemic cardiomyopathy and 17 matched controls.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 720, "offsetInEndSection": 800, "text": "Peripheral blood mononuclear cells of heart failure patients were also analyzed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 801, "offsetInEndSection": 872, "text": "LncRNA distribution in the heart was assessed by in situ hybridization.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 1036, "offsetInEndSection": 1177, "text": "RESULTS: Fourteen lncRNAs were significantly modulated in non end-stage heart failure patients, identifying a heart failure lncRNA signature.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 1178, "offsetInEndSection": 1333, "text": "Nine of these lncRNAs (CDKN2B-AS1/ANRIL, EGOT, H19, HOTAIR, LOC285194/TUSC7, RMRP, RNY5, SOX2-OT and SRA1) were also confirmed in end-stage failing hearts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}, {"offsetInBeginSection": 1334, "offsetInEndSection": 1454, "text": "Intriguingly, among the conserved lncRNAs, h19, rmrp and hotair were also induced in a mouse model of heart hypertrophy.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124"}]}, {"id": "5aae651ffcf456587200000d", "body": "What is the function of penicillinase, also known as beta lactamase?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/806305", "http://www.ncbi.nlm.nih.gov/pubmed/3541135", "http://www.ncbi.nlm.nih.gov/pubmed/3877980", "http://www.ncbi.nlm.nih.gov/pubmed/2406875", "http://www.ncbi.nlm.nih.gov/pubmed/9624479", "http://www.ncbi.nlm.nih.gov/pubmed/6448580", "http://www.ncbi.nlm.nih.gov/pubmed/11399858", "http://www.ncbi.nlm.nih.gov/pubmed/6803835", "http://www.ncbi.nlm.nih.gov/pubmed/9158769", "http://www.ncbi.nlm.nih.gov/pubmed/4985545"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 71, "text": "[Identification of the beta lactamase R-TEM of Pseudomonas aeruginosa].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305"}, {"offsetInBeginSection": 78, "offsetInEndSection": 160, "text": "aeruginosa resistant to classical beta lactam antibiotics including carbenicillin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305"}, {"offsetInBeginSection": 212, "offsetInEndSection": 501, "text": "In both cases, we have shown the simultaneous biosynthesis of two enzymes: an inducible and chromosome cephalosporinase frequently found in this germ, and a constitutive beta lactamase, with a penicillinase activity which has been identified with the extrachromosomic beta lactamase R-TEM.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305"}, {"offsetInBeginSection": 502, "offsetInEndSection": 766, "text": "These two enzymes have been separated by affinity chromatography, characterized by their kinetic constants given by computerized microacidimetry, and their isoelectric points which are respectively 9.2 for the cephalosporinase and 5.40 for the penicillinase R-TEM.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305"}, {"offsetInBeginSection": 767, "offsetInEndSection": 836, "text": "Isoelectric focussing also shows the separation of these two enzymes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305"}, {"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Mechanisms of beta-lactam resistance in anaerobic bacteria.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135"}, {"offsetInBeginSection": 0, "offsetInEndSection": 227, "text": "The known mechanisms of beta-lactam resistance in anaerobic bacteria involve production of beta-lactamases, alteration of penicillin-binding proteins, and blocking of the penetration of beta-lactams through the outer membranes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135"}, {"offsetInBeginSection": 228, "offsetInEndSection": 316, "text": "The most important factor in beta-lactam resistance is the production of beta-lactamase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135"}, {"offsetInBeginSection": 317, "offsetInEndSection": 416, "text": "beta-Lactamases in various Bacteroides, Fusobacterium, and Clostridium species have been described.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135"}, {"offsetInBeginSection": 417, "offsetInEndSection": 566, "text": "beta-Lactam resistance in Bacteroides fragilis is most commonly mediated by the production of beta-lactamase, primarily of the cephalosporinase type.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135"}]}, {"id": "5ac0817cd0c506ce46000001", "body": "Is p53 a transcription factor?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/7651386", "http://www.ncbi.nlm.nih.gov/pubmed/9690516", "http://www.ncbi.nlm.nih.gov/pubmed/1944276", "http://www.ncbi.nlm.nih.gov/pubmed/29125602", "http://www.ncbi.nlm.nih.gov/pubmed/9215863", "http://www.ncbi.nlm.nih.gov/pubmed/7478550", "http://www.ncbi.nlm.nih.gov/pubmed/8862400", "http://www.ncbi.nlm.nih.gov/pubmed/21042708", "http://www.ncbi.nlm.nih.gov/pubmed/9572492", "http://www.ncbi.nlm.nih.gov/pubmed/17762884"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386"}, {"offsetInBeginSection": 135, "offsetInEndSection": 241, "text": "p53, a transcription factor, controls the expression of genes, leading to cell cycle arrest and apoptosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386"}, {"offsetInBeginSection": 340, "offsetInEndSection": 402, "text": "This proliferation is likely to be signaled by growth factors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386"}, {"offsetInBeginSection": 403, "offsetInEndSection": 556, "text": "In this communication, we show that the transforming growth factor alpha (TGF-alpha) gene is a direct target for p53-mediated transcriptional activation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386"}, {"offsetInBeginSection": 1197, "offsetInEndSection": 1402, "text": "In addition to these results, we found that the TGF-alpha promoter contains a nonconsensus but functional TATA box-binding protein-binding site approximately 30 bp upstream of the transcription start site.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386"}, {"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "The p53 protein is a transcription factor involved in processes of cell growth and differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9690516"}, {"offsetInBeginSection": 100, "offsetInEndSection": 226, "text": "The muscle creatine kinase (MCK) gene whose transcription is induced during muscle differentiation contains p53-binding sites.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9690516"}, {"offsetInBeginSection": 227, "offsetInEndSection": 355, "text": "In this study we tested the involvement of p53 in the activation of MCK transcription during muscle differentiation of C2 cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9690516"}, {"offsetInBeginSection": 709, "offsetInEndSection": 821, "text": "The expression of a dominant negative p53 protein in muscle cells reduced the expression of endogenous MCK gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9690516"}, {"offsetInBeginSection": 912, "offsetInEndSection": 1027, "text": "Amino and carboxy terminal residues of MyoD required for the cooperation with p53 in transcription were identified.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9690516"}]}, {"id": "5abc9ecffcf4565872000021", "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25124333", "http://www.ncbi.nlm.nih.gov/pubmed/25193669", "http://www.ncbi.nlm.nih.gov/pubmed/22661583", "http://www.ncbi.nlm.nih.gov/pubmed/9128755", "http://www.ncbi.nlm.nih.gov/pubmed/15313545", "http://www.ncbi.nlm.nih.gov/pubmed/22529999", "http://www.ncbi.nlm.nih.gov/pubmed/16432145", "http://www.ncbi.nlm.nih.gov/pubmed/12090301", "http://www.ncbi.nlm.nih.gov/pubmed/7605803", "http://www.ncbi.nlm.nih.gov/pubmed/9375854"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "Association of G-quadruplex forming sequences with human mtDNA deletion breakpoints.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333"}, {"offsetInBeginSection": 0, "offsetInEndSection": 188, "text": "BACKGROUND: Mitochondrial DNA (mtDNA) deletions cause disease and accumulate during aging, yet our understanding of the molecular mechanisms underlying their formation remains rudimentary.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333"}, {"offsetInBeginSection": 552, "offsetInEndSection": 823, "text": "RESULTS: Here, we show an association between human mtDNA deletion breakpoint locations (sites where DNA ends rejoin after deletion of a section) and sequences with G-quadruplex forming potential (QFP), and establish the ability of selected sequences to form GQ in vitro.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333"}, {"offsetInBeginSection": 1073, "offsetInEndSection": 1320, "text": "We analyzed the position of each motif set relative to either 5' or 3' unique mtDNA deletion breakpoints, and found that intrastrand QFP sequences, but not ddi QFP sequences, showed significant association with mtDNA deletion breakpoint locations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333"}, {"offsetInBeginSection": 1321, "offsetInEndSection": 1457, "text": "Moreover, a large proportion of these QFP sequences occur at smaller distances to breakpoints relative to distribution-matched controls.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333"}, {"offsetInBeginSection": 1733, "offsetInEndSection": 1862, "text": "Notably, the most frequent deletion breakpoints, including those of the \"common deletion\", are bounded by 2G QFP sequence motifs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333"}, {"offsetInBeginSection": 0, "offsetInEndSection": 217, "text": "DNA sequences proximal to human mitochondrial DNA deletion breakpoints prevalent in human disease form G-quadruplexes, a class of DNA structures inefficiently unwound by the mitochondrial replicative Twinkle helicase.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}, {"offsetInBeginSection": 0, "offsetInEndSection": 88, "text": "Mitochondrial DNA deletions are prominent in human genetic disorders, cancer, and aging.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}, {"offsetInBeginSection": 89, "offsetInEndSection": 347, "text": "It is thought that stalling of the mitochondrial replication machinery during DNA synthesis is a prominent source of mitochondrial genome instability; however, the precise molecular determinants of defective mitochondrial replication are not well understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}, {"offsetInBeginSection": 348, "offsetInEndSection": 635, "text": "In this work, we performed a computational analysis of the human mitochondrial genome using the \"Pattern Finder\" G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669"}]}, {"id": "5ac721230340b9f058000005", "body": "Name 4 circular RNA molecules associated with carcinogenesis.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28185365", "http://www.ncbi.nlm.nih.gov/pubmed/28342987", "http://www.ncbi.nlm.nih.gov/pubmed/9154796", "http://www.ncbi.nlm.nih.gov/pubmed/27429839", "http://www.ncbi.nlm.nih.gov/pubmed/29081691", "http://www.ncbi.nlm.nih.gov/pubmed/26874353", "http://www.ncbi.nlm.nih.gov/pubmed/19010924", "http://www.ncbi.nlm.nih.gov/pubmed/850304", "http://www.ncbi.nlm.nih.gov/pubmed/28253710", "http://www.ncbi.nlm.nih.gov/pubmed/8692851"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "Circular RNAs: Biogenesis, properties, roles, and their relationships with liver diseases.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Circular RNAs (circRNAs) are a class of new-found RNA molecules that have a special covalent loop structure without a 5' cap and 3' tail.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365"}, {"offsetInBeginSection": 388, "offsetInEndSection": 600, "text": "By serving as sponges of microRNAs, interacting with long non-coding RNAs, mRNA, or proteins, circRNAs regulate gene expression at transcriptional and post-transcriptional levels and contribute to carcinogenesis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365"}, {"offsetInBeginSection": 855, "offsetInEndSection": 1065, "text": "Then we focus on the molecular mechanisms underlying some circRNAs, including hsa_circ_0001649, hsa_circ_0005075, and cerebellar degeneration-related protein 1 antisense, on hepatocellular carcinoma metastasis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365"}, {"offsetInBeginSection": 0, "offsetInEndSection": 25, "text": "Circular RNAs and cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "Circular RNAs (circRNAs) are a type of non-coding RNA molecules that lack a 5'-terminal cap and 3'-terminal poly A tail.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987"}, {"offsetInBeginSection": 731, "offsetInEndSection": 886, "text": "An in-depth study of circRNA will provide a better understanding of carcinogenesis and assist in developing clinical diagnostic and therapeutic strategies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987"}, {"offsetInBeginSection": 345, "offsetInEndSection": 516, "text": "Remarkably, circular RNA transcripts synthesized by the joining of the donor and acceptor splice sites of the same exon were detected in human epidermis for exons 4 and 5.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796"}, {"offsetInBeginSection": 1101, "offsetInEndSection": 1342, "text": "These results apparently substantiate the hypothesis that alternative pre-mRNA splicing has the potential to generate not only mRNAs that lack one or more exons but also circular RNA molecules that are composed of the exons that are skipped.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796"}, {"offsetInBeginSection": 1742, "offsetInEndSection": 1876, "text": "Moreover, the relative stability of these molecules is apparently the key factor that determines the relative ease of their detection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9154796"}]}, {"id": "5ab147edfcf4565872000013", "body": "The Mantoux test detects what latent infection/disease?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22527447", "http://www.ncbi.nlm.nih.gov/pubmed/17663901", "http://www.ncbi.nlm.nih.gov/pubmed/16307510", "http://www.ncbi.nlm.nih.gov/pubmed/17158278", "http://www.ncbi.nlm.nih.gov/pubmed/12238571", "http://www.ncbi.nlm.nih.gov/pubmed/1983096", "http://www.ncbi.nlm.nih.gov/pubmed/16956501", "http://www.ncbi.nlm.nih.gov/pubmed/19831558", "http://www.ncbi.nlm.nih.gov/pubmed/10524588", "http://www.ncbi.nlm.nih.gov/pubmed/18579028"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "Utility of QuantiFERON\u00ae-TB Gold test in diagnosis and management of suspected tubercular uveitis in India.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "The tuberculin skin test, used to detect latent systemic tuberculosis (TB), has its limitations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 97, "offsetInEndSection": 226, "text": "The utility of interferon-gamma assays, found useful in the diagnosis of latent TB, is still unestablished in tubercular uveitis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 227, "offsetInEndSection": 380, "text": "We present the results of QuantiFERON(\u00ae)-TB Gold (QFT-G) test and its relevance in the diagnosis and management of suspected tubercular uveitis in India.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 804, "offsetInEndSection": 886, "text": "Seven patients presented with active and three with a past history of systemic TB.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 887, "offsetInEndSection": 930, "text": "The QFT-G test was positive in 29 patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 931, "offsetInEndSection": 1051, "text": "Radiological findings of TB were seen in four patients with a positive QFT-G and one patient with a negative QFT-G test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 1052, "offsetInEndSection": 1110, "text": "In 11 patients both QFT-G and Mantoux tests were positive.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 1111, "offsetInEndSection": 1166, "text": "Eighteen Mantoux-negative patients were QFT-G-positive.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}, {"offsetInBeginSection": 1167, "offsetInEndSection": 1243, "text": "Significantly, no patient with a positive Mantoux had a negative QFT-G test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447"}]}, {"id": "5ac08478d0c506ce46000002", "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/29082276", "http://www.ncbi.nlm.nih.gov/pubmed/27167179", "http://www.ncbi.nlm.nih.gov/pubmed/19151744"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 63, "text": "Analysis of Protein Stability by the Cycloheximide Chase Assay.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276"}, {"offsetInBeginSection": 0, "offsetInEndSection": 184, "text": "Comparison of protein stability in eukaryotic cells has been achieved by cycloheximide, which is an inhibitor of protein biosynthesis due to its prevention in translational elongation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276"}, {"offsetInBeginSection": 185, "offsetInEndSection": 327, "text": "It is broadly used in cell biology in terms of determining the half-life of a given protein and has gained much popularity in cancer research.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276"}, {"offsetInBeginSection": 328, "offsetInEndSection": 452, "text": "Here we present a full cycloheximide chase assay in our laboratory using a lung adenocarcinoma cell line, CL1-5, as a model.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276"}, {"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 80, "offsetInEndSection": 181, "text": "Protein abundance reflects the integration of the rates of protein synthesis and protein degradation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 444, "offsetInEndSection": 648, "text": "This article describes the use of cycloheximide chase followed by western blotting to specifically analyze protein degradation in the model unicellular eukaryote, Saccharomyces cerevisiae (budding yeast).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 649, "offsetInEndSection": 755, "text": "In this procedure, yeast cells are incubated in the presence of the translational inhibitor cycloheximide.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 756, "offsetInEndSection": 870, "text": "Aliquots of cells are collected immediately after and at specific time points following addition of cycloheximide.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}, {"offsetInBeginSection": 1023, "offsetInEndSection": 1172, "text": "The cycloheximide chase procedure permits visualization of the degradation kinetics of the steady state population of a variety of cellular proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179"}]}, {"id": "5abcf6b9fcf4565872000027", "body": "What is caused by the ectopic expression of CTCF?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/11507042", "http://www.ncbi.nlm.nih.gov/pubmed/19369356", "http://www.ncbi.nlm.nih.gov/pubmed/21465478", "http://www.ncbi.nlm.nih.gov/pubmed/22724006", "http://www.ncbi.nlm.nih.gov/pubmed/15941718", "http://www.ncbi.nlm.nih.gov/pubmed/14980504", "http://www.ncbi.nlm.nih.gov/pubmed/28862757", "http://www.ncbi.nlm.nih.gov/pubmed/26929370", "http://www.ncbi.nlm.nih.gov/pubmed/26268681", "http://www.ncbi.nlm.nih.gov/pubmed/24725430"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "Cell growth inhibition by the multifunctional multivalent zinc-finger factor CTCF.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 0, "offsetInEndSection": 354, "text": "The 11-zinc finger protein CCTC-binding factor (CTCF) employs different sets of zinc fingers to form distinct complexes with varying CTCF- target sequences (CTSs) that mediate the repression or activation of gene expression and the creation of hormone-responsive gene silencers and of diverse vertebrate enhancer-blocking elements (chromatin insulators).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 355, "offsetInEndSection": 505, "text": "To determine how these varying effects would integrate in vivo, we engineered a variety of expression systems to study effects of CTCF on cell growth.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 506, "offsetInEndSection": 655, "text": "Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 656, "offsetInEndSection": 831, "text": "In asynchronous cultures, the cell-cycle profile of CTCF-expressing cells remained unaltered, which suggested that progression through the cycle was slowed at multiple points.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 832, "offsetInEndSection": 929, "text": "Although conditionally induced CTCF caused the S-phase block, CTCF can also arrest cell division.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 930, "offsetInEndSection": 1013, "text": "Viable CTCF-expressing cells could be maintained without dividing for several days.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 1014, "offsetInEndSection": 1315, "text": "While MYC is the well-characterized CTCF target, the inhibitory effects of CTCF on cell growth could not be ascribed solely to repression of MYC, suggesting that additional CTS-driven genes involved in growth-regulatory circuits, such as p19ARF, are likely to contribute to CTCF-induced growth arrest.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 1316, "offsetInEndSection": 1506, "text": "These findings indicate that CTCF may regulate cell-cycle progression at multiple steps within the cycle, and add to the growing evidence for the function of CTCF as a tumor suppressor gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042"}, {"offsetInBeginSection": 0, "offsetInEndSection": 113, "text": "Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356"}]}, {"id": "5ab2cdc5fcf4565872000016", "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23624983", "http://www.ncbi.nlm.nih.gov/pubmed/26290838", "http://www.ncbi.nlm.nih.gov/pubmed/29075945", "http://www.ncbi.nlm.nih.gov/pubmed/16967378", "http://www.ncbi.nlm.nih.gov/pubmed/20494064"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 72, "text": "A new cable-tie-based sternal closure device: infectious considerations.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 0, "offsetInEndSection": 220, "text": "OBJECTIVES: To determine the difference in sternal infection and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 433, "offsetInEndSection": 550, "text": "Between 1 February 2011 and 31 January 2012, 680 cardiac operations were performed via sternotomy at our institution.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 985, "offsetInEndSection": 1096, "text": "RESULTS: Total infection rate was 6.1%, with a total of 36 diagnosed sternal infections (5 in ZF and 31 in CW).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 1097, "offsetInEndSection": 1283, "text": "Comparing ZF with CW with regard to sternal infection, there is no statistically significant difference related to the device (odds ratio: 0.067, confidence interval: 0.04-9.16, P=0.72).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 1396, "offsetInEndSection": 1462, "text": "Thus, we have observed no difference in receiving either ZF or CW.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 1665, "offsetInEndSection": 1786, "text": "CONCLUSIONS: Our study underlines a neutral effect of the sternal ZipFix\u2122 system in patients regarding sternal infection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 1787, "offsetInEndSection": 1859, "text": "Postoperative complications are similar in both sternal closure methods.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "Multifilament Cable Wire versus Conventional Wire for Sternal Closure in Patients Undergoing Major Cardiac Surgery.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838"}, {"offsetInBeginSection": 0, "offsetInEndSection": 98, "text": "BACKGROUND: Stainless steel wiring remains the most popular technique for primary sternal closure.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838"}]}, {"id": "5ac09a7b19833b0d7b000001", "body": "Where is the EpCam protein mainly located?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21115857", "http://www.ncbi.nlm.nih.gov/pubmed/23026194", "http://www.ncbi.nlm.nih.gov/pubmed/26054340", "http://www.ncbi.nlm.nih.gov/pubmed/16054130"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Analysis of EPCAM protein expression in diagnostics of Lynch syndrome.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "PURPOSE: Lynch syndrome is an inherited tumor predisposition syndrome caused by germline mutations of DNA mismatch repair (MMR) genes, mainly MLH1 and MSH2.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 157, "offsetInEndSection": 400, "text": "Recently, germline deletions affecting the epithelial cell adhesion molecule (EPCAM) gene located upstream of MSH2 were identified as a novel mutational mechanism causing Lynch syndrome by epigenetic inactivation of the respective MSH2 allele.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 587, "offsetInEndSection": 717, "text": "We hypothesized that EPCAM protein expression might be altered in tumors from patients with a germline EPCAM deletion.PATIENTS AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 718, "offsetInEndSection": 843, "text": "METHODS: Immunohistochemistry was used to assess EPCAM expression in Lynch syndrome-associated MSH2-negative tumors (n = 26).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 844, "offsetInEndSection": 984, "text": "Multiplex ligation-dependent probe amplification (MLPA) analysis was performed to detect germline deletions of the EPCAM and MSH2 gene loci.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 984, "offsetInEndSection": 1075, "text": "RESULTS: In four MSH2-negative tumors, a concomitant lack of EPCAM expression was detected.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 1076, "offsetInEndSection": 1171, "text": "MLPA analysis revealed heterozygous EPCAM deletions in all patients with EPCAM-negative tumors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 1172, "offsetInEndSection": 1299, "text": "In contrast, EPCAM expression was positive in all cancers from patients with germline alterations affecting MSH2 but not EPCAM.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}, {"offsetInBeginSection": 1300, "offsetInEndSection": 1375, "text": "Two EPCAM deletions were detected in patients with an EPCAM-positive tumor.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857"}]}, {"id": "5ac24f7595d0062724000003", "body": "Is transcription of eRNA bidirectional?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23728302", "http://www.ncbi.nlm.nih.gov/pubmed/25810254", "http://www.ncbi.nlm.nih.gov/pubmed/25348400", "http://www.ncbi.nlm.nih.gov/pubmed/24778216", "http://www.ncbi.nlm.nih.gov/pubmed/25561718", "http://www.ncbi.nlm.nih.gov/pubmed/25934506", "http://www.ncbi.nlm.nih.gov/pubmed/27932455"], "snippets": [{"offsetInBeginSection": 94, "offsetInEndSection": 289, "text": "In addition to widespread transcription of long non-coding RNAs (lncRNAs) in mammalian cells, bidirectional ncRNAs are transcribed on enhancers, and are thus referred to as enhancer RNAs (eRNAs).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302"}, {"offsetInBeginSection": 405, "offsetInEndSection": 608, "text": "Here we report that in human breast cancer cells 17\u03b2-oestradiol (E2)-bound oestrogen receptor \u03b1 (ER-\u03b1) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302"}, {"offsetInBeginSection": 844, "offsetInEndSection": 1059, "text": "Cohesin, present on many ER-\u03b1-regulated enhancers even before ligand treatment, apparently contributes to E2-dependent gene activation, at least in part by stabilizing E2/ER-\u03b1/eRNA-induced enhancer-promoter looping.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302"}, {"offsetInBeginSection": 1060, "offsetInEndSection": 1177, "text": "Our data indicate that eRNAs are likely to have important functions in many regulated programs of gene transcription.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302"}, {"offsetInBeginSection": 188, "offsetInEndSection": 432, "text": "Very recent evidence has indicted that some eRNAs play a role in initiating or activating transcription, possibly by helping recruit and/or stabilize binding of the general transcription machinery to the proximal promoter of their target genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25810254"}, {"offsetInBeginSection": 834, "offsetInEndSection": 954, "text": "Knockdown of the more distal eRNA led to a drop in Cga mRNA levels, initially without effect on the forward eRNA levels.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25810254"}, {"offsetInBeginSection": 1062, "offsetInEndSection": 1161, "text": "We demonstrate that the interaction of the enhancer with the promoter is lost after eRNA knockdown.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25810254"}, {"offsetInBeginSection": 1382, "offsetInEndSection": 1568, "text": "Moreover, histone H3 Lys 27 (H3K27) acetylation, which was found at both enhancer and promoter in wild-type cells, appeared to have been replaced by H3K27 trimethylation at the enhancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25810254"}, {"offsetInBeginSection": 0, "offsetInEndSection": 97, "text": "Long-range enhancers of transcription are a key component of the genomic regulatory architecture.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400"}, {"offsetInBeginSection": 210, "offsetInEndSection": 300, "text": "However, it remains unclear how tightly coupled eRNA production is with enhancer activity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25348400"}]}, {"id": "5abbe429fcf456587200001c", "body": "What is the drug target for Eliquis (Apixaban)?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/23649961", "http://www.ncbi.nlm.nih.gov/pubmed/24624626", "http://www.ncbi.nlm.nih.gov/pubmed/26298448", "http://www.ncbi.nlm.nih.gov/pubmed/23305476", "http://www.ncbi.nlm.nih.gov/pubmed/23821689", "http://www.ncbi.nlm.nih.gov/pubmed/28008269", "http://www.ncbi.nlm.nih.gov/pubmed/27984753", "http://www.ncbi.nlm.nih.gov/pubmed/25195485", "http://www.ncbi.nlm.nih.gov/pubmed/22533680", "http://www.ncbi.nlm.nih.gov/pubmed/26369819"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 60, "text": "Use of new oral anticoagulants in antiphospholipid syndrome.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961"}, {"offsetInBeginSection": 0, "offsetInEndSection": 136, "text": "The current mainstay of treatment of thrombotic APS is long-term anticoagulation with oral vitamin K antagonists (VKA) such as warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961"}, {"offsetInBeginSection": 245, "offsetInEndSection": 458, "text": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961"}, {"offsetInBeginSection": 459, "offsetInEndSection": 702, "text": "Unlike warfarin, these agents do not interact with dietary constituents and alcohol, have few reported drug interactions, and monitoring of their anticoagulant intensity is not routinely required due to their predictable anticoagulant effects.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961"}, {"offsetInBeginSection": 0, "offsetInEndSection": 332, "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626"}, {"offsetInBeginSection": 0, "offsetInEndSection": 112, "text": "An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298448"}, {"offsetInBeginSection": 6, "offsetInEndSection": 175, "text": "OBJECTIVE: Rivaroxaban and apixaban are part of a new group of oral anticoagulants targeting factor Xa and approved by the Food and Drug Administration in 2011 and 2012.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298448"}, {"offsetInBeginSection": 176, "offsetInEndSection": 292, "text": "These oral anticoagulants are administered at fixed daily doses, without the need for laboratory-guided adjustments.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298448"}, {"offsetInBeginSection": 293, "offsetInEndSection": 390, "text": "There are limited data available on supratherapeutic doses or overdose of the oral Xa inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298448"}, {"offsetInBeginSection": 391, "offsetInEndSection": 484, "text": "This study characterizes the clinical effect in patients exposed to rivaroxaban and apixaban.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298448"}]}, {"id": "5ac0a36f19833b0d7b000002", "body": "What is an exosome?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26725667", "http://www.ncbi.nlm.nih.gov/pubmed/24462375", "http://www.ncbi.nlm.nih.gov/pubmed/27599779", "http://www.ncbi.nlm.nih.gov/pubmed/23376832", "http://www.ncbi.nlm.nih.gov/pubmed/27348448", "http://www.ncbi.nlm.nih.gov/pubmed/21618876", "http://www.ncbi.nlm.nih.gov/pubmed/21713679", "http://www.ncbi.nlm.nih.gov/pubmed/26341056", "http://www.ncbi.nlm.nih.gov/pubmed/27756426", "http://www.ncbi.nlm.nih.gov/pubmed/16087368"], "snippets": [{"offsetInBeginSection": 91, "offsetInEndSection": 188, "text": "They act as intercellular transporters by delivering their components to exosome recipient cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26725667"}, {"offsetInBeginSection": 691, "offsetInEndSection": 843, "text": "We selected lactadherin as an exosome tropic protein and developed it as a fusion protein with Gaussia luciferase to label exosomes for in vivo imaging.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26725667"}, {"offsetInBeginSection": 1268, "offsetInEndSection": 1381, "text": "We also examined the effect of exosome isolation methods on their physicochemical and pharmacokinetic properties.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26725667"}, {"offsetInBeginSection": 222, "offsetInEndSection": 330, "text": "What regulates the release and homoeostatic levels of exosomes, in cancer, in body fluids remains undefined.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24462375"}, {"offsetInBeginSection": 510, "offsetInEndSection": 656, "text": "Exosome numbers were quantified using a Nanosight LM10 and measured in culture supernatants in the absence and presence of exosomes in the medium.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24462375"}, {"offsetInBeginSection": 0, "offsetInEndSection": 105, "text": "Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27599779"}, {"offsetInBeginSection": 53, "offsetInEndSection": 268, "text": "Although its contents (e.g., proteins and microRNAs) have been focused on in cancer research, particularly as potential diagnostic markers, the exosome behavior and methods for exosome quantification remain unclear.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27599779"}, {"offsetInBeginSection": 1256, "offsetInEndSection": 1459, "text": "Although there was no correlation between the tumor progression and the exosome levels, exosome number was the independent prognostic marker and low levels of exosome predicted a poor prognosis (P=0.03).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27599779"}, {"offsetInBeginSection": 0, "offsetInEndSection": 52, "text": "Exosomes play important roles in cancer progression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27599779"}, {"offsetInBeginSection": 1608, "offsetInEndSection": 1716, "text": "In conclusion, exosomal protein content is influenced by the cell source and stimulus for exosome formation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23376832"}]}, {"id": "5ac3699f0340b9f058000001", "body": "Are human enhancers or promoters evolving faster?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/21282711", "http://www.ncbi.nlm.nih.gov/pubmed/8931987", "http://www.ncbi.nlm.nih.gov/pubmed/12610136", "http://www.ncbi.nlm.nih.gov/pubmed/8417365", "http://www.ncbi.nlm.nih.gov/pubmed/1668145", "http://www.ncbi.nlm.nih.gov/pubmed/28116828", "http://www.ncbi.nlm.nih.gov/pubmed/18367463", "http://www.ncbi.nlm.nih.gov/pubmed/8508026", "http://www.ncbi.nlm.nih.gov/pubmed/21326370", "http://www.ncbi.nlm.nih.gov/pubmed/21457775"], "snippets": [{"offsetInBeginSection": 267, "offsetInEndSection": 362, "text": "equisimilis is both a human commensal organism and a human pathogen, and S. dysgalactiae subsp.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711"}, {"offsetInBeginSection": 1215, "offsetInEndSection": 1328, "text": "Promoters were primarily evolving under purifying selection but with certain categories of genes evolving faster.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711"}, {"offsetInBeginSection": 1329, "offsetInEndSection": 1435, "text": "Many of these fast-evolving categories were the same as those associated with rapid evolution in proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711"}, {"offsetInBeginSection": 1436, "offsetInEndSection": 1675, "text": "Overall, these results suggest that adaptation to changing environments and new hosts in the SD species group has involved the acquisition of key virulence genes along with selection of orthologous protein-coding loci and operon promoters.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711"}, {"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "Independence and interdependence of the three human aldolase A promoters in transgenic mice.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "The human aldolase A gene is transcribed from three alternative promoters, clustered in a small 1.6-kb DNA domain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987"}, {"offsetInBeginSection": 948, "offsetInEndSection": 1106, "text": "By contrast, the pN promoter needs the presence of both enhancers to reproduce its correct pattern of activity and is unable to function autonomously in vivo.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987"}, {"offsetInBeginSection": 541, "offsetInEndSection": 717, "text": "In the present study, we use the transgenic mice model to further investigate the contribution of these two regulatory elements to the overall control of these three promoters.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987"}, {"offsetInBeginSection": 0, "offsetInEndSection": 196, "text": "The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12610136"}, {"offsetInBeginSection": 0, "offsetInEndSection": 317, "text": "To determine the effect of the human cytomegalovirus (CMV) major immediate-early (MIE) enhancer or promoter on the efficiency of viral replication in permissive human cells, we constructed recombinant viruses with their human MIE promoter, enhancer, and promoter plus enhancer replaced with the murine CMV components.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12610136"}]}, {"id": "5abbfd97fcf456587200001d", "body": "What is the Formalin test used for?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17166125", "http://www.ncbi.nlm.nih.gov/pubmed/19762763", "http://www.ncbi.nlm.nih.gov/pubmed/2247320", "http://www.ncbi.nlm.nih.gov/pubmed/16492837", "http://www.ncbi.nlm.nih.gov/pubmed/19168051", "http://www.ncbi.nlm.nih.gov/pubmed/15105218", "http://www.ncbi.nlm.nih.gov/pubmed/18799335", "http://www.ncbi.nlm.nih.gov/pubmed/15172765", "http://www.ncbi.nlm.nih.gov/pubmed/11226110", "http://www.ncbi.nlm.nih.gov/pubmed/9431444"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 106, "text": "Is the second phase of the formalin test useful to predict activity in chronic constriction injury models?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 0, "offsetInEndSection": 201, "text": "This study presents data of several reference drugs in rats and gerbils for both the second phase of the formalin test and the cold allodynia in animals with a constriction injury of the sciatic nerve.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 202, "offsetInEndSection": 295, "text": "A pharmacological validation of the formalin test and the CCI model in gerbils was performed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 296, "offsetInEndSection": 461, "text": "It was evaluated whether the second phase of the formalin test could be used as a pharmacological screening to predict outcome in the cold plate test in CCI animals.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 541, "offsetInEndSection": 710, "text": "For the formalin test, animals were injected in the right hind paw (5% formalin rat: 0.05 microl; gerbil: 0.01 microl) and flinching and licking or biting were recorded.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 989, "offsetInEndSection": 1184, "text": "Clonidine tends to have more activity in the second phase of the formalin test, whereas baclofen, tramadol, amitryptiline, ketamine and topiramate demonstrate to be more active in the cold plate.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 1284, "offsetInEndSection": 1479, "text": "Tramadol and CP-96345 tend to have more activity in the second phase of the formalin test, whereas morphine, SR-48968, SR-142801 and R116301 demonstrates to be more active in the cold plate test.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 1480, "offsetInEndSection": 1725, "text": "In the present acute test conditions, there is a correlation in the pharmacological activity in rats and gerbils for the tested compounds a correlation between the second phase of the formalin test and the cold allodynia in CCI animals is found.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125"}, {"offsetInBeginSection": 0, "offsetInEndSection": 135, "text": "Licking decreases phosphorylation of extracellular signal-regulated kinase in the dorsal horn of the spinal cord after a formalin test.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762763"}, {"offsetInBeginSection": 209, "offsetInEndSection": 301, "text": "We investigated, in a formalin test, whether pERK of the dorsal horn is affected by licking.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762763"}]}, {"id": "5ac2776195d0062724000006", "body": "List diseases caused by protein glutamine expanded repeats", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/9932422", "http://www.ncbi.nlm.nih.gov/pubmed/9536080", "http://www.ncbi.nlm.nih.gov/pubmed/21933837", "http://www.ncbi.nlm.nih.gov/pubmed/11200958", "http://www.ncbi.nlm.nih.gov/pubmed/8980137", "http://www.ncbi.nlm.nih.gov/pubmed/8202492", "http://www.ncbi.nlm.nih.gov/pubmed/19692580", "http://www.ncbi.nlm.nih.gov/pubmed/9536081", "http://www.ncbi.nlm.nih.gov/pubmed/10434299", "http://www.ncbi.nlm.nih.gov/pubmed/7604023"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422"}, {"offsetInBeginSection": 0, "offsetInEndSection": 118, "text": "Eight diseases are now known to be caused by an expansion mutation of the trinucleotide repeat CAG encoding glutamine.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422"}, {"offsetInBeginSection": 792, "offsetInEndSection": 1039, "text": "In addition, theoretical and experimental analysis of the chemistry of uninterrupted stretches of glutamine residues suggest that polyglutamine-containing proteins or protein fragments may aggregate, via a \"polar zipper\", into beta pleated sheets.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422"}, {"offsetInBeginSection": 1040, "offsetInEndSection": 1269, "text": "Recent findings have now established the presence of such aggregates in selected regions of brain from affected individuals, in transgenic mice expressing expanded repeats, and in isolated cells transfected with expanded repeats.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080"}, {"offsetInBeginSection": 86, "offsetInEndSection": 188, "text": "Mutant huntingtin contains 36-55 repeats in adult HD patients and >60 repeats in juvenile HD patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080"}, {"offsetInBeginSection": 319, "offsetInEndSection": 448, "text": "Aggregation of expanded polyglutamine is thought to be a common pathological mechanism in HD and other glutamine repeat diseases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080"}, {"offsetInBeginSection": 449, "offsetInEndSection": 546, "text": "It is not clear how the length of the repeats is correlated with formation of protein aggregates.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080"}, {"offsetInBeginSection": 547, "offsetInEndSection": 834, "text": "By expressing a series of huntingtin constructs encoding various glutamine repeats (23-150 units) in cultured cells we observed N-terminal fragments of huntingtin (amino acids 1-67 and 1-212), but not full-length huntingtins, with glutamine repeats >/=66 units formed protein aggregates.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080"}, {"offsetInBeginSection": 907, "offsetInEndSection": 1071, "text": "This study suggests that various N-terminal fragments of mutant huntingtin can form aggregates and that aggregation is prompted by lengthening the glutamine repeat.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080"}]}, {"id": "5ac37afc0340b9f058000002", "body": "What type of sequences do enhancers evolve from?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25956793", "http://www.ncbi.nlm.nih.gov/pubmed/21593416", "http://www.ncbi.nlm.nih.gov/pubmed/28760812", "http://www.ncbi.nlm.nih.gov/pubmed/21798176", "http://www.ncbi.nlm.nih.gov/pubmed/2134678", "http://www.ncbi.nlm.nih.gov/pubmed/1668145", "http://www.ncbi.nlm.nih.gov/pubmed/21151964", "http://www.ncbi.nlm.nih.gov/pubmed/24218638", "http://www.ncbi.nlm.nih.gov/pubmed/15014138", "http://www.ncbi.nlm.nih.gov/pubmed/29035697"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 40, "text": "What does it take to evolve an enhancer?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 0, "offsetInEndSection": 239, "text": "There is widespread interest today in understanding enhancers, which are regulatory elements typically harboring several transcription factor binding sites and mediating the combinatorial effect of transcription factors on gene expression.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 240, "offsetInEndSection": 418, "text": "The evolution of enhancers poses interesting unanswered questions, for example, the evolutionary time taken for a typical enhancer to emerge or the factors shaping its evolution.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 419, "offsetInEndSection": 585, "text": "Existing approaches to cis-regulatory evolution have often ignored the combinatorial nature and varied biochemical mechanisms of gene regulation encoded in enhancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 586, "offsetInEndSection": 847, "text": "We report on our investigation of enhancer evolution through the use of PEBCRES, a framework for evolutionary simulation of enhancers that employs a mechanistic and well-supported sequence-to-expression model to assign fitness to the evolving enhancer genotype.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 848, "offsetInEndSection": 1039, "text": "We estimated the time necessary to evolve, from genomic background, enhancers capable of driving complex gene expression patterns similar to those involved in early development in Drosophila.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 1040, "offsetInEndSection": 1281, "text": "We found the time-to-evolve to range between 0.5 and 10 Myr, and to vary greatly with the target expression pattern, complexity of the real enhancer known to encode that pattern, and the strength of input from specific transcription factors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 1282, "offsetInEndSection": 1378, "text": "To our knowledge, this is the first estimate of waiting times for realistic enhancers to evolve.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 1379, "offsetInEndSection": 1531, "text": "The in silico evolved enhancers had, with a few interesting exceptions, site compositions similar to those seen in real enhancers for the same patterns.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}, {"offsetInBeginSection": 1532, "offsetInEndSection": 1696, "text": "Our simulations also revealed that certain features of an enhancer might evolve not due to their biological function but as aids to the evolutionary process itself.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793"}]}, {"id": "5abcf66afcf4565872000026", "body": "What is Dupuytren's contracture?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22872850", "http://www.ncbi.nlm.nih.gov/pubmed/21992150", "http://www.ncbi.nlm.nih.gov/pubmed/21935843", "http://www.ncbi.nlm.nih.gov/pubmed/10409813", "http://www.ncbi.nlm.nih.gov/pubmed/20676061", "http://www.ncbi.nlm.nih.gov/pubmed/6130030", "http://www.ncbi.nlm.nih.gov/pubmed/18080603", "http://www.ncbi.nlm.nih.gov/pubmed/1769989", "http://www.ncbi.nlm.nih.gov/pubmed/26152183", "http://www.ncbi.nlm.nih.gov/pubmed/1616255"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 84, "text": "The Surgical Release of Dupuytren's Contracture Using Multiple Transverse Incisions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "Dupuytren's contracture is a condition commonly encountered by hand surgeons, although it is rare in the Asian population.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 123, "offsetInEndSection": 259, "text": "Various surgical procedures for Dupuytren's contracture have been reported, and the outcomes vary according to the treatment modalities.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 260, "offsetInEndSection": 396, "text": "We report the treatment results of segmental fasciectomies with multiple transverse incisions for patients with Dupuytren's contracture.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 397, "offsetInEndSection": 583, "text": "The cases of seven patients who underwent multiple segmental fasciectomies with multiple transverse incisions for Dupuytren's contracture from 2006 to 2011 were reviewed retrospectively.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 584, "offsetInEndSection": 812, "text": "Multiple transverse incisions to the severe contracture sites were performed initially, and additional incisions to the metacarpophalangeal (MCP) joints, and the proximal interphalangeal (PIP) joints were performed if necessary.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 1146, "offsetInEndSection": 1281, "text": "Multiple transverse incisions for Dupuytren's contracture are technically challenging, and require a high skill level of hand surgeons.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 1374, "offsetInEndSection": 1503, "text": "Therefore, segmental fasciectomies with multiple transverse incisions can be a good treatment option for Dupuytren's contracture.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850"}, {"offsetInBeginSection": 0, "offsetInEndSection": 108, "text": "Dupuytren's contracture: a retrospective database analysis to determine hospitalizations in the Netherlands.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150"}, {"offsetInBeginSection": 0, "offsetInEndSection": 130, "text": "BACKGROUND: Dupuytren's contracture is a condition of the palmar fascia involving contractures of the fascia and skin in the hand.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150"}]}, {"id": "5ad243e30340b9f058000016", "body": "What is the function of LOX proteins in the ECM?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17931358", "http://www.ncbi.nlm.nih.gov/pubmed/26024311", "http://www.ncbi.nlm.nih.gov/pubmed/24348049", "http://www.ncbi.nlm.nih.gov/pubmed/19592613", "http://www.ncbi.nlm.nih.gov/pubmed/16085123"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 128, "text": "Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "The extracellular matrix (ECM) plays a critical role during the development and invasion of primary brain tumours.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 115, "offsetInEndSection": 243, "text": "However, the function of ECM components and signalling between a permissive ECM and invasive astrocytes is not fully understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 244, "offsetInEndSection": 403, "text": "We have recently reported the ECM enzyme, lysyl oxidase (LOX), in the central nervous system and observed up-regulation of LOX in anaplastic astrocytoma cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 404, "offsetInEndSection": 645, "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 802, "offsetInEndSection": 950, "text": "Results demonstrate that increased expression and activity of LOX positively correlated with invasive phenotype of malignant astrocytoma cell lines.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 951, "offsetInEndSection": 1190, "text": "Immunohistochemistry detected increased LOX within tumour cells and ECM in grade I-IV astrocytic neoplasm compared with normal brain and coincidence of increased LOX with the loss of glial fibrillary acidic protein in higher-grade tumours.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 1191, "offsetInEndSection": 1486, "text": "Increased active LOX in invasive astrocytes was accompanied by phosphorylation of FAK[Tyr576] and paxillin[Tyr118]; furthermore, both FAK and paxillin tyrosine phosphorylation were diminished by beta-aminopropionitrile inhibition of LOX activity and depletion of H(2)O(2) via catalase treatment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 1487, "offsetInEndSection": 1688, "text": "Additionally, we provide evidence that in astrocytes, LOX is likely processed by bone morphogenic protein-1 and LOX activity might be further stimulated by the expression of fibronectin in these cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}, {"offsetInBeginSection": 1689, "offsetInEndSection": 1818, "text": "These results demonstrate an important LOX-mediated mechanism that promotes migratory/invasive behaviour of malignant astrocytes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358"}]}, {"id": "5ace12be0340b9f058000007", "body": "Which gene is responsible for proper speech development?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20571508", "http://www.ncbi.nlm.nih.gov/pubmed/26980647", "http://www.ncbi.nlm.nih.gov/pubmed/15884233", "http://www.ncbi.nlm.nih.gov/pubmed/17574010", "http://www.ncbi.nlm.nih.gov/pubmed/18554997", "http://www.ncbi.nlm.nih.gov/pubmed/22644823", "http://www.ncbi.nlm.nih.gov/pubmed/27771768", "http://www.ncbi.nlm.nih.gov/pubmed/25269856", "http://www.ncbi.nlm.nih.gov/pubmed/17565757"], "snippets": [{"offsetInBeginSection": 282, "offsetInEndSection": 381, "text": "These findings suggest the possibility that FOXP1 may also contribute to proper speech development.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508"}, {"offsetInBeginSection": 443, "offsetInEndSection": 605, "text": "Recently, a child was reported who presented with a 3p13-14.1 deletion of four genes, including FOXP1, and a constellation of deficits that included speech delay.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508"}, {"offsetInBeginSection": 0, "offsetInEndSection": 89, "text": "The FOXP2 gene is important for the development of proper speech motor control in humans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647"}, {"offsetInBeginSection": 566, "offsetInEndSection": 730, "text": "In addition, Foxp2+/- song also exhibited irregular rhythmic structure, and its development did not follow the consistent trajectories observed in WT vocalizations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647"}, {"offsetInBeginSection": 731, "offsetInEndSection": 971, "text": "These results demonstrate that the Foxp2 gene is critical for normal vocal behavior in juvenile and adult mice, and that Foxp2 mutant mice may provide a tractable model system for the study of the gene's role in general vocal motor control.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "[Influence of selected family environment factors on the child's speech development].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}, {"offsetInBeginSection": 167, "offsetInEndSection": 285, "text": "A speech, as one of elements enabling adaptation to life in community is formed individually with particular children.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}, {"offsetInBeginSection": 286, "offsetInEndSection": 369, "text": "The basis of such process is always the possibility of the intercourse with speech.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}, {"offsetInBeginSection": 370, "offsetInEndSection": 503, "text": "The aim of undertaken subject was the analysis of influence of selected family environment factors on the child's speech development.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}, {"offsetInBeginSection": 504, "offsetInEndSection": 654, "text": "The study was conducted with children of six and seven year old, where speech should be mastered with fixed pronunciation and proper speech technique.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15884233"}]}, {"id": "5abcf755fcf4565872000028", "body": "Please list 3 diseases treated with Valtrex(valacyclovir)", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28089147", "http://www.ncbi.nlm.nih.gov/pubmed/15043175", "http://www.ncbi.nlm.nih.gov/pubmed/28961065", "http://www.ncbi.nlm.nih.gov/pubmed/24736271", "http://www.ncbi.nlm.nih.gov/pubmed/21404597", "http://www.ncbi.nlm.nih.gov/pubmed/9589847", "http://www.ncbi.nlm.nih.gov/pubmed/24284060", "http://www.ncbi.nlm.nih.gov/pubmed/9514622", "http://www.ncbi.nlm.nih.gov/pubmed/19841603"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 118, "text": "SeQuent Please vs. Pantera Lux drug coated balloon angioplasty in real life: Results from the D\u00fcsseldorf DCB registry.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 323, "offsetInEndSection": 461, "text": "Therefore, in this registry analysis, we compared two frequently used paclitaxel eluting DCBs, the SeQuent Please and the Pantera Lux DCB.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 804, "offsetInEndSection": 1006, "text": "RESULTS: Patient characteristics, prior diseases, clinical presentation, ejection fraction, procedural success and lost-for-follow-up did not differ between patients treated with the SeQuent Please and.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 1028, "offsetInEndSection": 1209, "text": "MACE during hospital course were similar as well (Pantera Lux: 6 patients [1.6%] vs. SeQuent\u00aePlease: 3 patients [1.5%], relative risk 1.06, 95% confidence interval 0.3-4.2, P=0.93).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 1424, "offsetInEndSection": 1549, "text": "CONCLUSION: MACE free survival was longer in Pantera Lux DCB treated patients as compared to SeQuent Please treated patients.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147"}, {"offsetInBeginSection": 0, "offsetInEndSection": 80, "text": "Descriptions of barriers to self-care by persons with comorbid chronic diseases.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043175"}, {"offsetInBeginSection": 297, "offsetInEndSection": 416, "text": "OBJECTIVE: Our objective was to identify perceived barriers to self-care among patients with comorbid chronic diseases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043175"}, {"offsetInBeginSection": 644, "offsetInEndSection": 805, "text": "Using a free-listing technique, participants were asked, \"Please list everything you can think of that affects your ability to care for your medical conditions.\"", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043175"}, {"offsetInBeginSection": 1309, "offsetInEndSection": 1497, "text": "CONCLUSIONS: Persons with comorbid chronic diseases experience a wide range of barriers to self-care, including several that are specifically related to having multiple medical conditions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043175"}, {"offsetInBeginSection": 0, "offsetInEndSection": 47, "text": "Repairing Mitochondrial Dysfunction in Disease.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28961065"}]}, {"id": "5ad35933133db5eb78000001", "body": "Is the protein pelota a ribosomal rescue factor?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27493551", "http://www.ncbi.nlm.nih.gov/pubmed/25061210", "http://www.ncbi.nlm.nih.gov/pubmed/9584085"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 140, "text": "Recent structural studies on Dom34/aPelota and Hbs1/aEF1\u03b1: important factors for solving general problems of ribosomal stall in translation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 271, "offsetInEndSection": 398, "text": "In eukaryotes, Pelota (Dom34 in yeast) and Hbs1 are responsible for solving general problems of ribosomal stall in translation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 399, "offsetInEndSection": 521, "text": "In archaea, aPelota and aEF1\u03b1, homologous to Pelota and Hbs1, respectively, are considered to be involved in that process.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 627, "offsetInEndSection": 771, "text": "In this review, we focus on the functional roles of Dom34/aPelota and Hbs1/aEF1\u03b1 in ribosome rescue, based on recent structural studies of them.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551"}, {"offsetInBeginSection": 0, "offsetInEndSection": 13, "text": "RNA function.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210"}, {"offsetInBeginSection": 14, "offsetInEndSection": 100, "text": "Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210"}, {"offsetInBeginSection": 308, "offsetInEndSection": 571, "text": "Here, we discover that loss of GTPBP2, a novel binding partner of the ribosome recycling protein Pelota, in mice with a mutation in a tRNA gene that is specifically expressed in the central nervous system causes ribosome stalling and widespread neurodegeneration.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210"}, {"offsetInBeginSection": 572, "offsetInEndSection": 716, "text": "Our results not only define GTPBP2 as a ribosome rescue factor but also unmask the disease potential of mutations in nuclear-encoded tRNA genes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210"}, {"offsetInBeginSection": 111, "offsetInEndSection": 317, "text": "Analysis of dom34 strains shows that progression through the G1 phase of the cell cycle is delayed, mutant cells enter meiosis aberrantly, and their ability to form pseudohyphae is significantly diminisehd.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085"}, {"offsetInBeginSection": 318, "offsetInEndSection": 448, "text": "RPS30A, which encodes ribosomal protein S30, was identified in a screen for high-copy suppressors of the dom34delta growth defect.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085"}]}, {"id": "5ace17c30340b9f058000009", "body": "Which olfactory gene senses androsterone?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26140380", "http://www.ncbi.nlm.nih.gov/pubmed/23321429", "http://www.ncbi.nlm.nih.gov/pubmed/23230501", "http://www.ncbi.nlm.nih.gov/pubmed/8043710", "http://www.ncbi.nlm.nih.gov/pubmed/18808328", "http://www.ncbi.nlm.nih.gov/pubmed/20221768", "http://www.ncbi.nlm.nih.gov/pubmed/25091523", "http://www.ncbi.nlm.nih.gov/pubmed/1737068", "http://www.ncbi.nlm.nih.gov/pubmed/23721465", "http://www.ncbi.nlm.nih.gov/pubmed/9566734"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 111, "text": "Dexamethasone affects mouse olfactory mucosa gene expression and attenuates genes related to neurite outgrowth.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26140380"}, {"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "BACKGROUND: Olfaction is one of the important senses for humans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26140380"}, {"offsetInBeginSection": 199, "offsetInEndSection": 305, "text": "However, their effect on olfactory function is still controversial and the precise mechanism is not clear.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26140380"}, {"offsetInBeginSection": 306, "offsetInEndSection": 540, "text": "To gain a global view of the effect of systematic glucocorticoid treatment on gene expression in the olfactory mucosa (OM), we profiled these changes in a murine model of olfaction in order to identify underlying molecular mechanisms.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26140380"}, {"offsetInBeginSection": 1038, "offsetInEndSection": 1176, "text": "RESULTS: Between the WK2 and Ctrl groups, 3351 genes were differentially expressed, of which 236 genes were related to olfactory function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26140380"}, {"offsetInBeginSection": 0, "offsetInEndSection": 236, "text": "The present study examined differences in olfactory sensitivity between 16 naturally cycling (NC) women and 17 women taking monophasic oral contraceptives (OCs) to six odors: lemon, peppermint, rose, musk, androstenone and androsterone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "Evaluation of the effect of upper complete denture on gustatory and olfactory senses.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}, {"offsetInBeginSection": 71, "offsetInEndSection": 292, "text": "Clinical experience suggests that complete denture wearers have various disorders in their gustatory and olfactory senses due to disturbance of airways between the oral and nasal cavities caused by upper complete denture.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}, {"offsetInBeginSection": 293, "offsetInEndSection": 438, "text": "The purpose of this study was to evaluate the effect of upper complete denture on gustatory and olfactory senses in denture wearers.MATERIALS AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}, {"offsetInBeginSection": 439, "offsetInEndSection": 683, "text": "METHODS: In this study, gustatory and olfactory senses in 30 patients (15 men and 15 women with a mean age of 52.93 \u00b1 12.97 years) were evaluated three times: before complete denture insertion, three days after insertion and 1 month after that.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23230501"}]}, {"id": "5abd13e1fcf4565872000029", "body": "Where in the body would the navicular bone be found?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20525052", "http://www.ncbi.nlm.nih.gov/pubmed/2681808", "http://www.ncbi.nlm.nih.gov/pubmed/28099198", "http://www.ncbi.nlm.nih.gov/pubmed/9622323", "http://www.ncbi.nlm.nih.gov/pubmed/10029187", "http://www.ncbi.nlm.nih.gov/pubmed/27588043", "http://www.ncbi.nlm.nih.gov/pubmed/27298914", "http://www.ncbi.nlm.nih.gov/pubmed/24788547", "http://www.ncbi.nlm.nih.gov/pubmed/24719271", "http://www.ncbi.nlm.nih.gov/pubmed/9776073"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 152, "text": "The distal sesamoidean impar ligament: comparison between its appearance on magnetic resonance imaging and histology of the axial third of the ligament.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 235, "offsetInEndSection": 461, "text": "HYPOTHESES: There would be: 1) a correlation between histopathology and MRI findings; and 2) a relationship between MR abnormalities at the origin and the insertion of the DSIL, between insertion and body; and origin and body.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 552, "offsetInEndSection": 667, "text": "MR abnormalities of the DSIL, its origin on the navicular bone and its insertion on the distal phalanx were graded.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 956, "offsetInEndSection": 1273, "text": "RESULTS: There were significant correlations between the presence of a cystic structure in the distal third of the navicular bone, or a distal border fragment, or increased signal intensity in fat suppressed images at the insertion of the DSIL on the distal phalanx and the histological grade of the body of the DSIL.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 1274, "offsetInEndSection": 1873, "text": "There were significant associations between a cystic structure in the distal third of the navicular bone and the presence of either a distal border fragment or entheseous new bone at the insertion of the DSIL, swelling of the DSIL and increased signal intensity in the DSIL in fat suppressed images; between distal elongation of the flexor border of the navicular bone and the presence of one or more distal border fragments and between swelling of the body of the DSIL and irregularity of its palmar border or increased signal intensity in fat suppressed images in the DSIL.CONCLUSIONS AND CLINICAL", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 1874, "offsetInEndSection": 2142, "text": "RELEVANCE: The presence of a cystic structure in the distal third of the navicular bone detected using MRI, a distal border fragment or increased signal intensity at the insertion of the DSIL are suggestive of significant alterations in the infrastructure of the DSIL.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052"}, {"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "Fractures of the body of the tarsal navicular bone: case reports and literature review.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808"}, {"offsetInBeginSection": 0, "offsetInEndSection": 71, "text": "Four patients sustaining tarsal navicular body fractures are presented.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808"}, {"offsetInBeginSection": 423, "offsetInEndSection": 568, "text": "Favorable results are obtained in a vertical two-part fracture, by an open reduction and internal fixation of the tarsal navicular body fracture.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808"}, {"offsetInBeginSection": 569, "offsetInEndSection": 657, "text": "In highly comminuted fractures, talo-navicular-cuneiform arthrodesis can be carried out.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808"}]}, {"id": "5a9d9ab94e03427e73000003", "body": "Is Cystatin D a biomarker?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27861242", "http://www.ncbi.nlm.nih.gov/pubmed/26066476", "http://www.ncbi.nlm.nih.gov/pubmed/29087712", "http://www.ncbi.nlm.nih.gov/pubmed/21151566", "http://www.ncbi.nlm.nih.gov/pubmed/22350134", "http://www.ncbi.nlm.nih.gov/pubmed/19444952", "http://www.ncbi.nlm.nih.gov/pubmed/21918259", "http://www.ncbi.nlm.nih.gov/pubmed/24713815", "http://www.ncbi.nlm.nih.gov/pubmed/24266750", "http://www.ncbi.nlm.nih.gov/pubmed/22795897"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 92, "text": "Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242"}, {"offsetInBeginSection": 0, "offsetInEndSection": 140, "text": "OBJECTIVE: The study aims to determine whether cystatin C is associated with HIV disease and HIV-associated neurocognitive impairment (NCI).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242"}, {"offsetInBeginSection": 322, "offsetInEndSection": 436, "text": "Cystatin C, a biomarker of kidney functioning that has been linked to poor health outcomes, was measured in blood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242"}, {"offsetInBeginSection": 553, "offsetInEndSection": 659, "text": "RESULTS: The HIV+ group had significantly higher cystatin C concentrations than the HIV- group (d = 0.79 P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242"}, {"offsetInBeginSection": 660, "offsetInEndSection": 881, "text": "CONCLUSIONS: Our results confirm that HIV+ older adults have higher cystatin C than HIV- older adults and further identify that cystatin C may be associated with NCI in this population, particularly if they use tenofovir.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242"}, {"offsetInBeginSection": 0, "offsetInEndSection": 68, "text": "Cystatin C as a biomarker for estimating glomerular filtration rate.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26066476"}, {"offsetInBeginSection": 11, "offsetInEndSection": 137, "text": "REVIEW: Glomerular filtration rate (GFR) is rarely measured in clinical practice because of the complexity of the measurement.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26066476"}, {"offsetInBeginSection": 321, "offsetInEndSection": 455, "text": "Contemporary research suggests that cystatin C may be an improved alternative to creatinine for inclusion in GFR estimating equations.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26066476"}, {"offsetInBeginSection": 456, "offsetInEndSection": 583, "text": "The purpose of this article is to evaluate the benefits and limitations of using cystatin C as a biomarker of filtration.RECENT", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26066476"}, {"offsetInBeginSection": 584, "offsetInEndSection": 673, "text": "FINDINGS: Cystatin C has fewer non-GFR determinants, when compared with serum creatinine.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26066476"}]}, {"id": "5ace19420340b9f05800000a", "body": "Which gene is responsible for red hair?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/12876664", "http://www.ncbi.nlm.nih.gov/pubmed/9302268", "http://www.ncbi.nlm.nih.gov/pubmed/28024137", "http://www.ncbi.nlm.nih.gov/pubmed/2363420"], "snippets": [{"offsetInBeginSection": 238, "offsetInEndSection": 386, "text": "The majority of affected individuals develop some cutaneous melanin; this is predominantly seen as yellow/blond hair, whereas fewer have brown hair.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664"}, {"offsetInBeginSection": 628, "offsetInEndSection": 775, "text": "Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664"}, {"offsetInBeginSection": 776, "offsetInEndSection": 840, "text": "We identified eight probands with OCA who had red hair at birth.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664"}, {"offsetInBeginSection": 841, "offsetInEndSection": 1114, "text": "Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664"}, {"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268"}, {"offsetInBeginSection": 335, "offsetInEndSection": 588, "text": "The previously reported Val92Met allele shows no association with hair colour, but the three alleles Arg151Cys, Arg160Trp and Asp294His were associated with red hair and one Val60Leu variant was most frequent in fair/blonde and light brown hair colours.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268"}, {"offsetInBeginSection": 589, "offsetInEndSection": 666, "text": "Variant MSHR genotypes are associated with lighter skin types and red hair (P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268"}, {"offsetInBeginSection": 0, "offsetInEndSection": 28, "text": "[Secrets of the red-headed].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137"}, {"offsetInBeginSection": 115, "offsetInEndSection": 190, "text": "A specific variant of MC1R gene (R allele) is responsible for the red hair.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137"}, {"offsetInBeginSection": 191, "offsetInEndSection": 237, "text": "The gene encodes a receptor for melanocortins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137"}]}, {"id": "5abd5a62fcf4565872000031", "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/10573394", "http://www.ncbi.nlm.nih.gov/pubmed/2695392", "http://www.ncbi.nlm.nih.gov/pubmed/6263856", "http://www.ncbi.nlm.nih.gov/pubmed/1979278", "http://www.ncbi.nlm.nih.gov/pubmed/403933", "http://www.ncbi.nlm.nih.gov/pubmed/6265073", "http://www.ncbi.nlm.nih.gov/pubmed/8246264", "http://www.ncbi.nlm.nih.gov/pubmed/18183461", "http://www.ncbi.nlm.nih.gov/pubmed/776705", "http://www.ncbi.nlm.nih.gov/pubmed/8760442"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "Characterisation of lactic acid bacteria from spoiled, vacuum-packaged, cold-smoked rainbow trout using ribotyping.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10573394"}, {"offsetInBeginSection": 0, "offsetInEndSection": 258, "text": "A total of 405 lactic acid bacteria (LAB) isolated from spoiled, vacuum-packaged, salted, sodium nitrite- or potassium nitrate-treated, cold-smoked rainbow trout stored at 4 degrees C or 8 degrees C were characterised and identified using a molecular method.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10573394"}, {"offsetInBeginSection": 259, "offsetInEndSection": 473, "text": "The isolates were initially classified according to their restriction endonuclease profiles using HindIII and EcoRI restriction endonucleases and further characterised by rRNA gene restriction patterns (ribotypes).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10573394"}, {"offsetInBeginSection": 628, "offsetInEndSection": 769, "text": "The strains were divided with HindIII and EcoRI ribopatterns into ten and nine clusters at the similarity level of 65% and 50%, respectively.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/10573394"}, {"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Comparison of the nucleotide and amino acid sequences of the RsrI and EcoRI restriction endonucleases.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392"}, {"offsetInBeginSection": 0, "offsetInEndSection": 138, "text": "The RsrI endonuclease, a type-II restriction endonuclease (ENase) found in Rhodobacter sphaeroides, is an isoschizomer of the EcoRI ENase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392"}, {"offsetInBeginSection": 547, "offsetInEndSection": 644, "text": "A 50% identity exists within a 266-aa overlap between the deduced aa sequences of RsrI and EcoRI.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392"}, {"offsetInBeginSection": 645, "offsetInEndSection": 746, "text": "Regions of 75-100% aa sequence identity correspond to key structural and functional regions of EcoRI.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392"}, {"offsetInBeginSection": 0, "offsetInEndSection": 127, "text": "Ten plasmids were isolated as covalently closed circular deoxyribonucleic acid from antibiotic-resistant thermophilic bacteria.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6263856"}, {"offsetInBeginSection": 547, "offsetInEndSection": 645, "text": "The restriction endonuclease cleavage maps of the two plasmids, pTB19 and pTB20, were constructed.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/6263856"}]}, {"id": "5a9da37e4e03427e73000004", "body": "What is Mendelian randomization?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26291580", "http://www.ncbi.nlm.nih.gov/pubmed/26201704", "http://www.ncbi.nlm.nih.gov/pubmed/19432981", "http://www.ncbi.nlm.nih.gov/pubmed/23199790", "http://www.ncbi.nlm.nih.gov/pubmed/20978399", "http://www.ncbi.nlm.nih.gov/pubmed/19674341", "http://www.ncbi.nlm.nih.gov/pubmed/16410347", "http://www.ncbi.nlm.nih.gov/pubmed/20616999", "http://www.ncbi.nlm.nih.gov/pubmed/19174578", "http://www.ncbi.nlm.nih.gov/pubmed/27486138"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 87, "text": "Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 0, "offsetInEndSection": 122, "text": "OBJECTIVE: Mendelian randomization is a popular technique for assessing and estimating the causal effects of risk factors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 590, "offsetInEndSection": 765, "text": "RESULTS: A list of guidelines based on the 'Bradford Hill criteria' for judging the plausibility of a causal finding from an applied Mendelian randomization study is provided.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 766, "offsetInEndSection": 983, "text": "We also give a framework for performing and interpreting investigations performed in the style of Mendelian randomization, but where the choice of genetic variants is statistically, rather than biologically motivated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 984, "offsetInEndSection": 1091, "text": "Such analyses should not be assigned the same evidential weight as a Mendelian randomization investigation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 1091, "offsetInEndSection": 1259, "text": "CONCLUSION: We discuss the role of such investigations (in the style of Mendelian randomization), and what they add to our understanding of potential causal mechanisms.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 1260, "offsetInEndSection": 1506, "text": "If the genetic variants are selected solely according to statistical criteria, and the biological roles of genetic variants are not investigated, this may be little more than what can be learned from a well-designed classical observational study.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580"}, {"offsetInBeginSection": 0, "offsetInEndSection": 93, "text": "Mendelian Randomization versus Path Models: Making Causal Inferences in Genetic Epidemiology.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704"}, {"offsetInBeginSection": 82, "offsetInEndSection": 227, "text": "The first aim of this work is to describe the idea of Mendelian randomization studies and the assumptions required for drawing valid conclusions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704"}, {"offsetInBeginSection": 228, "offsetInEndSection": 353, "text": "The second aim is to contrast Mendelian randomization and path modeling when different 'omics' levels are considered jointly.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704"}]}, {"id": "5ace1a590340b9f05800000b", "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17146600", "http://www.ncbi.nlm.nih.gov/pubmed/17110569", "http://www.ncbi.nlm.nih.gov/pubmed/10788336", "http://www.ncbi.nlm.nih.gov/pubmed/27429943", "http://www.ncbi.nlm.nih.gov/pubmed/18768141", "http://www.ncbi.nlm.nih.gov/pubmed/21404232", "http://www.ncbi.nlm.nih.gov/pubmed/21078988"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 46, "text": "Evaluating Neanderthal genetics and phylogeny.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600"}, {"offsetInBeginSection": 0, "offsetInEndSection": 246, "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600"}, {"offsetInBeginSection": 247, "offsetInEndSection": 407, "text": "Recently, however, both the authenticity of the Neanderthal sequences and their phylogenetic position outside contemporary human diversity have been questioned.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600"}, {"offsetInBeginSection": 408, "offsetInEndSection": 669, "text": "Using Bayesian inference and the largest dataset to date, we find strong support for a monophyletic Neanderthal clade outside the diversity of contemporary humans, in agreement with the expectations of the Out-of-Africa replacement model of modern human origin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600"}, {"offsetInBeginSection": 670, "offsetInEndSection": 867, "text": "From average pairwise sequence differences, we obtain support for claims that the first published Neanderthal sequence may include errors due to postmortem damage in the template molecules for PCR.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600"}, {"offsetInBeginSection": 868, "offsetInEndSection": 1139, "text": "In contrast, we find that recent results implying that the Neanderthal sequences are products of PCR artifacts are not well supported, suffering from inadequate experimental design and a presumably high percentage (>68%) of chimeric sequences due to \"jumping PCR\" events.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600"}, {"offsetInBeginSection": 0, "offsetInEndSection": 51, "text": "Sequencing and analysis of Neanderthal genomic DNA.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569"}, {"offsetInBeginSection": 181, "offsetInEndSection": 380, "text": "Here, we describe the characterization of these extinct hominids from a new perspective, based on the development of a Neanderthal metagenomic library and its high-throughput sequencing and analysis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569"}, {"offsetInBeginSection": 381, "offsetInEndSection": 674, "text": "Several lines of evidence indicate that the 65,250 base pairs of hominid sequence so far identified in the library are of Neanderthal origin, the strongest being the ascertainment of sequence identities between Neanderthal and chimpanzee at sites where the human genomic sequence is different.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569"}, {"offsetInBeginSection": 675, "offsetInEndSection": 805, "text": "These results enabled us to calculate the human-Neanderthal divergence time based on multiple randomly distributed autosomal loci.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569"}]}, {"id": "5ac0f7b919833b0d7b000006", "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26378211", "http://www.ncbi.nlm.nih.gov/pubmed/25485923", "http://www.ncbi.nlm.nih.gov/pubmed/27082776", "http://www.ncbi.nlm.nih.gov/pubmed/28314985", "http://www.ncbi.nlm.nih.gov/pubmed/12516682", "http://www.ncbi.nlm.nih.gov/pubmed/23953907", "http://www.ncbi.nlm.nih.gov/pubmed/19351313", "http://www.ncbi.nlm.nih.gov/pubmed/28471371", "http://www.ncbi.nlm.nih.gov/pubmed/27626268", "http://www.ncbi.nlm.nih.gov/pubmed/21254900"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 101, "text": "Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 381, "offsetInEndSection": 623, "text": "Inhibition of clotting factor Xa has been evaluated as a potential target for anticoagulation therapy with the hypothesis that using target-specific therapy will alleviate some of the dosing variability observed with the vitamin K antagonist.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 624, "offsetInEndSection": 718, "text": "Three factor Xa inhibitors are currently indicated for use in nonvalvular atrial fibrillation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 719, "offsetInEndSection": 822, "text": "Similar to the vitamin K antagonist, warfarin, all of the factor Xa inhibitors are administered orally.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 823, "offsetInEndSection": 905, "text": "Rivaroxaban and edoxaban are dosed once daily while apixaban is dosed twice daily.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 1050, "offsetInEndSection": 1124, "text": "The therapeutic dose of factor Xa inhibitors vary based on renal function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 1125, "offsetInEndSection": 1282, "text": "Unlike warfarin, there are no currently available antidotes for the factor Xa inhibitors although this is an area of interest for current and future studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 1283, "offsetInEndSection": 1428, "text": "In the event of a life-threatening bleed there are established management strategies to reverse the bleeding effects of the factor Xa inhibitors.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211"}, {"offsetInBeginSection": 0, "offsetInEndSection": 70, "text": "Strategies for urgent reversal of target-specific oral anticoagulants.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25485923"}, {"offsetInBeginSection": 0, "offsetInEndSection": 326, "text": "The direct thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban and apixaban are US Food and Drug Administration (FDA)-approved target-specific oral anticoagulants (TSOACs) that have emerged onto the market for use in some indications similar to those for warfarin; in addition, edoxaban is seeking FDA approval.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25485923"}]}, {"id": "5a9da59c4e03427e73000005", "body": "What is PNPPP?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26551787", "http://www.ncbi.nlm.nih.gov/pubmed/25658120", "http://www.ncbi.nlm.nih.gov/pubmed/21747892", "http://www.ncbi.nlm.nih.gov/pubmed/24201366"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 210, "text": "OBJECTIVE: To study the impact of genetic and lifestyle factors on protein biomarkers and develop personally normalized plasma protein profiles (PNPPP) controlling for non-disease-related variance.MATERIALS AND", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787"}, {"offsetInBeginSection": 514, "offsetInEndSection": 717, "text": "CONCLUSION: PNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787"}, {"offsetInBeginSection": 1152, "offsetInEndSection": 1224, "text": "It lacked phosphomonoesterase, phosphotriesterase, and RNAse activities.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120"}, {"offsetInBeginSection": 233, "offsetInEndSection": 357, "text": "The relaxation effect of this plant was tested on phenylephrine precontracted rabbit corpus cavernosum smooth muscle (CCSM).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892"}, {"offsetInBeginSection": 654, "offsetInEndSection": 918, "text": "The extract, when tested colorimetrically for its inhibitory activities on phosphordiesterase-5 (PDE-5) in vitro towards p-nitrophenyl phenyl phosphate (PNPPP), was observed to induce significant dose-dependent inhibition of PDE-5, with an ID(50) of 0.161\u2009mg/ml (P", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892"}, {"offsetInBeginSection": 165, "offsetInEndSection": 531, "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366"}]}, {"id": "5ace20fa0340b9f05800000c", "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25501874", "http://www.ncbi.nlm.nih.gov/pubmed/20961960", "http://www.ncbi.nlm.nih.gov/pubmed/28585439", "http://www.ncbi.nlm.nih.gov/pubmed/26053282", "http://www.ncbi.nlm.nih.gov/pubmed/22503288", "http://www.ncbi.nlm.nih.gov/pubmed/20838600", "http://www.ncbi.nlm.nih.gov/pubmed/28585440", "http://www.ncbi.nlm.nih.gov/pubmed/23874230", "http://www.ncbi.nlm.nih.gov/pubmed/27501156", "http://www.ncbi.nlm.nih.gov/pubmed/23666208"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874"}, {"offsetInBeginSection": 0, "offsetInEndSection": 138, "text": "EPAS1 involves in the hypoxic response and is suggested to be responsible for the genetic adaptation of high-altitude hypoxia in Tibetans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874"}, {"offsetInBeginSection": 198, "offsetInEndSection": 404, "text": "In this study, a single nucleotide polymorphism rs56721780:G>C and an insertion/deletion (indel) polymorphism -742 indel in the promoter region showed divergence between Tibetans and non-Tibetan lowlanders.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874"}, {"offsetInBeginSection": 405, "offsetInEndSection": 568, "text": "rs56721780:G>C regulated the transcription of EPAS1 by IKAROS family zinc finger 1 (IKZF1), which was identified as a new transcriptional repressor for EPAS1 gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874"}, {"offsetInBeginSection": 838, "offsetInEndSection": 1041, "text": "Further functional analysis revealed that lysyl oxidase (LOX) gene, which was reported to be responsible for extracellular matrix protein cross-linking of amnion previously, was a direct target of EPAS1.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874"}, {"offsetInBeginSection": 0, "offsetInEndSection": 73, "text": "A genome-wide search for signals of high-altitude adaptation in Tibetans.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20961960"}, {"offsetInBeginSection": 268, "offsetInEndSection": 460, "text": "We conducted a genome-wide study of 1,000,000 genetic variants in 46 Tibetans (TBN) and 92 Han Chinese (HAN) for identifying the signals of high-altitude adaptations (HAAs) in Tibetan genomes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20961960"}, {"offsetInBeginSection": 1186, "offsetInEndSection": 1319, "text": "All of our population genomic and statistical analyses indicate that EPAS1 and EGLN1 are most likely responsible for HAA of Tibetans.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20961960"}, {"offsetInBeginSection": 1420, "offsetInEndSection": 1559, "text": "We reanalyzed the available data and found the escaped top signal (EPAS1) could be recaptured with data quality control and our approaches.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20961960"}, {"offsetInBeginSection": 0, "offsetInEndSection": 51, "text": "Tibetans are well adapted to high-altitude hypoxia.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585439"}]}, {"id": "5a74eaa50384be955100000b", "body": "What part of the body is affected by mesotheliomia?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22879850", "http://www.ncbi.nlm.nih.gov/pubmed/16163658", "http://www.ncbi.nlm.nih.gov/pubmed/17509761", "http://www.ncbi.nlm.nih.gov/pubmed/26007284", "http://www.ncbi.nlm.nih.gov/pubmed/869834", "http://www.ncbi.nlm.nih.gov/pubmed/25274322", "http://www.ncbi.nlm.nih.gov/pubmed/24531623", "http://www.ncbi.nlm.nih.gov/pubmed/16051171", "http://www.ncbi.nlm.nih.gov/pubmed/23204474", "http://www.ncbi.nlm.nih.gov/pubmed/11058423"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 131, "text": "Systemic lupus erythematosus (SLE) is a chronic, multifaceted autoimmune inflammatory disease that can affect any part of the body.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850"}, {"offsetInBeginSection": 628, "offsetInEndSection": 764, "text": "Symptoms vary from person to person, and may come and go, depend on what part of the body is affected, can be mild, moderate, or severe.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850"}, {"offsetInBeginSection": 0, "offsetInEndSection": 120, "text": "[Movement alterations following cerebrovascular damage in the intact hemisphere ipsilateral to the affected upper limb].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16163658"}, {"offsetInBeginSection": 379, "offsetInEndSection": 538, "text": "DEVELOPMENT: To review the main hypotheses which try to explain the presence of AM in the part of the body ipsilesional to the injured hemisphere of the brain.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16163658"}, {"offsetInBeginSection": 1369, "offsetInEndSection": 1616, "text": "These movements appear in the non-affected part of the body throughout cerebrovascular disease evolution, and which could be caused by maintained hypersolicitation of the unaffected part of the body and the neuroplastic process following a stroke.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16163658"}, {"offsetInBeginSection": 0, "offsetInEndSection": 93, "text": "Body perception disturbance: a contribution to pain in complex regional pain syndrome (CRPS).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761"}, {"offsetInBeginSection": 0, "offsetInEndSection": 175, "text": "In spite of pain in the CRPS limb, clinical observations show patients pay little attention to, and fail to care for, their affected limb as if it were not part of their body.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761"}, {"offsetInBeginSection": 421, "offsetInEndSection": 595, "text": "Twenty-seven participants who met the IASP CRPS classification were interviewed using qualitative methods to explore feelings and perceptions about their affected body parts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761"}, {"offsetInBeginSection": 684, "offsetInEndSection": 865, "text": "Participants revealed bizarre perceptions about a part of their body and expressed a desperate desire to amputate this part despite the prospect of further pain and functional loss.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761"}, {"offsetInBeginSection": 946, "offsetInEndSection": 1039, "text": "Anatomical parts of the CRPS limb were erased in mental representations of the affected area.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761"}]}, {"id": "5a9db99ffd02ddc336000001", "body": "Is CXCL7 a chemokine?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/20652876", "http://www.ncbi.nlm.nih.gov/pubmed/28245630", "http://www.ncbi.nlm.nih.gov/pubmed/28368308", "http://www.ncbi.nlm.nih.gov/pubmed/26233476", "http://www.ncbi.nlm.nih.gov/pubmed/18707017", "http://www.ncbi.nlm.nih.gov/pubmed/23136963", "http://www.ncbi.nlm.nih.gov/pubmed/20022386", "http://www.ncbi.nlm.nih.gov/pubmed/12193731", "http://www.ncbi.nlm.nih.gov/pubmed/29038657", "http://www.ncbi.nlm.nih.gov/pubmed/20652010"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 126, "text": "Chondrogenic differentiation of human mesenchymal stem cells in micro-masses is impaired by high doses of the chemokine CXCL7.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652876"}, {"offsetInBeginSection": 0, "offsetInEndSection": 111, "text": "Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308"}, {"offsetInBeginSection": 92, "offsetInEndSection": 240, "text": "Multiple chemokines are expressed at the site of infection; thus chemokine synergy by heterodimer formation may play a role in determining function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308"}, {"offsetInBeginSection": 241, "offsetInEndSection": 353, "text": "Chemokine function involves interactions with G-protein-coupled receptors and sulfated glycosaminoglycans (GAG).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308"}, {"offsetInBeginSection": 461, "offsetInEndSection": 802, "text": "Solution nuclear magnetic resonance (NMR) and molecular dynamics characterization of platelet-derived chemokine CXCL7 heterodimerization with chemokines CXCL1, CXCL4, and CXCL8 indicated that packing interactions promote CXCL7-CXCL1 and CXCL7-CXCL4 heterodimers, and electrostatic repulsive interactions disfavor the CXCL7-CXCL8 heterodimer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308"}, {"offsetInBeginSection": 977, "offsetInEndSection": 1171, "text": "NMR and modeling studies indicated that GAG heparin binding to the heterodimer is distinctly different from the CXCL7 monomer and that the GAG-bound heterodimer is unlikely to bind the receptor.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308"}, {"offsetInBeginSection": 90, "offsetInEndSection": 267, "text": "Levels of CXC chemokine ligand 7 (CXCL7) protein vary during tumorigenesis, and the evidence suggests that this chemokine serves as a novel biomarker of early-stage lung cancer.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26233476"}, {"offsetInBeginSection": 758, "offsetInEndSection": 882, "text": "The extent of CD4(+) T cell, CD8(+) T cell, and natural killer T cell infiltration was similar between the two tumor groups.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26233476"}, {"offsetInBeginSection": 0, "offsetInEndSection": 116, "text": "Gene expression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707017"}, {"offsetInBeginSection": 0, "offsetInEndSection": 188, "text": "A variety of chemokines has been shown to recruit human bone marrow-derived mesenchymal stem cells (MSC) and may be potential candidates for chemokine-based tissue regeneration approaches.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707017"}]}, {"id": "5ace2d600340b9f05800000e", "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25794181", "http://www.ncbi.nlm.nih.gov/pubmed/24045876", "http://www.ncbi.nlm.nih.gov/pubmed/15972726", "http://www.ncbi.nlm.nih.gov/pubmed/20876876", "http://www.ncbi.nlm.nih.gov/pubmed/26103569", "http://www.ncbi.nlm.nih.gov/pubmed/16567973", "http://www.ncbi.nlm.nih.gov/pubmed/17616515"], "snippets": [{"offsetInBeginSection": 80, "offsetInEndSection": 221, "text": "Polymorphisms in this gene have been associated with variation in skin and hair color and with elevated risk for the development of melanoma.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794181"}, {"offsetInBeginSection": 222, "offsetInEndSection": 421, "text": "Here we used 11 computational tools based on different approaches to predict the damage-associated non-synonymous single nucleotide polymorphisms (nsSNPs) in the coding region of the human MC1R gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794181"}, {"offsetInBeginSection": 628, "offsetInEndSection": 731, "text": "Alleles associated with the red hair color (RHC) phenotype and with the risk of melanoma were examined.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794181"}, {"offsetInBeginSection": 332, "offsetInEndSection": 596, "text": "By analyzing 3,142 human MC1R alleles from different regions of Spain in the context of additional haplotypic information from the 1000 Genomes (1000G) Project data, we show that purifying selection is also strong in southern Europe, but not so in northern Europe.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876"}, {"offsetInBeginSection": 684, "offsetInEndSection": 1010, "text": "Thus, at least in Spain, regions at opposite ends of the incident UV-B radiation distribution show significantly different frequencies for the melanoma-risk allele V60L (a mutation also associated to red hair and fair skin and even blonde hair), with higher frequency of V60L at those regions of lower incident UV-B radiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876"}, {"offsetInBeginSection": 0, "offsetInEndSection": 117, "text": "Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726"}, {"offsetInBeginSection": 0, "offsetInEndSection": 180, "text": "The human melanocortin-1 receptor gene (MC1R) encodes a G-protein coupled receptor that is primarily expressed on melanocytes, where it plays a key role in pigmentation regulation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726"}, {"offsetInBeginSection": 181, "offsetInEndSection": 304, "text": "Variant alleles are associated with red hair colour and fair skin, known as the RHC phenotype, as well as skin cancer risk.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726"}, {"offsetInBeginSection": 305, "offsetInEndSection": 502, "text": "The R151C, R160W and D294H alleles, designated 'R', are strongly associated with the RHC phenotype and have been proposed to result in loss of function receptors due to impaired G-protein coupling.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726"}, {"offsetInBeginSection": 1263, "offsetInEndSection": 1407, "text": "The V60L, V92M and R163Q weakly associated RHC alleles, designated 'r', were expressed with normal or intermediate cell surface receptor levels.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726"}]}, {"id": "5aae6499fcf456587200000c", "body": "What is BORSA?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28893360", "http://www.ncbi.nlm.nih.gov/pubmed/2261916", "http://www.ncbi.nlm.nih.gov/pubmed/20880412", "http://www.ncbi.nlm.nih.gov/pubmed/21337531", "http://www.ncbi.nlm.nih.gov/pubmed/15770100", "http://www.ncbi.nlm.nih.gov/pubmed/21875361", "http://www.ncbi.nlm.nih.gov/pubmed/17108271", "http://www.ncbi.nlm.nih.gov/pubmed/2069374", "http://www.ncbi.nlm.nih.gov/pubmed/26064878", "http://www.ncbi.nlm.nih.gov/pubmed/18630132"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 99, "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) - a more common problem than expected?", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360"}, {"offsetInBeginSection": 0, "offsetInEndSection": 159, "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360"}, {"offsetInBeginSection": 160, "offsetInEndSection": 301, "text": "BORSA strains show low, borderline resistance to penicillinase-resistant penicillins (PRPs), with oxacillin MICs typically equal to 1-8\u2009\u00b5g\u2009ml", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360"}, {"offsetInBeginSection": 0, "offsetInEndSection": 121, "text": "Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916"}, {"offsetInBeginSection": 0, "offsetInEndSection": 443, "text": "Eighty-eight Staphylococcus aureus clinical isolates meeting criteria for borderline oxacillin resistance (intermediate susceptibility or resistance to oxacillin but susceptibility to amoxicillin/clavulanic acid upon disk diffusion testing) were studied to determine optimal test techniques and conditions for differentiating borderline oxacillin-resistant Staphylococcus aureus (BORSA) from methicillin-resistant Staphylococcus aureus (MRSA).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916"}, {"offsetInBeginSection": 444, "offsetInEndSection": 895, "text": "Further testing revealed three distinct resistance patterns: 61 strains (69%) consistently met BORSA criteria and had average beta-lactamase levels five- to six-fold higher than oxacillin-susceptible controls; 11 strains (13%) were markedly heteroresistant MRSA with delayed appearance of resistant colonies leading to spurious susceptibility to amoxicillin/clavulanic acid; 16 strains (18%) appeared to be oxacillin-susceptible on repetitive testing.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916"}, {"offsetInBeginSection": 896, "offsetInEndSection": 1065, "text": "Under conditions used to elicit intrinsic methicillin resistance in Staphylococcus aureus, a large percentage of BORSA appeared resistant to amoxicillin/clavulanic acid.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916"}, {"offsetInBeginSection": 0, "offsetInEndSection": 138, "text": "Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412"}, {"offsetInBeginSection": 0, "offsetInEndSection": 301, "text": "Since it is unknown whether \u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/L, the in vitro bactericidal activity and pharmacodynamic effect of oxacillin against clinical BORSA isolates was evaluated.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412"}, {"offsetInBeginSection": 302, "offsetInEndSection": 521, "text": "Time-kill experiments with oxacillin were performed and the results compared with those obtained with vancomycin, daptomycin and linezolid against BORSA with oxacillin MICs \u22654 mg/L and BORSA with oxacillin MICs \u22642 mg/L.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880412"}]}, {"id": "5a9e202bde7cb99d40000002", "body": "Which method is Proseek based on?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25987887", "http://www.ncbi.nlm.nih.gov/pubmed/19040730", "http://www.ncbi.nlm.nih.gov/pubmed/28936257"], "snippets": [{"offsetInBeginSection": 677, "offsetInEndSection": 881, "text": "This study was designed to meet the longstanding unmet clinical need for earlier CRC detection by measuring plasma candidate biomarkers of cancer onset and progression in a clinical stage-specific manner.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 882, "offsetInEndSection": 1166, "text": "EDTA plasma samples (1\u00a0\u03bcL) obtained from 75 patients with Dukes' staged CRC or unaffected controls (age and sex matched with stringent inclusion/exclusion criteria) were assayed for expression of 92 human proteins employing the Proseek\u00ae Multiplex Oncology I proximity extension assay.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 1279, "offsetInEndSection": 1488, "text": "RESULTS: Similar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 1489, "offsetInEndSection": 1617, "text": "Proseek found that expression of Carcinoembryonic Antigen (CEA), IL-8 and prolactin are significantly correlated with CRC stage.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 0, "offsetInEndSection": 44, "text": "ProSeeK: a web server for MLPA probe design.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730"}, {"offsetInBeginSection": 332, "offsetInEndSection": 494, "text": "Multiplex Ligation-dependent Probe Amplification (MLPA) is a targeted method to assess copy number differences for up to 40 genomic loci in one single experiment.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730"}, {"offsetInBeginSection": 1007, "offsetInEndSection": 1118, "text": "RESULTS: We have developed a web tool for facilitating and optimising custom probe design for MLPA experiments.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730"}, {"offsetInBeginSection": 1545, "offsetInEndSection": 1673, "text": "ProSeeK will become a useful tool for all laboratories that are currently using MLPA in their research projects for CNV studies.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730"}, {"offsetInBeginSection": 0, "offsetInEndSection": 150, "text": "Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card\u2122.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 195, "offsetInEndSection": 292, "text": "This card is not recommended for protein analyses, since surface treatment may denature proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}]}, {"id": "5ace34eb0340b9f058000010", "body": "Which genes are associated with Epidermolysis Bullosa Simplex?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/9406827", "http://www.ncbi.nlm.nih.gov/pubmed/12655565", "http://www.ncbi.nlm.nih.gov/pubmed/23894602", "http://www.ncbi.nlm.nih.gov/pubmed/19797037", "http://www.ncbi.nlm.nih.gov/pubmed/11851893", "http://www.ncbi.nlm.nih.gov/pubmed/10494094", "http://www.ncbi.nlm.nih.gov/pubmed/9036937", "http://www.ncbi.nlm.nih.gov/pubmed/20199538", "http://www.ncbi.nlm.nih.gov/pubmed/25354580", "http://www.ncbi.nlm.nih.gov/pubmed/7561171"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "A novel mutation in the helix termination peptide of keratin 5 causing epidermolysis bullosa simplex Dowling-Meara.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827"}, {"offsetInBeginSection": 0, "offsetInEndSection": 137, "text": "Epidermolysis bullosa simplex Dowling-Meara (MIM# 1317600) is the most severe of the three common epidermolysis bullosa simplex subtypes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827"}, {"offsetInBeginSection": 138, "offsetInEndSection": 360, "text": "In addition to the palmoplantar distribution seen in other epidermolysis bullosa simplex subtypes, extensive herpetiform blistering spontaneously develops on the trunk and limbs and may lead to scarring or milia formation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827"}, {"offsetInBeginSection": 570, "offsetInEndSection": 670, "text": "In this study we sequenced these genes in a family with epidermolysis bullosa simplex Dowling-Meara.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827"}, {"offsetInBeginSection": 859, "offsetInEndSection": 1004, "text": "This mutation adds to those previously reported and provides further evidence of phenotype-genotype correlation in epidermolysis bullosa simplex.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827"}, {"offsetInBeginSection": 0, "offsetInEndSection": 140, "text": "Mutation analysis of the entire keratin 5 and 14 genes in patients with epidermolysis bullosa simplex and identification of novel mutations.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565"}, {"offsetInBeginSection": 0, "offsetInEndSection": 132, "text": "Epidermolysis bullosa simplex is a group of blistering skin disorders caused by defects in one of the keratin genes, KRT5 and KRT14.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565"}, {"offsetInBeginSection": 485, "offsetInEndSection": 691, "text": "In two patients, with the Koebner and the Weber-Cockayne subtypes of epidermolysis bullosa simplex respectively, we could, however, not identify any mutation in one of the hotspot domains of KRT5 and KRT14.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565"}, {"offsetInBeginSection": 927, "offsetInEndSection": 1092, "text": "For the amplification of the KRT14 genes, we make use of restriction sites to exempt the keratin 14 pseudogene sequence from polymerase chain reaction amplification.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/12655565"}, {"offsetInBeginSection": 0, "offsetInEndSection": 88, "text": "MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23894602"}]}, {"id": "5aafc37afcf4565872000010", "body": "What is the function of HDAC  proteins?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/27345839", "http://www.ncbi.nlm.nih.gov/pubmed/26927903", "http://www.ncbi.nlm.nih.gov/pubmed/17786239", "http://www.ncbi.nlm.nih.gov/pubmed/10220385", "http://www.ncbi.nlm.nih.gov/pubmed/10869435", "http://www.ncbi.nlm.nih.gov/pubmed/26232305", "http://www.ncbi.nlm.nih.gov/pubmed/22621256", "http://www.ncbi.nlm.nih.gov/pubmed/15050820", "http://www.ncbi.nlm.nih.gov/pubmed/28337317", "http://www.ncbi.nlm.nih.gov/pubmed/17227860"], "snippets": [{"offsetInBeginSection": 243, "offsetInEndSection": 406, "text": "Although the functions of HDAC proteins are becoming apparent both biochemically and clinically, how this class of proteins is regulated remains poorly understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 407, "offsetInEndSection": 485, "text": "We identified a novel interaction between nuclear actin and HDAC 1 and HDAC 2.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 486, "offsetInEndSection": 662, "text": "Nuclear actin has been previously shown to interact with a growing list of nuclear proteins including chromatin remodeling complexes, transcription factors and RNA polymerases.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 663, "offsetInEndSection": 733, "text": "We find that monomeric actin is able to bind the class I HDAC complex.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 734, "offsetInEndSection": 853, "text": "Furthermore, increasing the concentration of actin in HeLa nuclear extracts was able to suppress overall HDAC function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 854, "offsetInEndSection": 951, "text": "Conversely, polymerizing nuclear actin increased HDAC activity and decreased histone acetylation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 952, "offsetInEndSection": 1053, "text": "Moreover, the interaction between class I HDACs and nuclear actin was found to be activity dependent.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839"}, {"offsetInBeginSection": 0, "offsetInEndSection": 170, "text": "The epigenetic regulation of DNA structure and function is essential for changes in gene expression involved in development, growth, and maintenance of cellular function.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903"}, {"offsetInBeginSection": 291, "offsetInEndSection": 393, "text": "Histone deacetylase (HDAC) proteins have a major role in epigenetic regulation of chromatin structure.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903"}, {"offsetInBeginSection": 780, "offsetInEndSection": 896, "text": "Rpd3, the Drosophila HDAC1 homolog, is a class I lysine deacetylase and a member of a large family of HDAC proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26927903"}]}, {"id": "5aacd487fcf4565872000007", "body": "Which human gene encode for DNA polymerase \u03b8?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28668117", "http://www.ncbi.nlm.nih.gov/pubmed/27264557", "http://www.ncbi.nlm.nih.gov/pubmed/27657134", "http://www.ncbi.nlm.nih.gov/pubmed/28695890", "http://www.ncbi.nlm.nih.gov/pubmed/28570559", "http://www.ncbi.nlm.nih.gov/pubmed/28687761", "http://www.ncbi.nlm.nih.gov/pubmed/25775267", "http://www.ncbi.nlm.nih.gov/pubmed/24375106"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 68, "text": "Expression and Structural Analyses of Human DNA Polymerase \u03b8 (POLQ).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117"}, {"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "DNA polymerase \u03b8 (POLQ), double-strand break repair, and cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 0, "offsetInEndSection": 95, "text": "DNA polymerase theta (pol \u03b8) is encoded in the genomes of many eukaryotes, though not in fungi.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 96, "offsetInEndSection": 149, "text": "Pol \u03b8 is encoded by the POLQ gene in mammalian cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 150, "offsetInEndSection": 283, "text": "The C-terminal third of the protein is a family A DNA polymerase with additional insertion elements relative to prokaryotic homologs.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 367, "offsetInEndSection": 457, "text": "Pol \u03b8 is important in the repair of genomic double-strand breaks (DSBs) from many sources.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 698, "offsetInEndSection": 783, "text": "Pol \u03b8 participates in a route of DSB repair termed \"alternative end-joining\" (altEJ).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 875, "offsetInEndSection": 969, "text": "Pol \u03b8 is able to mediate joining of two resected 3' ends harboring DNA sequence microhomology.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 970, "offsetInEndSection": 1127, "text": "\"Signatures\" of Pol \u03b8 action during altEJ are the frequent utilization of longer microhomologies, and the insertion of additional sequences at joining sites.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}, {"offsetInBeginSection": 1128, "offsetInEndSection": 1310, "text": "The mechanism of end-joining employs the ability of Pol \u03b8 to tightly grasp a 3' terminus through unique contacts in the active site, allowing extension from minimally paired primers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557"}]}, {"id": "5ace3e3f0340b9f058000012", "body": "What is the biological role of Neddylation?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25628956", "http://www.ncbi.nlm.nih.gov/pubmed/18247557", "http://www.ncbi.nlm.nih.gov/pubmed/25918018", "http://www.ncbi.nlm.nih.gov/pubmed/27956554", "http://www.ncbi.nlm.nih.gov/pubmed/18793140", "http://www.ncbi.nlm.nih.gov/pubmed/25531226", "http://www.ncbi.nlm.nih.gov/pubmed/25742093", "http://www.ncbi.nlm.nih.gov/pubmed/29074978", "http://www.ncbi.nlm.nih.gov/pubmed/23148618", "http://www.ncbi.nlm.nih.gov/pubmed/27591266"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 49, "text": "Neddylation and deneddylation in cardiac biology.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 0, "offsetInEndSection": 123, "text": "Neddylation is a post-translational protein modification that conjugates a ubiquitin-like protein NEDD8 to target proteins.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 306, "offsetInEndSection": 396, "text": "Neddylation is countered by the action of deneddylases via a process termed deneddylation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 397, "offsetInEndSection": 678, "text": "By altering the substrate's conformation, stability, subcellular localization or binding affinity to DNA or proteins, neddylation regulates diverse cellular processes including the ubiquitin-proteasome system-mediated protein degradation, protein transcription, cell signaling etc.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 679, "offsetInEndSection": 799, "text": "Dysregulation of neddylation has been linked to cancer, neurodegenerative disorders, and more recently, cardiac disease.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 800, "offsetInEndSection": 907, "text": "Here we comprehensively overview the biochemistry, the proteome and the biological function of neddylation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 908, "offsetInEndSection": 1045, "text": "We also summarize the recent progress in revealing the physiological and pathological role of neddylation and deneddylation in the heart.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956"}, {"offsetInBeginSection": 0, "offsetInEndSection": 119, "text": "Nedd8 is a small ubiquitin-like protein that can be conjugated to substrate-proteins in a process known as neddylation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18247557"}, {"offsetInBeginSection": 120, "offsetInEndSection": 299, "text": "Although neddylation plays a critical regulatory role in cell proliferation and development, the spectrum of Nedd8 substrates and its interaction network remain poorly understood.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18247557"}, {"offsetInBeginSection": 530, "offsetInEndSection": 791, "text": "A total of 496 GST-Nedd8 modified and associated proteins have been identified, including all of the eight cullin family members (i.e., Cul-1, -2, -3, -4A, -4B, -5, -7, and Parc) that are involved in the neddylation and ubiquitin-proteasome degradation pathway.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18247557"}]}, {"id": "5ab144fefcf4565872000012", "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/24646197", "http://www.ncbi.nlm.nih.gov/pubmed/28970008", "http://www.ncbi.nlm.nih.gov/pubmed/24931166", "http://www.ncbi.nlm.nih.gov/pubmed/21140288", "http://www.ncbi.nlm.nih.gov/pubmed/18503142", "http://www.ncbi.nlm.nih.gov/pubmed/27919223", "http://www.ncbi.nlm.nih.gov/pubmed/16252251", "http://www.ncbi.nlm.nih.gov/pubmed/15708008", "http://www.ncbi.nlm.nih.gov/pubmed/8800739", "http://www.ncbi.nlm.nih.gov/pubmed/11380448"], "snippets": [{"offsetInBeginSection": 327, "offsetInEndSection": 455, "text": "We aimed to examine the effects on TRPM2 and TRPM7 gene expression of C(60)HyFn due to marked antioxidant activity in HHcy mice.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197"}, {"offsetInBeginSection": 608, "offsetInEndSection": 732, "text": "TRPM2 and TRPM7 gene expression in brains of mice were detected by real-time PCR, Western blotting and immunohistochemistry.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197"}, {"offsetInBeginSection": 1118, "offsetInEndSection": 1273, "text": "CONCLUSION: Administration of C(60)HyFn in HHcy mice significantly reduces serum homocysteine level, neuronal apoptosis and expression level of TRPM2 gene.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "The effects of hydrated C(60) fullerene on gene expression profile of TRPM2 and TRPM7 in hyperhomocysteinemic mice.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197"}, {"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}, {"offsetInBeginSection": 0, "offsetInEndSection": 161, "text": "Genetic polymorphisms in plasminogen activator inhibitor-1 gene-675 4G/5G (PAI-1 4G/5G) are claimed to contribute to an increased risk of venous thromboembolism.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}, {"offsetInBeginSection": 162, "offsetInEndSection": 265, "text": "Inherited thrombophilia, on the other hand, is associated with the occurrence of spontaneous abortions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}, {"offsetInBeginSection": 266, "offsetInEndSection": 506, "text": "The objective of this study was, to explore the significance of genetic polymorphisms of PAI-1 4G/5G with particular emphasis on 4G alleles in pregnant women suffering from venous thromboembolism or early spontaneous abortion, respectively.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}, {"offsetInBeginSection": 507, "offsetInEndSection": 663, "text": "Therefore genetic PAI-1 4G/5G polymorphisms were studied in 108 pregnant females suffering from venous thromboembolism (n=69) or from spontaneous abortion (", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142"}, {"offsetInBeginSection": 0, "offsetInEndSection": 177, "text": "TRPM2 SNP genotype previously associated with susceptibility to Rhodococcus equi pneumonia in Quarter Horse foals displays differential gene expression identified using RNA-Seq.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223"}]}, {"id": "5abd2ce0fcf456587200002a", "body": "Which are the two main bacterial phyla in human gut?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19321416", "http://www.ncbi.nlm.nih.gov/pubmed/26061054", "http://www.ncbi.nlm.nih.gov/pubmed/19553672", "http://www.ncbi.nlm.nih.gov/pubmed/23982459", "http://www.ncbi.nlm.nih.gov/pubmed/24324923", "http://www.ncbi.nlm.nih.gov/pubmed/25516615", "http://www.ncbi.nlm.nih.gov/pubmed/24522631", "http://www.ncbi.nlm.nih.gov/pubmed/25873372", "http://www.ncbi.nlm.nih.gov/pubmed/25601048", "http://www.ncbi.nlm.nih.gov/pubmed/22205877"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 100, "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 0, "offsetInEndSection": 141, "text": "The adult human distal gut microbial community is typically dominated by 2 bacterial phyla (divisions), the Firmicutes and the Bacteroidetes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 467, "offsetInEndSection": 655, "text": "Comparison of these and 25 other gut Firmicutes and Bacteroidetes indicated that the Firmicutes possess smaller genomes and a disproportionately smaller number of glycan-degrading enzymes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 656, "offsetInEndSection": 947, "text": "Germ-free mice were then colonized with E. rectale and/or a prominent human gut Bacteroidetes, Bacteroides thetaiotaomicron, followed by whole-genome transcriptional profiling, high-resolution proteomic analysis, and biochemical assays of microbial-microbial and microbial-host interactions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 1517, "offsetInEndSection": 1764, "text": "This simplified model of the human gut microbiota illustrates niche specialization and functional redundancy within members of its major bacterial phyla, and the importance of host glycans as a nutrient foundation that ensures ecosystem stability.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 298, "offsetInEndSection": 466, "text": "Finished genome sequences were generated from Eubacterium rectale and E. eligens, which belong to Clostridium Cluster XIVa, one of the most common gut Firmicute clades.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416"}, {"offsetInBeginSection": 0, "offsetInEndSection": 53, "text": "Association of the Intestinal Microbiota and Obesity.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054"}, {"offsetInBeginSection": 176, "offsetInEndSection": 236, "text": "The human gut is heavily populated with microbial organisms.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054"}, {"offsetInBeginSection": 237, "offsetInEndSection": 393, "text": "Recent evidence suggests that obesity is influenced by specific bacterial phyla present in the human gut that have increased energy harvesting capabilities.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054"}, {"offsetInBeginSection": 507, "offsetInEndSection": 682, "text": "In this review, we also discuss the differences between the phylum ratio of the gut microbiota population of obese individuals and that of individuals who have healthy weight.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054"}]}, {"id": "5ad6e431133db5eb7800000e", "body": "Which test is used for the definition of colour-blindness?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25452008", "http://www.ncbi.nlm.nih.gov/pubmed/26591383", "http://www.ncbi.nlm.nih.gov/pubmed/310055", "http://www.ncbi.nlm.nih.gov/pubmed/314267", "http://www.ncbi.nlm.nih.gov/pubmed/16431664", "http://www.ncbi.nlm.nih.gov/pubmed/22076482", "http://www.ncbi.nlm.nih.gov/pubmed/28274040", "http://www.ncbi.nlm.nih.gov/pubmed/306798", "http://www.ncbi.nlm.nih.gov/pubmed/9893853", "http://www.ncbi.nlm.nih.gov/pubmed/18942220"], "snippets": [{"offsetInBeginSection": 25, "offsetInEndSection": 84, "text": "Behavioural evidence for colour-blindness in harbour seals.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 0, "offsetInEndSection": 114, "text": "All seals and cetaceans have lost at least one of two ancestral cone classes and should therefore be colour-blind.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 115, "offsetInEndSection": 295, "text": "Nevertheless, earlier studies showed that these marine mammals can discriminate colours and a colour vision mechanism has been proposed which contrasts signals from cones and rods.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 469, "offsetInEndSection": 632, "text": "Using a psychophysical discrimination experiment, we showed that a harbour seal can solve a colour discrimination task by means of brightness discrimination alone.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 890, "offsetInEndSection": 964, "text": "This finding speaks against rod-cone-based colour vision in harbour seals.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 965, "offsetInEndSection": 1096, "text": "To test for colour-blindness, we used a cognitive approach involving a harbour seal trained to use a concept of same and different.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 1097, "offsetInEndSection": 1196, "text": "We tested this seal with pairs of isoluminant stimuli that were either same or different in colour.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 1294, "offsetInEndSection": 1382, "text": "However, the seal responded with \"same\", providing strong evidence for colour-blindness.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008"}, {"offsetInBeginSection": 0, "offsetInEndSection": 104, "text": "[Evaluation of an immunochromatographic dipstick test for the assessment of tetanus immunity in horses].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26591383"}, {"offsetInBeginSection": 162, "offsetInEndSection": 256, "text": "The Fassisi\u00ae TetaCheck is a stall-side rapid test which was developed to address these issues.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26591383"}]}, {"id": "5ab1483bfcf4565872000014", "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/26154131", "http://www.ncbi.nlm.nih.gov/pubmed/16772461", "http://www.ncbi.nlm.nih.gov/pubmed/17727851", "http://www.ncbi.nlm.nih.gov/pubmed/21846752", "http://www.ncbi.nlm.nih.gov/pubmed/15474307", "http://www.ncbi.nlm.nih.gov/pubmed/27135263", "http://www.ncbi.nlm.nih.gov/pubmed/7777329", "http://www.ncbi.nlm.nih.gov/pubmed/10640803", "http://www.ncbi.nlm.nih.gov/pubmed/25162450", "http://www.ncbi.nlm.nih.gov/pubmed/22233209"], "snippets": [{"offsetInBeginSection": 31, "offsetInEndSection": 116, "text": "A review of cat (Felis silvestris catus) cognition research past, present and future.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131"}, {"offsetInBeginSection": 0, "offsetInEndSection": 158, "text": "The domestic cat (Felis silvestris catus) has shared an intertwined existence with humans for thousands of years, living on our city streets and in our homes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131"}, {"offsetInBeginSection": 159, "offsetInEndSection": 338, "text": "Yet, little scientific research has focused on the cognition of the domestic cat, especially in comparison with human's other companion, the domestic dog (Canis lupus familiaris).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131"}, {"offsetInBeginSection": 0, "offsetInEndSection": 107, "text": "The evolutionary basis for the feeding behavior of domestic dogs (Canis familiaris) and cats (Felis catus).", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}, {"offsetInBeginSection": 0, "offsetInEndSection": 157, "text": "The dentition, sense of taste and meal patterning of domestic dogs and cats can be interpreted in terms of their descent from members of the order Carnivora.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}, {"offsetInBeginSection": 158, "offsetInEndSection": 295, "text": "The dog is typical of its genus, Canis, in its relatively unspecialized dentition, and a taste system that is rather insensitive to salt.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}, {"offsetInBeginSection": 296, "offsetInEndSection": 444, "text": "The preference of many dogs for large infrequent meals reflects the competitive feeding behavior of its pack-hunting ancestor, the wolf Canis lupus.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}, {"offsetInBeginSection": 608, "offsetInEndSection": 817, "text": "Morphologically and physiologically domestic cats are highly specialized carnivores, as indicated by their dentition, nutritional requirements, and sense of taste, which is insensitive to both salt and sugars.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}, {"offsetInBeginSection": 818, "offsetInEndSection": 1001, "text": "Their preference for several small meals each day reflects a daily pattern of multiple kills of small prey items in their ancestor, the solitary territorial predator Felis silvestris.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}, {"offsetInBeginSection": 1002, "offsetInEndSection": 1172, "text": "Although in the wild much of their food selection behavior must focus on what to hunt, rather than what to eat, cats do modify their food preferences based on experience.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461"}]}, {"id": "5abd31e0fcf456587200002c", "body": "What is ATAC-seq?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28550296", "http://www.ncbi.nlm.nih.gov/pubmed/28075484", "http://www.ncbi.nlm.nih.gov/pubmed/27903897", "http://www.ncbi.nlm.nih.gov/pubmed/29155775", "http://www.ncbi.nlm.nih.gov/pubmed/27832532", "http://www.ncbi.nlm.nih.gov/pubmed/29030848", "http://www.ncbi.nlm.nih.gov/pubmed/28723572", "http://www.ncbi.nlm.nih.gov/pubmed/29052193", "http://www.ncbi.nlm.nih.gov/pubmed/27146274", "http://www.ncbi.nlm.nih.gov/pubmed/25559105"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 59, "text": "Reducing mitochondrial reads in ATAC-seq using CRISPR/Cas9.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296"}, {"offsetInBeginSection": 0, "offsetInEndSection": 82, "text": "ATAC-seq is a high-throughput sequencing technique that identifies open chromatin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296"}, {"offsetInBeginSection": 1159, "offsetInEndSection": 1397, "text": "This strategy reduced the amount of sequencing required to call a high number of peaks, which could lead to cost reduction when performing ATAC-seq on large numbers of samples and in cell types that contain a large amount of mitochondria.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296"}, {"offsetInBeginSection": 0, "offsetInEndSection": 85, "text": "Assay for Transposase-Accessible Chromatin Using Sequencing (ATAC-seq) Data Analysis.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28075484"}, {"offsetInBeginSection": 248, "offsetInEndSection": 471, "text": "have developed a rapid method, requiring low numbers of living cells as input, for examining chromatin accessibility across the epigenome, known as the assay for transposase-accessible chromatin using sequencing (ATAC-seq).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28075484"}, {"offsetInBeginSection": 646, "offsetInEndSection": 772, "text": "In addition, a number of quality control parameters are discussed to ensure the integrity and confidence in the ATAC-seq data.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28075484"}, {"offsetInBeginSection": 0, "offsetInEndSection": 96, "text": "Combining ATAC-seq with nuclei sorting for discovery of cis-regulatory regions in plant genomes.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/27903897"}, {"offsetInBeginSection": 0, "offsetInEndSection": 168, "text": "Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-seq) is a method used for the identification of open (accessible) regions of chromatin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775"}, {"offsetInBeginSection": 631, "offsetInEndSection": 1000, "text": "ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775"}, {"offsetInBeginSection": 1001, "offsetInEndSection": 1086, "text": "We present a detailed ATAC-seq protocol optimized for human primary immune cells i.e.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775"}]}, {"id": "5abce6acfcf4565872000022", "body": "Please list 7 classes of drugs that interact with Warfarin.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19587643", "http://www.ncbi.nlm.nih.gov/pubmed/21397772"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 125, "text": "Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 0, "offsetInEndSection": 83, "text": "Interactions of warfarin with other drugs or substances can pose a serious problem.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 84, "offsetInEndSection": 388, "text": "We assessed three drug information compendia-Clinical Pharmacology, ePocrates, and Micromedex-and the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 389, "offsetInEndSection": 521, "text": "The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 611, "offsetInEndSection": 797, "text": "The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643"}, {"offsetInBeginSection": 0, "offsetInEndSection": 110, "text": "Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 0, "offsetInEndSection": 205, "text": "BACKGROUND: Because interactions with warfarin represent a serious risk to patients, drug information sources used by clinicians should contain accurate, timely, and practical drug interaction information.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 205, "offsetInEndSection": 395, "text": "OBJECTIVE: The aim of this study was to assess the information regarding warfarin interactions that is included in the official labeling of prescription products that interact with warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 1188, "offsetInEndSection": 1298, "text": "RESULTS: Of the labeling for 73 products evaluated, 62 (85%) included mention of an interaction with warfarin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}, {"offsetInBeginSection": 1400, "offsetInEndSection": 1578, "text": "Among the labels listing an interaction with warfarin, the location of the information, the terminology used, and the inclusion of evidence for the interaction was inconsistent .", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772"}]}, {"id": "5ac0aee419833b0d7b000004", "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28916391", "http://www.ncbi.nlm.nih.gov/pubmed/28049830", "http://www.ncbi.nlm.nih.gov/pubmed/28971967", "http://www.ncbi.nlm.nih.gov/pubmed/28239447", "http://www.ncbi.nlm.nih.gov/pubmed/27876396", "http://www.ncbi.nlm.nih.gov/pubmed/28383800", "http://www.ncbi.nlm.nih.gov/pubmed/27355570", "http://www.ncbi.nlm.nih.gov/pubmed/28931684", "http://www.ncbi.nlm.nih.gov/pubmed/28198446", "http://www.ncbi.nlm.nih.gov/pubmed/27647195"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 66, "text": "Zika virus structural biology and progress in vaccine development.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 0, "offsetInEndSection": 198, "text": "The growing number of zika virus (ZIKV) infections plus a 20-fold increase in neonatal microcephaly in newborns in Brazil have raised alarms in many countries regarding the threat to pregnant women.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 199, "offsetInEndSection": 312, "text": "Instances of microcephaly and central nervous system malformations continue to increase in ZIKV outbreak regions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 313, "offsetInEndSection": 426, "text": "ZIKV is a small enveloped positive-strand RNA virus belonging to the Flavivirus genus of the Flaviviridae family.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 427, "offsetInEndSection": 590, "text": "High-resolution ZIKV structures recently identified by cryo-electron microscopy indicate that the overall ZIKV structure is similar to those of other flaviviruses.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 591, "offsetInEndSection": 676, "text": "With its compact surface, ZIKV is more thermally stable than the dengue virus (DENV).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 677, "offsetInEndSection": 772, "text": "ZIKV E proteins have a characteristic \"herringbone\" structure with a single glycosylation site.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 1286, "offsetInEndSection": 1386, "text": "To date, more than 50 ZIKV vaccine candidates are now in various stages of research and development.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 1387, "offsetInEndSection": 1607, "text": "Candidate ZIKV vaccines that are currently in phase I/II clinical trials include inactivated whole viruses, recombinant measles viral vector-based vaccines, DNA and mRNA vaccines, and a mosquito salivary peptide vaccine.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}, {"offsetInBeginSection": 1974, "offsetInEndSection": 2122, "text": "Several forms of ZIKV VLPs have been reported featuring the co-expression of the prM-E, prM-E-NS1, C-prM-E, and NS2B/NS3 viral genes in human cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28916391"}]}, {"id": "5abcf0b0fcf4565872000024", "body": "What causes leishmaniasis?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/18457726", "http://www.ncbi.nlm.nih.gov/pubmed/23219435", "http://www.ncbi.nlm.nih.gov/pubmed/23286822", "http://www.ncbi.nlm.nih.gov/pubmed/15071036", "http://www.ncbi.nlm.nih.gov/pubmed/25228325", "http://www.ncbi.nlm.nih.gov/pubmed/26081889", "http://www.ncbi.nlm.nih.gov/pubmed/25988048", "http://www.ncbi.nlm.nih.gov/pubmed/2670376", "http://www.ncbi.nlm.nih.gov/pubmed/15259461", "http://www.ncbi.nlm.nih.gov/pubmed/25116660"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 72, "text": "[Primary Leishmania infantum MON-80 endonasal leishmaniasis in Tunisia].", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726"}, {"offsetInBeginSection": 81, "offsetInEndSection": 183, "text": "It causes massive mutilating and disfiguring lesions and can lead to destruction of facial structures.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726"}, {"offsetInBeginSection": 184, "offsetInEndSection": 328, "text": "In Tunisia, leishmaniasis of the mucous membranes is rare, usually developing as a complication of cutaneous leishmaniasis via direct extension.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726"}, {"offsetInBeginSection": 1054, "offsetInEndSection": 1187, "text": "DISCUSSION: There have been few reports of similar cases of primary and isolated mucosal leishmaniasis caused by Leishmania infantum.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726"}, {"offsetInBeginSection": 329, "offsetInEndSection": 413, "text": "We report the first case in Tunisia of isolated and primary nasal leishmaniasis.CASE", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726"}, {"offsetInBeginSection": 0, "offsetInEndSection": 183, "text": "Leishmaniasis is a neglected tropical disease caused by Leishmania protozoa and associated with three main clinical presentations: cutaneous, mucocutaneous and visceral leishmaniasis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435"}, {"offsetInBeginSection": 184, "offsetInEndSection": 302, "text": "Visceral leishmaniasis is the second most lethal parasitic disease after malaria and there is so far no human vaccine.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435"}, {"offsetInBeginSection": 303, "offsetInEndSection": 408, "text": "Leishmania donovani is a causative agent of visceral leishmaniasis in South East Asia and Eastern Africa.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435"}, {"offsetInBeginSection": 409, "offsetInEndSection": 520, "text": "However, in Sri Lanka, L. donovani causes mainly cutaneous leishmaniasis, while visceral leishmaniasis is rare.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435"}, {"offsetInBeginSection": 963, "offsetInEndSection": 1120, "text": "These results provide a possible rationale for the scarcity of visceral leishmaniasis in Sri Lanka and could guide leishmaniasis vaccine development efforts.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435"}]}, {"id": "5ac138aa95d0062724000001", "body": "Which is the enzymatic activity of nardilysin?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/15544571", "http://www.ncbi.nlm.nih.gov/pubmed/21801775", "http://www.ncbi.nlm.nih.gov/pubmed/19234765"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 102, "text": "Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571"}, {"offsetInBeginSection": 0, "offsetInEndSection": 117, "text": "Nardilysin (NRDc), a metallopeptidase of the M16 family, presents, in vitro, cleavage specificity for basic residues.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571"}, {"offsetInBeginSection": 202, "offsetInEndSection": 352, "text": "As a new receptor for heparin-binding EGF-like growth factor (HB-EGF), NRDc was recently shown to be involved in cellular migration and proliferation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571"}, {"offsetInBeginSection": 353, "offsetInEndSection": 499, "text": "Since for those processes its enzymatic activity is not required, it is now evident that nardilysin fulfills at least two distinct functions, i.e.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571"}, {"offsetInBeginSection": 500, "offsetInEndSection": 536, "text": "an HB-EGF modulator and a peptidase.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571"}, {"offsetInBeginSection": 0, "offsetInEndSection": 191, "text": "Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42(IP4) (centaurin \u03b1 1; ADAP1) in neuroblastoma cells.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}, {"offsetInBeginSection": 0, "offsetInEndSection": 214, "text": "The mainly neuronally expressed protein p42(IP4) (centaurin \u03b11; ADAP1), which interacts with the metalloendopeptidase nardilysin (NRD) was found to be localized in neuritic plaques in Alzheimer disease (AD) brains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}, {"offsetInBeginSection": 668, "offsetInEndSection": 745, "text": "Here, we show that p42(IP4) enhances the enzymatic activity of NRD 3-4 times.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}, {"offsetInBeginSection": 1239, "offsetInEndSection": 1418, "text": "Interestingly, SH-SY5Y cells, which we stably transfected with GFP-tagged-p42(IP4) showed an enhanced NRD protein expression already at an earlier time point after RA stimulation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775"}, {"offsetInBeginSection": 0, "offsetInEndSection": 147, "text": "Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765"}]}, {"id": "5aaef38dfcf456587200000f", "body": "Please list 10 conditions which play a role in causing atrial fibrillation.", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/19151857", "http://www.ncbi.nlm.nih.gov/pubmed/11978585", "http://www.ncbi.nlm.nih.gov/pubmed/24111315", "http://www.ncbi.nlm.nih.gov/pubmed/12781903", "http://www.ncbi.nlm.nih.gov/pubmed/7759722", "http://www.ncbi.nlm.nih.gov/pubmed/10646954", "http://www.ncbi.nlm.nih.gov/pubmed/16793213", "http://www.ncbi.nlm.nih.gov/pubmed/10535368", "http://www.ncbi.nlm.nih.gov/pubmed/10409531", "http://www.ncbi.nlm.nih.gov/pubmed/12746748"], "snippets": [{"offsetInBeginSection": 288, "offsetInEndSection": 453, "text": "Of the long list of various cardiac conditions associated with an increased risk of cardioembolic strokes, non-valvular atrial fibrillation is the most common cause.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857"}, {"offsetInBeginSection": 454, "offsetInEndSection": 618, "text": "Unsurprisingly, the stroke risk associated with these conditions is highly variable and non-homogenous, with many risk factors additive to the overall risk profile.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857"}, {"offsetInBeginSection": 619, "offsetInEndSection": 801, "text": "Treatment with vitamin K-antagonists substantially reduces the long-term complications associated with cardioembolism in some high-risk patients, for example, in atrial fibrillation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857"}, {"offsetInBeginSection": 963, "offsetInEndSection": 1161, "text": "Apart from atrial fibrillation, there is relatively limited evidence for the role of antithrombotic therapy for other cardiac conditions associated with cardioembolism and how long one should treat.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857"}, {"offsetInBeginSection": 0, "offsetInEndSection": 66, "text": "Increased atrial fibrillation mortality: United States, 1980-1998.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585"}, {"offsetInBeginSection": 0, "offsetInEndSection": 262, "text": "The authors used death certificate data to evaluate national trends in the reporting of atrial fibrillation as an underlying or contributory cause of death for groups defined by age (45 years or older), sex, and race (Black vs. White) and to examine comorbidity.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585"}, {"offsetInBeginSection": 263, "offsetInEndSection": 498, "text": "The multiple-causes mortality files from 1980 through 1998 were analyzed for decedents, with atrial fibrillation (International Classification of Diseases, Ninth Revision, code 427.3) listed as one of up to 20 conditions causing death.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585"}, {"offsetInBeginSection": 499, "offsetInEndSection": 723, "text": "The number of decedents with atrial fibrillation increased from 18,947 in 1980 to 61,946 in 1998, and the proportion with atrial fibrillation reported as the underlying cause of death rose from 8.3% in 1980 to 11.6% in 1998.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585"}, {"offsetInBeginSection": 0, "offsetInEndSection": 64, "text": "Simulating the role of anisotropy in human atrial cardioversion.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24111315"}, {"offsetInBeginSection": 134, "offsetInEndSection": 267, "text": "An established biophysical human cell model was adopted to reproduce Control and chronic atrial fibrillation (CAF) action potentials.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/24111315"}]}, {"id": "5ad3aa47133db5eb78000004", "body": "Which organ express and secretes the hormone FGF21?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22917661", "http://www.ncbi.nlm.nih.gov/pubmed/26116622", "http://www.ncbi.nlm.nih.gov/pubmed/25811804", "http://www.ncbi.nlm.nih.gov/pubmed/18467542", "http://www.ncbi.nlm.nih.gov/pubmed/26993043", "http://www.ncbi.nlm.nih.gov/pubmed/26654352", "http://www.ncbi.nlm.nih.gov/pubmed/24432989", "http://www.ncbi.nlm.nih.gov/pubmed/25215270", "http://www.ncbi.nlm.nih.gov/pubmed/28089565", "http://www.ncbi.nlm.nih.gov/pubmed/17623664"], "snippets": [{"offsetInBeginSection": 264, "offsetInEndSection": 494, "text": "The intestine is a unique organ that operates in a physiologically hypoxic environment, and is responsible for the fat absorption processes including triglyceride breakdown, re-synthesis and absorption into the portal circulation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661"}, {"offsetInBeginSection": 694, "offsetInEndSection": 799, "text": "Physical hypoxia (1% oxygen) and CoCl(2) treatment decreased both FGF21 mRNA and secreted protein levels.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661"}, {"offsetInBeginSection": 140, "offsetInEndSection": 323, "text": "Fibroblast growth factor 21 (FGF21), a hormone induced by a variety of environmental or metabolic stimuli, plays a crucial role in the adaptive response to these stressful conditions.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/26116622"}, {"offsetInBeginSection": 137, "offsetInEndSection": 231, "text": "Although the pancreas is an FGF21 target organ, its role in pancreatic islets remains obscure.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25811804"}, {"offsetInBeginSection": 0, "offsetInEndSection": 124, "text": "Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25811804"}, {"offsetInBeginSection": 0, "offsetInEndSection": 136, "text": "Fibroblast growth factor (FGF) 21 is an endocrine factor that normalizes glucose homeostasis and reduces insulin resistance in diabetes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25811804"}, {"offsetInBeginSection": 0, "offsetInEndSection": 133, "text": "Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542"}, {"offsetInBeginSection": 0, "offsetInEndSection": 98, "text": "Adipose tissue is a metabolically responsive endocrine organ that secretes a myriad of adipokines.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542"}, {"offsetInBeginSection": 99, "offsetInEndSection": 292, "text": "Antidiabetic drugs such as peroxisome proliferator-activated receptor (PPAR) gamma agonists target adipose tissue gene expression and correct hyperglycemia via whole-body insulin sensitization.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542"}, {"offsetInBeginSection": 790, "offsetInEndSection": 998, "text": "Of the 379 genes robustly regulated by two structurally distinct PPARgamma agonists in the epididymal white adipose tissue (EWAT) of db/db mice, 33 encoded for known secreted proteins, one of which was FGF21.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542"}]}, {"id": "5ad4f4f5133db5eb7800000a", "body": "What is the aim of the PhenCode database?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/25385275"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 56, "text": "VariSNP, a benchmark database for variations from dbSNP.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275"}]}, {"id": "5a9d99ac4e03427e73000002", "body": "What is measured with the Proseek panels?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/28936257", "http://www.ncbi.nlm.nih.gov/pubmed/28586402", "http://www.ncbi.nlm.nih.gov/pubmed/25987887", "http://www.ncbi.nlm.nih.gov/pubmed/28694499", "http://www.ncbi.nlm.nih.gov/pubmed/19040730", "http://www.ncbi.nlm.nih.gov/pubmed/28437237", "http://www.ncbi.nlm.nih.gov/pubmed/28948068", "http://www.ncbi.nlm.nih.gov/pubmed/28734077"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 150, "text": "Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card\u2122.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 863, "offsetInEndSection": 1038, "text": "Our results demonstrate that samples applied to the indicating FTA elute micro card\u2122 are amendable to protein analyses, given that a sensitive protein detection assay is used.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 1039, "offsetInEndSection": 1149, "text": "The results imply that biological samples applied to FTA cards can be used for DNA, RNA and protein detection.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 474, "offsetInEndSection": 654, "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 293, "offsetInEndSection": 473, "text": "We studied the ability to analyse proteins in human plasma and vaginal fluid as applied to the indicating FTA elute micro card\u2122 using the sensitive proximity extension assay (PEA).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257"}, {"offsetInBeginSection": 0, "offsetInEndSection": 115, "text": "OBJECTIVE: The present study evaluates the effect of food intake on 92 biomarkers for cardiovascular disease (CVD).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402"}, {"offsetInBeginSection": 215, "offsetInEndSection": 361, "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402"}, {"offsetInBeginSection": 361, "offsetInEndSection": 427, "text": "RESULTS: The levels for eight biomarkers decreased significantly (", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402"}, {"offsetInBeginSection": 356, "offsetInEndSection": 517, "text": "Equally, known examples of cancer protein biomarkers (e.g., PSA, CA125, CA19-9, CEA, AFP) are frequently found in plasma at very low concentration (pg/mL-ng/mL).", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}, {"offsetInBeginSection": 882, "offsetInEndSection": 1166, "text": "EDTA plasma samples (1\u00a0\u03bcL) obtained from 75 patients with Dukes' staged CRC or unaffected controls (age and sex matched with stringent inclusion/exclusion criteria) were assayed for expression of 92 human proteins employing the Proseek\u00ae Multiplex Oncology I proximity extension assay.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887"}]}, {"id": "5ad247720340b9f058000017", "body": "What is a fibrocyte?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/22043022", "http://www.ncbi.nlm.nih.gov/pubmed/22022512", "http://www.ncbi.nlm.nih.gov/pubmed/18427397", "http://www.ncbi.nlm.nih.gov/pubmed/28915889", "http://www.ncbi.nlm.nih.gov/pubmed/18025235", "http://www.ncbi.nlm.nih.gov/pubmed/24507087", "http://www.ncbi.nlm.nih.gov/pubmed/18052725", "http://www.ncbi.nlm.nih.gov/pubmed/26948996", "http://www.ncbi.nlm.nih.gov/pubmed/24822215", "http://www.ncbi.nlm.nih.gov/pubmed/22796709"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 156, "text": "Subcellular distribution and relative expression of fibrocyte markers in the CD/1 mouse cochlea assessed by semiquantitative immunogold electron microscopy.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022"}, {"offsetInBeginSection": 0, "offsetInEndSection": 196, "text": "Spiral ligament fibrocytes function in cochlear homeostasis, maintaining the endocochlear potential by participating in potassium recycling, and fibrocyte degeneration contributes to hearing loss.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022"}, {"offsetInBeginSection": 288, "offsetInEndSection": 462, "text": "Fibrocyte cultures offer one source of transplantable cells, but determining what fibrocyte types they contain and what phenotype transplanted cells may adopt is problematic.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22043022"}, {"offsetInBeginSection": 395, "offsetInEndSection": 555, "text": "FINDINGS: In this report, we show that HMWHA potentiates the differentiation of human monocytes into fibrocytes, while LMWHA inhibits fibrocyte differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 556, "offsetInEndSection": 690, "text": "Digestion of HMWHA with hyaluronidase produces small hyaluronic acid fragments, and these fragments inhibit fibrocyte differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 1012, "offsetInEndSection": 1194, "text": "The addition of anti-CD44 antibodies potentiates fibrocyte differentiation, suggesting that CD44 mediates at least some of the effect of hyaluronic acid on fibrocyte differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 1195, "offsetInEndSection": 1355, "text": "The fibrocyte differentiation-inhibiting factor serum amyloid P (SAP) inhibits HMWHA-induced fibrocyte differentiation and potentiates LMWHA-induced inhibition.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 1356, "offsetInEndSection": 1490, "text": "Conversely, LMWHA inhibits the ability of HMWHA, interleukin-4 (IL-4), or interleukin-13 (IL-13) to promote fibrocyte differentiation.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 1490, "offsetInEndSection": 1676, "text": "CONCLUSIONS: We hypothesize that hyaluronic acid signals at least in part through CD44 to regulate fibrocyte differentiation, with a dominance hierarchy of SAP>LMWHA\u2265HMWHA>IL-4 or IL-13.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}, {"offsetInBeginSection": 691, "offsetInEndSection": 871, "text": "Monocytes internalize HMWHA and LMWHA equally well, suggesting that the opposing effects on fibrocyte differentiation are not due to differential internalization of HMWHA or LMWHA.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512"}]}, {"id": "5ad255210340b9f058000018", "body": "Is lumican a secreted protein?", "documents": ["http://www.ncbi.nlm.nih.gov/pubmed/17050378", "http://www.ncbi.nlm.nih.gov/pubmed/22266188", "http://www.ncbi.nlm.nih.gov/pubmed/15466200", "http://www.ncbi.nlm.nih.gov/pubmed/23480731", "http://www.ncbi.nlm.nih.gov/pubmed/20138170", "http://www.ncbi.nlm.nih.gov/pubmed/27126993", "http://www.ncbi.nlm.nih.gov/pubmed/12381269", "http://www.ncbi.nlm.nih.gov/pubmed/21421073", "http://www.ncbi.nlm.nih.gov/pubmed/12128073", "http://www.ncbi.nlm.nih.gov/pubmed/16259954"], "snippets": [{"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378"}, {"offsetInBeginSection": 403, "offsetInEndSection": 527, "text": "The role of a keratan sulphate SLRP lumican, has recently been investigated in the growth and metastasis of several cancers.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378"}, {"offsetInBeginSection": 528, "offsetInEndSection": 816, "text": "In this study, the expression of lumican was studied in two human melanoma cell lines (WM9, M5) as well as in normal neonatal human melanocytes (HEMN) using real time PCR, western blotting with antibodies against the protein core and keratan sulfate, and treatments with specific enzymes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378"}, {"offsetInBeginSection": 817, "offsetInEndSection": 1017, "text": "Both human metastatic melanoma cell lines were found to express lumican mRNA and effectively secrete lumican in a proteoglycan form, characterized to be substituted mostly with keratan sulfate chains.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378"}, {"offsetInBeginSection": 1018, "offsetInEndSection": 1070, "text": "Lumican mRNA was not detected in normal melanocytes.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378"}, {"offsetInBeginSection": 200, "offsetInEndSection": 402, "text": "The small leucine-rich proteoglycans (SLRPs) constitute important constituents of the dermis extracellular matrix (ECM), participating in both the structural and the functional organization of the skin.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378"}, {"offsetInBeginSection": 0, "offsetInEndSection": 90, "text": "Secreted 70kDa lumican stimulates growth and inhibits invasion of human pancreatic cancer.", "beginSection": "title", "endSection": "title", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188"}, {"offsetInBeginSection": 0, "offsetInEndSection": 160, "text": "Lumican expression in the stromal tissues of pancreatic ductal adenocarcinoma (PDAC) correlates with tumor invasion, and tends to correlate with poor prognosis.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188"}, {"offsetInBeginSection": 161, "offsetInEndSection": 266, "text": "We used gene transfection techniques to examine the biological roles of lumican secreted from PDAC cells.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188"}, {"offsetInBeginSection": 267, "offsetInEndSection": 364, "text": "Lumican-transfected PANC-1 cells secreted a 70-kDa lumican protein and had an active ERK pathway.", "beginSection": "abstract", "endSection": "abstract", "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188"}]}]}